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ABSTRACT 
Directly incorporating noncanonical amino acids (NCAAs) into proteins in 
living cells is an indispensible technique for investigating structures and functions of 
proteins. This co-translational insertion of NCAAs, which is similar to post-translational 
modifications (PTM), amends proteins with new functionalities. With the idea of 
synthesizing proteins with defined modifications to generate proteins with enhanced 
properties, the first goal was to assess the capacity of codon recognition of the original 
or derivative Methanosarcina mazei pyrrolysyl (Pyl)-tRNA synthetase (PylRS)-tRNAPyl 
pair, and also expand the current NCAA-coding codons to sense or quadruplet codons. 
These systematic studies expounded on the cross recognition between nonsense or sense 
codons with various tRNAPyl anticodons in E. coli.  
One interesting result that was obtained showed that E. coli itself displays a 
relatively high opal suppression level; tryptophan (Trp) is incorporated at an opal 
mutation site. Although the PylRS-
Pyl
UCAtRNA  pair can be used to encode N
ε-tert-
butoxycarbonyl-l-lysine (BocK) at an opal codon, the pair fails to suppress the 
incorporation of Trp at the same site. For the sense and quadruplet codons, their tRNA 
did not fully deliver BocK at the AGG and AGGA codon sites when co-expressed with 
PylRS in E. coli, hence contamination by natural amino acids were spotted. 
Based on the above studies carried out, the next goal was to use the highly 
orthogonal pair, mutant PylRS-
Pyl
CUAtRNA , to genetically encode five tyrosine derivatives. 
These derivatives contain either a norbornene, trans-cyclooctene, or cyclooctyne entity 
iii 
encoded into proteins for site specific protein labeling. These NCAAs were successfully 
labeled with a fluorescein tetrazine dye and a diaryl nitrilimine both in vitro and in living 
cells. Detailed kinetic analyses of inverse electron-demand Diels–Alder cycloaddition 
and nitrilimine-alkene/alkyne 1,3-diploar cycloaddition reactions were conducted and 
the reactions were applied for rapid protein bioconjugation. When reacted with a 
tetrazine or a diaryl nitrilimine, strained alkene/alkyne entities including norbornene, 
trans-cyclooctene, and cyclooctyne displayed rapid kinetics. 
Lastly, the study of histone PTM is a crucial step in chromatin states and 
epigenetic regulations of gene expressions in all eukaryotes because of its complex 
network of possible PTM combinations which, to this day, is being deciphered. Here, the 
goal of the research is to profile different lysine sites on histones by mapping out the 
effects of epigenetic erasers such as HKDMs on the sites. Results showed catalytic 
activity of LSD1 on various lysine sites on H2A, H2B and H3 histone substrates using a 
peroxidase-coupled assay of the catalytic activity of LSD1. 
 iv 
 
DEDICATION 
 
To my dear big brother 
Abednego Amartey Ocloo-Lee 
Thank you for your love and support from the very beginning. This is also your dream 
come true! May you continue to rest in perfect peace, I love you! 
 
 
 v 
 
ACKNOWLEDGEMENTS 
 
I would like to thank my committee chair, Dr. Wenshe Liu, and my committee 
members, Dr. Batteas, Dr. Begley, Dr. Hilty, and Dr. Lockless, for their guidance and 
support throughout my graduate studies. To the faculty who have taught me a great deal 
of chemistry, to my teaching supervisors and to the staff members that have helped me 
in any way possible I say thank you! 
I also thank all my lab colleagues from the Liu research lab group for all their 
intellectual contribution and brainstorming on the various research projects I have 
worked on. Not forgetting all the wonderful friends I made while at Texas A&M 
University. Thank you for making Texas A&M home away from home; these are 
friendships I will cherish for a lifetime. 
To the various campus organizations that I have been a part of: Believers’ 
LoveWorld (BLW) Campus Ministry–TAMU, National Organization for the 
Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE), 
Ghanafuo Association-TAMU, TAMU Center for Teaching Excellence. Each 
organization gave me the opportunity to serve in different leadership roles, thank you for 
that privilege. 
To my church family, Christ Embassy-Houston and Texas Region BLW Campus 
Ministry, thank you for all your encouragement and prayers, I know without them I 
would not have accomplished all that I have been able to accomplish. 
 vi 
 
A big thank you to my loving and supportive parents, siblings and close friends 
and family who have stood there with me throughout this whole journey cheering me on 
to the finish line, I am eternally grateful.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
TABLE OF CONTENTS 
Page 
ABSTRACT .......................................................................................................................ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
TABLE OF CONTENTS .................................................................................................vii 
LIST OF FIGURES ........................................................................................................... ix 
LIST OF TABLES .......................................................................................................... xiv 
CHAPTER I  INTRODUCTION AND LITERATURE REVIEW ................................... 1 
Protein Biosynthesis ................................................................................................... 1 
Protein Post-translational Modification ...................................................................... 3 
Discovery of Two New Amino Acids ........................................................................ 4 
Selenocysteine Incorporation System ........................................................................ 6 
Pyrrolysine Incorporation System .............................................................................. 9 
Synthesis of NCAAs into Proteins ........................................................................... 16 
Genetic Code Expansion Tool .................................................................................. 17 
Genetic Incorporation of NCAAs ............................................................................. 17 
CHAPTER II  ALTERNATIVE CODON STUDY FOR GENETIC CODE 
EXPANSION IN ESCHERICHIA COLI ....................................................................... 21 
Introduction .............................................................................................................. 21 
Experimental Section ............................................................................................... 25 
Results and Discussion ............................................................................................. 41 
Conclusion ................................................................................................................ 70 
CHAPTER III  RAPID CATALYST-FREE CLICK REACTIONS FOR IN VIVO 
PROTEIN LABELING MEDIATED BY GENETICALLY ENCODED STRAIN-
PROMOTED ALKENE/ALKYNE FUNCTIONALITIES ............................................ 72 
Introduction .............................................................................................................. 72 
Experimental Section ............................................................................................... 74 
 viii 
 
Page 
Results and Discussion ........................................................................................... 101 
Conclusion .............................................................................................................. 118 
CHAPTER IV  DEMETHYLASE: SUBSTRATE SPECIFICITY ANALYSIS ON 
HISTONE PROTEINS ................................................................................................... 119 
Introduction ............................................................................................................ 119 
Experimental Section ............................................................................................. 126 
Results and Discussion ........................................................................................... 142 
Conclusion .............................................................................................................. 146 
CHAPTER V  CONCLUDING REMARKS AND FUTURE OUTLOOK .................. 148 
REFERENCES ............................................................................................................... 151 
 ix 
 
LIST OF FIGURES 
Page 
Figure I-1. The standard genetic code. ............................................................................... 2 
Figure I-2. Lysine post-translational modifications on proteins. ....................................... 5 
Figure I-3. Structure of Selenocysteine and Pyrrolysine. ................................................... 6 
Figure I-4. Sec-tRNASec biosynthesis in bacteria. .............................................................. 8 
Figure I-5. Sec-tRNASec biosynthesis in eukaryotes. ....................................................... 10 
Figure I-6. The pyrrolysine incorporation machinery. ..................................................... 11 
Figure I-7. Biosynthetic pathway of Pyrrolysine. ............................................................ 12 
Figure I-8. The active site of PylRS. Structure obtained from PDB entry: 2Q7E ........... 14 
Figure I-9. Pyrrolysine and its analogs activated PylRS. ................................................. 15 
Figure I-10. Amino acid derivatives incorporated by PylRS-tRNACUAPyl. ................... 19 
Figure II-1. Structures of NCAAs incorporated. .............................................................. 22 
Figure II-2. Suppression of amber, opal, and ochre mutations at N134 of sfGFP by 
their corresponding PylRS-tRNAPyl pairs in the absence and presence of 
BocK. (A) Proteins shown in the gel represent their real relative sfGFP 
expression levels. Lanes 1 and 2 were transformed with pETtrio-
PylT(CUA)-PylRS-sfGFP134TAG; lanes 3 and 4 were transformed 
with pETtrio-PylT(UUA)-PylRS-sfGFP134TAA; lanes 5 and 6 were 
transformed with pETtrio-PylT(UCA)-PylRS-sfGFP134TGA. ESI-MS 
spectra of sfGFP expressed in cells (B1) transformed with pETtrio-
PylT(CUA)-PylRSsfGFP134TAG and grown in the presence of 5 mM 
BocK, (B2) transformed with pETtrio-PylT(UUA)-PylRS-
sfGFP134TAA and grown in the presence of 5 mM BocK, (B3) 
transformed with pETtrio-PylT(UCA)-PylRS-sfGFP134TGA and 
grown in the absence of BocK, and (B4) transformed with 
pETtrioPylT(UCA)-PylRS-sfGFP134TGA and grown in the presence of 
5 mM BocK. ..................................................................................................... 43 
 
 
 x 
 
Page 
Figure II-3. Suppression of an opal mutation at S2 of sfGFP by the PylRS-
tRNAPyl UCA pair. (A) Expression of sfGFP with an opal mutation. 
Lanes 1 and 2 were transformed with pETtrio-pylT(UCA)-
sfGFP134TGA and grown in the absence or presence of 5 mM BocK; 
lanes 3 and 4 were transformed with pETtrio-pylT(UCA)-sfGFP2TGA 
and grown in the absence or presence of 5 mM BocK. Each protein 
shown in the gel represents their real relative expression levels. ESI-MS 
of sfGFP expressed in cells transformed with pETtrio-pylT(UCA)-
sfGFP2TGA and grown in the (B1) absence or (B2) presence of 5 mM 
BocK. ................................................................................................................ 44 
Figure II-4. Suppression of an opal mutation at N134 of sfGFP at different 
conditions. (A) Proteins shown in the gel represent their real relative 
expression levels. Lane 1 was transformed with pET-sfGFP134TGA; 
lanes 2 and 3 were transformed with pET-pylT(UCA)-sfGFP134TGA 
and grown in the absence or presence of 5 mM BocK. (B) ESI-MS of 
sfGFP expressed in cells transformed with pETtrio-sfGFP134TGA. .............. 46 
Figure II-5. Suppression of an opal mutation at N134 of sfGFP by different 
tRNAPyl UCA variants. (A) Proteins shown in the gel represent their real 
relative expression levels. Lanes 1 and 2 were transformed with 
pETtrio-pylT(UCA)G73C-sfGFP134TGA and grown in the absence or 
presence of 5 mM BocK; lanes 3 and 4 were transformed with pETtrio-
pylT(UCA)G73A-sfGFP134TGA and grown in the absence or presence 
of 5 mM BocK; lanes 5 and 6 were transformed with pETtrio-
pylT(UCA)G73U sfGFP134TGA and grown in the absence or presence 
of 5 mM BocK; lanes 7 and 8 were transformed with pETtrio-
pylT(UCA)-sfGFP134TGA and grown in the absence or presence of 5 
mM BocK. The ESI-MS analysis of sfGFP expressed in cells 
transformed with pETtrio-pylT(UCA)G73U-sfGFP134TGA and grown 
in the (B1) absence or (B2) presence of 5 mM BocK. ..................................... 47 
Figure II-6. In vitro aminoacylation of tRNAPyl variants by M. mazei PylRS with 
BocK or Nε-cyclopentyloxycarbonyl-L-lysine (Cyc). An additional spot 
(representing <5% of total radiolabel) between the aa-AMP and AMP is 
an unidentified possibly degraded reaction product, often seen in 
aminoacylation assays. ..................................................................................... 49 
Figure II-7. In vitro aminoacylation of tRNAPyl variants and tRNATrp by E. coli 
TrpRS with Trp. ................................................................................................ 50 
 
 xi 
 
Page 
Figure II-8. Cross recognitions between different anticodons of tRNAPyl and 
nonsense mutations at N134 of sfGFP. Cells were transformed with 
pETtrio-PylT(NNN)-PylRS-sfGFP134N’N’N’ and grown in the 
presence of 5 mM BocK (NNN and N’N’N’ denote anticodons and 
codons specified in the figure). Proteins shown in the gel represent their 
real relative expression levels. .......................................................................... 51 
Figure II-9. Expression of sfGFP in cells transformed with pETtrio-PylT(UUA)-
PylRS-sfGFP134TAG. (A) Cells grown in 2YT medium supplemented 
without or with BocK. ESI-MS of sfGFP expressed in the (B1) absence 
or (B2) presence of 5 mM BocK. ..................................................................... 53 
Figure II-10. Expression of sfGFP in cells transformed with pETtrio-PylT(UUA)-
PylRS-sfGFP134TAG and pEVOL-AzFRS. (A)Cells were grown in 
2YT medium supplemented with different combinations of NCAAs. 
ESI-MS of sfGFP expressed in the(B1) absence of both AzF and BocK; 
(B2) presence of 1 mM AzF; (B3) presence of 5 mM BocK; and (B4) 
presence of both 1 mM AzF and 5 mM BocK.................................................. 55 
Figure II-11. Quadruplet codon AGGA encodes arginine in vivo in E. coli. (A) 
Protein produced by BL21(DE3) cells transformed with pETtrio-
pylT(UCCU)-sfGFP134AGGA, grown with or without BocK. (B) ESI-
MS of sfGFP produced by cells grown with (B) or without (C) BocK. ........... 57 
Figure II-12. In vitro aminoacylation of tRNAPyl quadruplet (UCCU) anticodon 
by M. mazei PylRS with BocK or Cyc. ............................................................ 58 
Figure II-13. In vitro aminoacylation of tRNAPyl variants and tRNAArg by E. coli 
ArgRS. .............................................................................................................. 59 
Figure II-14. Suppression of an AGG mutation at S2 of sfGFP by tRNAPyl CCU. 
(A) Expression of sfGFP in cells transformed with pETtrio-pylT(CCU)-
sfGFP2AGG and grown in the absence or presence of 5 mM BocK. (B) 
The ESI-MS analysis of sfGFP expressed in the presence of 5 mM 
BocK. ................................................................................................................ 62 
Figure II-15. ESI-MS spectra of GFPUV variants expressed in different NCAA 
conditions. (10 mm; (A) BocK (B) AllocK and (C) ProK). ............................. 63 
Figure II-16. Labeling of GFPUV expressed in the absence and in the presence of 
ProK. ................................................................................................................. 65 
 
 xii 
 
Page 
Figure III-1. Structure of a (A) Fluorescein Tetrazine Dye (FITC-TZ) (B) 
Hydrozonoyl Chloride, HZCL. ......................................................................... 99 
Figure III-2. Structures of four strain-promoted alkene/alkyne molecules. ................... 101 
Figure III-3. Characterization of FITC reactions with (A) NOR, (B) DS1, (C) 
DS2, and (D) COY. All reactions were carried out in the PBS buffer at 
pH 7.4. The fluorescence emission was detected at 515 nm with the 
excitation light at 493 nm. For A-D, each presents the fluorescence 
change as a function of time at a given condition shown in the top left 
corner. The insets show the linear dependence of pseudo-first-order rate 
constants of a reaction on dienophile concentrations. .................................... 106 
Figure III-4. Characterization of HZCL reactions with (A) DS1, (B) DS2, and (C) 
COY. All reactions were carried out in PBS/acetonitrile (1:1) at pH 7.4. 
HZCL was provided at 1 μM. The fluorescence emission was detected 
at 480 nm with excitation at 318 nm. The detected at 480 nm with 
excitation at 318 nm. The insets show the linear dependence of the 
pseudo-first-order rate constants on the dipolarophile concentrations. .......... 107 
Figure III-5. Structures of O-alkylated tyrosine derivatives that contain strain-
promoted alkene/alkyne functionalities. ......................................................... 111 
Figure III-6. Site-specific incorporation of five NCAAs that contain strain-
promoted alkene/alkyne functionalities into sfGFP at its S2 position. 
Proteins were expressed in E. coil BL21 cells transformed with pEVOL-
pylT-Y306A/N346A/C348A and pET-pylT-sfGFP2TAG. Cells were 
grown in LB medium supplemented with 2 mM of a NCAA for 8 hours. 
Supplementing LB with 2 mM of 3 or 7 did not yield sfGFP expression 
increase. Therefore, data for these two NCAAs are not presented. ................ 113 
Figure III-7. Selective labeling of sfGFP proteins incorporated with strain-
promoted alkene/alkyne functionalities with (A) FITC-TZ and (B) 
HZCL. In A and B, top panels show denaturing SDS-PAGE analysis of 
proteins stained with Coomassie blue and the bottom panels are from 
fluorescent imaging of the same gels before Coomassie blue staining. In 
A, the fluorescent image was captured by a digital camera and displayed 
was real color of the emitting light. In B, the fluorescent image was 
captured by a Bio-Rad ChemiDoc XRS system. ............................................ 115 
 
 
 xiii 
 
Page 
Figure III-8. Selective labeling of sfGFPs that contained site-specifically 
incorporated NCAAs with strained alkene/alkyne functionalities with 
(A) FITC-TZ and (B) HZCL in E. coli cells. Cells were labeled with 
FITC-TZ and HZCL for 3 hours and then washed with PBS buffer 3 
times before undertaking epifluorescent and differential interface 
contrast (DIC) imaging. .................................................................................. 117 
Figure IV-1. Several Nε-amine lysine modification on H2A and H2B histone 
proteins. .......................................................................................................... 121 
Figure IV-2. Structures of mono-, di-, tri-methyl-L-lysines and compound 1 for 
M1K synthesis. ............................................................................................... 122 
Figure IV-3. Reduction of compound 1 with E. coli nitroreductase to recover 
M1K. ............................................................................................................... 125 
Figure IV-4. Ampliflu Red fluorescence mediated LSD1 demethylase assay used 
to detect generation of hydrogen peroxide to test the activity of LSD1 
on different Lys sites on each histone protein. ............................................... 141 
Figure IV-5. Incorporation of MNCK into sfGFP. (A) SDS-PAGE and western 
blot analysis shows the incorporation of MNCK by NCKRS-tRNACUA. 
Lane 1 contains no added NCAA, lane 2 is expressed wild-type of 
sfGFP, and lane 3 has MNCK incorporated. (B) ESI-MS of sfGFP 
incorporated with MNCK but has been converted to M1K. ........................... 143 
Figure IV-6. Incorporation of MNCK into Histone H3 at various Lys sites. (A) 
SDS-PAGE analysis shows the incorporation of MNCK by the mutant 
NCKRS-tRNACUA. Each lane represents the Lys sites which MNCK 
incorporated. (B) SDS-PAGE ad western blot analysis of MNCK 
incorporation at H3K4. ................................................................................... 144 
Figure IV-7. Incorporation of MNCK into Histone H2A and H2B Lys sites 
respectively. SDS-PAGE analysis shows the incorporation of MNCK by 
the mutant NCKRS-tRNACUA. ....................................................................... 145 
Figure IV-8. Ampliflu Red based fluorescence studies on LSD1 demethylase 
assay on (A) mono-methyl-H3K4 peptide (B) di-methyl-H3K4 peptide. ...... 147 
 
 xiv 
 
LIST OF TABLES 
 Page 
Table II-1. Plateau aminoacylation levels. ....................................................................... 51 
Table III-1. Second-order rate constants of reactions of strain-promoted 
alkene/alkyne dienophiles with FITC-TZ. ...................................................... 103 
Table III-2. Second-order rate constants of reactions between strain-promoted 
alkene/alkyne dipolarphiles and HZCL. ......................................................... 109 
Table III-3. Detected and theoretical molecular weights (MWs) of sfGFP proteins 
with different NCAAs incorporated at the S2 position. ................................. 114 
Table IV-1 Primer sequences of Lys site mutations on H2A. ........................................ 135 
Table IV-2. Primer sequences of Lys site mutations on H2B. ....................................... 136 
 
 
 
 1 
 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Protein Biosynthesis 
Protein biosynthesis that involves 20 canonical amino acids is a well-established 
system in living organisms. This occurs when the amino acid sequence in a protein is 
translated from its corresponding nucleotide sequence in mRNA. For every amino acid, 
a nucleotide triplet in mRNA known as the codon, codes for the amino acid. Several 
amino acids use more than one codon for their coding which results in 61 triplet codons 
being use to code for 20 canonical amino acids (Figure I-1). The other 3 triplet codons 
code for the protein translation termination, making it a total of 64 codons for the protein 
biosynthesis.1 
For protein biosynthesis, translation occurs when an aminoacyl-tRNA synthetase 
(aaRS) acylates its cognate tRNA with an amino acid by esterification. Each aaRS is 
characterized under two classes based on their binding patterns when acylating their 
respective tRNAs. Class I aaRSs interact with their tRNA acceptors from the tRNA 
minor grove while class II enzymes associates with their tRNA acceptors from the major 
groove.2 Of the 20 amino acids, methionine, valine, isoleucine, cysteine, glutamate, 
leucine, lysine, arginine, tryptophan and tyrosine all belong to class I and the rest of the 
20 amino acids belong to class II. To acylate the tRNA, the amino acid must first be 
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Figure I-1. The standard genetic code. 
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activated by ATP to produce the aminoacyl-AMP. In the case of class I aaRSs, the 
amino acid acylation occurs at the 2’ OH of the ribose of the last nucleotide (A76) of 
tRNAs while for class II aaRSs the acylation occurs at the 3’ OH.3 This occurs because 
the aaRS possesses an ATP binding site, amino acid activation site, and tRNA binding 
domain.2 
After acylation, the tRNA is transferred to the ribosome where protein synthesis 
actually takes place. The ribosome which carries out the translation has two main units 
which differs in prokaryotes and eukaryotes. Over at the ribosome site, the anticodons 
matches with their complementary codons through base-pairing. This shows that the 
tRNA has two distinct ends; one binds to its corresponding amino acid and the other end 
binds to its matched mRNA codon. Through the base-pairing of a particular anticodon 
with its successive codon, the amino acid is linked together to extend the growing 
peptide chain. 
Protein Post-translational Modification 
As previously mentioned, there are 20 canonical amino acids that form the 
building blocks of proteins. It is in the specific sequence of the amino acids that allows 
the protein to fold in a particular three-dimensional shape to carry out several cellular 
processes such as DNA replication, transcription, translation, metabolism etc. Many of 
these proteins require additional modifications on their amino acids via a process called 
post-translational modification (PTM) to carry out their native functions in the cells. 
Many of these modifications occur covalently on the side chains of the amino acids. The 
distinct functional groups on the amino acids gives it the name noncanonical amino acids 
 4 
 
(NCAAs). These modifications include acetylation, methylation, phosphorylation, 
sulfation, glycosylation, hydroxylation, lipidation, ubiquitination etc on amino acids 
such as lysine, arginine, tyrosine etc (Figure I-2). These modifications expand the 
functions of the protein such as regulating signal transduction, controlling gene 
expression etc.  
Discovery of Two New Amino Acids 
Aside the known 20 amino acids, two other amino acids have been found: 
selenocysteine and pyrrolysine (Figure I-3).  Selenocysteine (Sec) is the 21st amino acid 
found in 1976 in Clostridium stricklandii glycine reductase where Stadtman and her 
group found out that the selenium moiety on the clostridial glycine reductase 
selenoprotein is in fact from a Sec residue.4 Sec is structurally similar to cysteine (Cys) 
with the exception of selenium instead of the sulfur group in cysteine. Its pKa (5.47) is 
lower than Cys.  On the other hand, the 22nd amino acid, Pyrrolysine (Pyl), was 
discovered in 2002 in methylamine methyltransferase in Methanosarcina barkeri.5, 6 
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Figure I-2. Lysine post-translational modifications on proteins. 
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Selenocysteine Incorporation System 
Selenium is a well-known trace element essential for cell growth and 
development but can be toxic to cells when in high dosage. It is a part of the glutathione 
cycle which is shown to detoxify free radicals by activating the key enzyme, glutathione 
peroxidase to protect against oxidative damage.7, 8 The first sequence of selenoprotein 
sparked a great interest in Sec which is found in the catalytic site of glutathione 
peroxidase.9 Earlier research demonstrated that Sec was incorporated post-translationally 
but a decade after, results showed that it was actually found to be co-translationally 
incorporated into proteins by using an in-frame UGA opal stop codon.10, 11  
Selenoprotein biosynthesis is now known to occur in all three domains of life: 
eukaryotes, prokaryotes, and archaea.12, 13 
 
 
 
 
 
 
 
  
Figure I-3. Structure of Selenocysteine and Pyrrolysine. 
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Sec has its own tRNA, Selenocysteinyl tRNA (tRNASec), but lacks its own aaRS. 
The tRNASec is used to synthesis selenocysteine-containing proteins in bacteria. This 
occurs indirectly when SelC gene encodes tRNASec followed by aminoacylation of a 
non-cognate amino acid, L-serine, by a class II aaRS, seryl-tRNA synthetase (SerRS),  
on the tRNASec.14 The Seryl- tRNASec is then converted to Sec-tRNASec using 
selenocysteine synthase (SelA), a PLP-dependent enzyme.15  
Selenium activated by one ATP molecule is obtained from selenophosphate 
synthase (SelD) to produce selenophosphate.16, 17 To avoid translational termination at 
the UGA opal stop codon, a specific elongation factor, selB, is required.18 
Selenocysteine insertion sequence (SECIS), cis -acting mRNA element which possesses 
a stem-loop structure lies just downstream from the UGA opal stop codon.19 This 
element leads the cell to translate the opal stop codon as selenocysteines (Figure I-4).13, 
20 
Unlike the biosynthesis of Sec-tRNASec in bacteria, the Ser-tRNASec in archaea 
and eukaryotes is phosphorylated by O-phosphorylseryl-tRNASec kinase (PstK) to form 
Sep-tRNASec after the tRNASec has been first aminoacylated with Ser.21-23 Sep-
tRNA:Sec-tRNA synthase (SepSecS), a PLP dependent enzyme, modifies the O-
phosphoserine (Sep) to Sec on the tRNA (Figure I-5).23, 24 Compared to the bacteria, 
eukaryotes also require the SECIS element for the UGA opal stop codon to incorporate 
Sec instead of terminate the protein. The difference between them is the location of the 
SECIS. In eukaryotes, it is located at the 3` untranslated region of the mRNA.25 The 
distance between the UGA opal stop codon and this element is naturally variable 
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between 500 and 5300 nucleotides. Due to the distance, a special elongation factor 
(EFSec) and a SECIS-binding protein (SBP2) form a complex to facilitate the binding of 
SECIS with Sec-tRNASec for the correct recognition of an UGA opal codon in mRNA 
for eukaryotes.26, 27 In archaea, for the Sec-tRNASec to be recognized by the UGA opal 
stop codon, SelB must be present to assist SECIS in that process.28-30 
 
 
 
Figure I-4. Sec-tRNASec biosynthesis in bacteria. 
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Pyrrolysine Incorporation System 
Two possible routes were proposed for the biosynthesis of the Pyl. One route is 
by post-translational modification occurring on a Lys and the other route is co-
translationally incorporate Pyl. Studies showed that Pyl is actually co-translationally 
inserted by its own pyrrolysyl-tRNA, tRNAPyl (pylT) and its own pyrrolysyl-tRNA 
synthetase (PylRS) which is a class II aminoacyl-tRNA synthetase. Pyl is coded by a 
UAG amber stop codon in the open reading frame of monomethylamine 
methyltransferase (MtmB) in Methanosarcina barkeri, methane producing species that 
does not prevent translation of the full-length protein (Figure I-6). 5, 31, 32 Others have 
been discovered in six archaeal genomes which belong to the Methanosarcinaceae 
family: Methanosarcina acetivorans, Methanosarcina mazei, the cold-adapted 
Methanococcoides burtonii, halophilic methanogens Methanohalobium evestigatum, 
Methanohalophilus mahii, and Methanosalsum zhilinae.33 
In bacteria, the PylRS and pylT is found in the class of Clostridia: 
Desulfitobacterium hafniense, Desulfotomaculum acetoxidans, Acetohalobium 
arabaticum, Thermincola sp. JR; and the δ- proteobacteria Bilophila wadsworthia and 
metagenomeidentified δ-proteobacterial symbiont of gutless worm Olavius 
algarvensis.32-34  
For M. barkeri, the pylT gene is among a gene cluster (pylT, PylRS, pylB, pylC, 
pylD) to synthesize Pyl.32 The pylT varies but the similarities include the three-base 
variable loop, small D-loop, long anticodon stem etc.32 The genes coding for pylRS was  
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Figure I-5. Sec-tRNASec biosynthesis in eukaryotes. 
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Figure I-6. The pyrrolysine incorporation machinery. 
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found to be in two domains: C-terminal (PylRSc) which is the catalytic domain of the 
PylRS and N-terminal (PylRSn). PylRSc is highly conserved in different 
Methanosarcina strains unlike the N-terminal domains which vary in length.35, 36 The 
catalytic core has a unique fold structure with typical β sheets mixed with α helices 
which forms a binding for ATP. 3 The synthesis of the Pyl amino acid include the 
conversion of lysine to 3 –methylornithine by the SAM-dependent enzyme, pylB. 
Another lysine is added on by pylC, then pylD promotes the oxidation to yield Pyl37 
(Figure I-7). 
 
 
 
Figure I-7. Biosynthetic pathway of Pyrrolysine. 
 
 
  
 13 
 
Studies showed that for the crystal structure of M. mazei PylRS, Pyl was present 
in the active site, where its side chain is bound to the deep hydrophobic binding pocket 
(A302, L305, Y306, L309, N346, C348, and W417). The pocket provides a bulky cavity 
to house the long side chain. The side chain was determined to be a (4R,5R)-4-methyl-
pyrroline-5- caboxylate, with the carboxylate in the amide linkage to the Lys side chain. 
The hydroxyl group of Tyr384 forms a hydrogen bond with nitrogen of the pyrrole 
ring.6, 36, 38 Another interaction involves of the hydrogen bonding between the nitrogen 
of Asn346 and the Pyl side chain oxygen.37 From the above interaction between the 
PylRS and Pyl, it shows the hydrophobic interactions between the binding pocket and 
the pyrroline region. NCAA substrates similar to Pyl containing large hydrophobic side 
chains may fit the binding pocket due to the bulky cavity of PylRS (Figure I-8). 
Aside the non-specific hydrophobic interactions with other PylRS substrates, 
PylRS does not possess an editing domain as compared to other aaRS. Editing domains 
provides high translation fidelity by preventing misacylation of its tRNAs. The lack of 
an editing domain in PylRS makes it promiscuous and allows misacylated tRNAPyl 
possible to incorporate the linked NCAA at the UAG amber stop codon.  
Polycarpo et al. demonstrated that Nε-cyclopentyloxycarbonyl-L-lysine (Cyc), 
Nε-D-prolyl-L-lysine (D-prolyl-lysine) are charged with PylRS but cannot recognize 
lysine. This gave insight on the structure-activity relationship between Pyl and its 
synthetase, PylRS. The pyrrolysine ring on Pyl plays a crucial role during its activation 
by PylRS. For instance, the Pyl analog D-prolyl-lysine was recognized by PylRS but not 
in the case of analogLL-prolyl-lysine because of the C-5 stereocenter on the pyrrolysine 
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ring.39, 40 Additionally, Li et al. also used different Pyl analogs to determine the 
interactions necessary for recognition of PylRS substrates. These analogs include 2-
amino-6-((R)-tetrahydro-furan-2-carboxamido) hexanoic acid (2-Thf-lys), and 2-amino-
6-(cyclopentanecarboxamino)hexanoic acid (Cpn-lys)41 (Figure I-9). 
Not only does PylRS show low selectivity towards the side chain of the Pyl, it 
also has low selectivity towards the tRNA anticodon meaning the anticodon region has 
no direct interactions with PylRS. The PylRS has a unique tRNA-binding domain, a 
special C-terminal, tail, a loop region etc. Mutating the anticodon on the pylT does not 
affect the aminoacylation by the PylRS.  
                 
Figure I-8. The active site of PylRS. Structure obtained from PDB entry: 2Q7E 
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Figure I-9. Pyrrolysine and its analogs activated PylRS. 
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Synthesis of NCAAs into Proteins 
As previously mentioned, many proteins require additional modifications to 
provide their native functions that goes beyond the 20 amino acids.42 These covalent 
modifications such as acetylation, methylation, and phosphorylation occurs on the side 
chain of the amino acid. Due to the mixture of these modifications, it is a challenge to 
study their function. A homogeneous protein with specific modification(s) is needed to 
understand the function of a particular PTM in cellular activities. Several approaches 
such as cysteine-mediated native chemical ligation and expression protein ligation have 
been used to install several NCAAs into proteins.43, 44 Though these methods have been 
successfully used to incorporate NCAAs, there are a few drawbacks associated with the 
methods. For instance, the semi synthetic techniques is limited to in vitro studies and 
cannot be applied to in vivo. Considering the fact that many proteins have over 100 
residues, it is not feasible to synthesize these using the solid phase peptide synthesis 
because of the tedious process and low yield.45 
Proteins bearing special chemical groups such as alkenes, alkynes, hydrazine 
groups are also a huge focus in research because of its protein labeling properties under 
physiological conditions via click-chemistry, copper-catalyzed azide-alkyne 
cycloaddition to study protein functions such as protein folding, protein-protein 
interactions etc.46-50 Our group has attempted to build proteins with unique 
functionalities for biophysical and biochemical studies by genetically incorporating the 
NCAAs into proteins in vivo using the PylRS-tRNAPyl pair. 
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Genetic Code Expansion Tool 
To genetically incorporate NCAAs into proteins, one of the factors that needs to 
be addressed is the orthogonality of the aaRS-tRNA pair. To consider a pair as 
orthogonal, the pair must not cross-interact with the endogeneous aaRS-tRNA pair. The 
tRNA should not be recognized by any endogenous aaRS or decode any codon except 
one corresponding to its anticodon and assigned to its amino acid. Also, the aaRS should 
not acylate any endogenous tRNA except its orthogonal tRNA with the amino acid 
associated.  
The  archaea PylRS-tRNAPyl pair is orthogonal in both bacterial and eukaryotic 
cells hence evolving the pair is made possible.38 Over a decade, the wild-type and 
evolved PylRS-tRNAPyl pair have used the UAG amber stop codon to site specifically 
incorporate a variety of NCAAs into proteins in different cells Escherichia coli (E. coli), 
Saccharomyces cerevisiae, mammalian cells etc. As of now over 100 different NCAAs 
with the natural PTMs and unique biofunctionalities such as ketone, strained alkene and 
alkyne, azide, hydroxylamine, aldehydes, phenylhalides, etc have been incorporated into 
the proteins.32, 51, 52 
Genetic Incorporation of NCAAs 
 Several aaRS-tRNA system have been successfully used to genetically 
incorporate NCAAs into proteins. A suppressor tRNATyr and mutant tyrosyl-tRNA 
synthetase (TyrRS) pair from E. coli was evolved to incorporate 3-iodo-l-tyrosine into 
proteins in mammalian cells.53 Another TyrRS-tRNATyr from Methanococcus 
jannaschii TyrRS-tRNATyr incorporated  O-methyl-l-tyrosine.54 Yeast suppressor 
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tRNAPhe and phenylalanyl-tRNA synthetase incorporates p-fluoro-phenylalanine in E. 
coli.55 B. subtilis TrpRS-tRNATrp pair has been used to selectively introduce 5- 
hydroxytryptophan (5-HTTP) into proteins in 293T cells.56 For all the mentioned aaRS-
tRNA pair, there was no recognition between the aaRS and the endogeneous  tRNAs, 
while the endogeneous aaRSs did not recognize the suppressor tRNA.57 
Now the use of the PylRS-tRNAPyl has gained great attention because of its 
orthogonality in diverse species. The main requirement is that the pair found in bacteria 
should be orthogonal to the pairs in archaea and eukaryotes. In the case of the PylRS-
tRNAPyl pair, it is orthogonal in both E. coli and eukaryotes making it a great tool for 
genetic code expansion. For example, in 2008,  Yokoyama’s group developed a site-
specific incorporation of L-lysine derivatives such as  Nε-acetyllysine (AcK), Nε-tert-
butyloxycarbonyl-L-lysine (BocK), Nε-benzyloxycarbonyl-L-lysine (ZK) into proteins in 
mammalian cells.58 Pyrroline-carboxy-lysine (Pcl), a demethylated form of pyrrolysine 
was incorporated into the proteins in both E. coli and in mammalian cells using the 
native PylRS-tRNAPyl pair.59 A cyclic pyrrolysine Nε -(((1R,2R)-2-
azidocyclopentyloxy)carbonyl)-L-lysine (ACPK) was also incorporated into protein 
using an evolved mutant PylRS-tRNAPyl pair.60 Another evolved mutant pair was 
specific for the Nε-photocaged lysine analogue, o-nitrobenzyloxycarbonyl-Nε-l-lysine 
(ONBK).61 With the ability to evolve the PylRS to specifically recognize specific NCAA 
by using selection occurs in the active site where the active site residues are randomly 
mutated to determine which evolved pair can take a particular NCAA. There has been 
more diversity in NCAAs because of the use wild-type or mutant PylRS. As of now, 
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over a number of 100 different kinds of amino acids has been found in the proteins due 
to the PTM processes that occur covalently (Figure I-10). 
 
 
Figure I-10. Amino acid derivatives incorporated by PylRS-tRNACUA
Pyl
. 
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For the research projects discussed in this writing, the PylRS-tRNAPyl pair for 
incorporation of diverse NCAAs into proteins in E.coli was utilized. Alternative codons 
were explored (ochre, opal, rare and even four base codons) and reassigned because of 
the non-interaction between PylRS and its tRNA anticodon.62, 63 With the explored 
alternative codons, dual labeling can be set up to use two different aaRS-tRNA pair to 
incorporate two distinctive NCAAs for protein labeling to study protein folding or 
dynamics via Förster resonance energy transfer (FRET) studies.  
Another work discussed here is a detailed kinetic analyses of inverse electron-
demand Diels–Alder cycloaddition and nitrilimine-alkene/alkyne 1,3-diploar 
cycloaddition reactions conducted when a tetrazine or a diaryl nitrilimine is reacted with 
strained alkene/alkyne entities including norbornene, trans-cyclooctene, and cyclooctyne 
to display rapid kinetics. These unique strained alkyne and alkyne functionalities were 
incorporated using a mutant PylRS.48 Lastly, the synthesis of histones with post-
translational lysine methylation for probing substrate specificities of histone 
demethylases are shown. 
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CHAPTER II  
ALTERNATIVE CODON STUDY FOR GENETIC CODE EXPANSION IN 
ESCHERICHIA COLI* 
 
Introduction 
Pyrrolysine (Pyl, Figure II-1), the 22nd proteinogenic amino acid originally 
discovered in methanogenic methylamine methyltransferase, was genetically encoded by 
the RNA nucleotide triplet UAG, a stop codon that halts translation of mRNA during a 
regular protein translation process6. The delivery of Pyl to ribosome was mediated by a 
unique tRNA, 
Pyl
CUAtRNA , that is specifically aminoacylated by a unique aminoacyl-tRNA 
synthetase (aaRS), pyrrolysyl-tRNA synthetase (PylRS)32 (Figure I-7).  
Pyl
CUAtRNA  contains a special nucleotide triplet CUA, an anticodon that recognizes 
a UAG stop codon in mRNA. Unlike tRNASec that needs a special elongation factor 
(SelB in E. coli and EFsec in mammalian cells) and an mRNA secondary structure for its 
binding to the ribosome A site and recognition of a UGA stop codon for the delivery of 
selenocysteine, 
Pyl
CUAtRNA  hijacks the regular translation elongation process to suppress a 
UAG codon for the incorporation of Pyl64-66.  
 
*Reprinted from “Nonsense and sense suppression abilities of original and derivative 
methanosarcina mazei pyrrolysyl-tRNA synthetase-tRNApyl pairs in the Escherichia 
coli BL21(De3) cell strain”, Odoi, K. A., Huang, Y., Rezenom, Y. H., Liu, W.R. 
PLoS ONE. 2013. 8, e57035. Copyright 2013, with permission from PLOS. 
I performed all experiments except protein labeling of GFPuv with ProK. 
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Figure II-1. Structures of NCAAs incorporated. 
. 
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Previous studies also demonstrated that PylRS shows remarkably high substrate 
promiscuity charges 
Pyl
CUAtRNA  with a variety of noncanonical amino acids (NCAAs). For 
these reasons and due to the naturally high orthogonality of the PylRS-
Pyl
CUAtRNA  pair in 
bacteria, yeast, and mammalian cells, this pair has been directly transferred to E. coli, 
Saccharomyces cerevisiae, and human cells for the genetic incorporation of more than 
ten lysine derivatives including Nε-tert-butoxycarbonyl-L-lysine (BocK) into proteins at 
amber mutation sites67-73. 
Engineered PylRS-
Pyl
CUAtRNA  pairs have also been used to genetically encode 
other lysine derivatives and even phenylalanine derivatives that are structurally 
distinctive from Pyl74-82. The genetic incorporation of these NCAAs into proteins and 
their following modifications allow a variety of biochemistry studies such as the 
functional investigation of protein post-translational modifications, protein folding 
dynamic analysis, biosensor development, tracking signal transduction processes, and 
probing enzyme mechanisms83. Pioneered by Schultz and coworkers on the 
incorporation of two different NCAAs84, two methods were recently developed 
independently in the Chin Group and our group that couple the wild-type or a derivative 
PylRS-tRNAPyl pair with another suppressing aaRS-tRNA pair for the genetic 
incorporation of two different NCAAs into one protein in E. coli85, 86 
The method developed in the Chin Group used one amber codon and one 
quadruple AGGA codon that were suppressed by the PylRS-
Pyl
CUAtRNA  pair and an 
evolved M. jannaschii tyrosyl-tRNA synthetase MjTyrRS-
Tyr
UCCUtRNA  pair, respectively to 
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code two different NCAAs. A specially engineered ribosome, Ribo-Q1, was used to 
improve the AGGA suppression level. Our method relied on the suppression of two stop 
codons, namely one amber UAG codon and one ochre UAA codon, which was achieved 
by genetically encoding an evolved MjTyrRS-
Tyr
CUAtRNA  pair for amber suppression and a 
wild type or evolved PylRS-
Pyl
UUAtRNA  pair for ochre suppression in E. coli. The genetic 
incorporation of two different NCAAs into one protein can be potentially applied to 
install a FRET pair in a protein for conformation and dynamic studies as demonstrated in 
a separate publication in our lab87. The synthesized proteins with two different post-
translational modifications can also be used for functional investigation, building phage-
displayed peptide libraries with the expanded chemical diversities.  
Although the PylRS-
Pyl
CUAtRNA  pair has been used extensively for the genetic 
incorporation of different NCAAs in the past few years, two questions related to the pair 
have not been fully addressed. While our lab and other groups have showed that 
mutating the anticodon of PylRS-
Pyl
CUAtRNA   does not significantly affect its interaction 
with the catalytic domain of PylRS88, further investigation need to be done to determine 
whether the mutant tRNAPyl forms can be directly used for the genetic incorporation of 
NCAAs at an opal or ochre codon or even a quadruplet codon or a sense codon in E. 
coli. Another study is necessary to clarify whether an aminoacylated 
Pyl
UUAtRNA  can lead 
to amber suppression since a UUA anticodon can recognize a UAG codon based on the 
wobble hypothesis89. In this study, two questions were addressed and all the experiments 
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were carried out in E. coli BL21(DE3) cell strain which has been broadly used for the 
genetic incorporation of NCAAs. 
Experimental Section 
Materials 
Phusion high-fidelity DNA polymerase, T4 DNA ligase, T4 polynucleotide kinase, 
and restriction enzymes were purchased from New England Biolabs. Oligonucleotide 
primers were ordered from Integrated DNA Technologies. Ni-NTA superflow resins 
were purchased from Qiagen. All polymerase chain reactions (PCRs) were performed 
using Phusion high-fidelity DNA polymerase. BocK was purchased from Chem Impex. 
p-Azido-L-phenylalanine (AzF) (Figure II-1) was synthesized according to a revised 
literature procedure90. 
DNA and Protein Sequences 
DNA Sequence: pylT 
ggaaacctgatcatgtagatcgaatggactctaaatccgttcagccgggttagattcccggggtttccgcca 
DNA Sequence: sfGFP wild type (different mutation sites are indicated in red) 
Atggttagcaaaggtgaagaactgtttaccggcgttgtgccgattctggtggaactggatggtgatgtgaatggccataaattta
gcgttcgtggcgaaggcgaaggtgatgcgaccaacggtaaactgaccctgaaatttatttgcaccaccggtaaactgccggttc
cgtggccgaccctggtgaccaccctgacctatggcgttcagtgctttagccgctatccggatcatatgaaacgccatgatttcttt
aaaagcgcgatgccggaaggctatgtgcaggaacgtaccattagcttcaaagatgatggcacctataaaacccgtgcggaagt
taaatttgaaggcgataccctggtgaaccgcattgaactgaaaggtattgattttaaagaagatggcaacattctgggtcataaac
tggaatataatttcaacagccataatgtgtatattaccgccgataaacagaaaaatggcatcaaagcgaactttaaaatccgtcac
aacgtggaagatggtagcgtgcagctggcggatcattatcagcagaataccccgattggtgatggcccggtgctgctgccgga
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taatcattatctgagcacccagagcgttctgagcaaagatccgaatgaaaaacgtgatcatatggtgctgctggaatttgttaccg
ccgcgggcattacccacggtatggatgaactgtataaaggcagccaccatcatcatcaccattga 
 
Protein Sequence: sfGFP wild type (different mutation sites are indicated in red) 
MVSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKL
PVPWPTLVTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTY
KTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGI
KANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKR
DHMVLLEFVTAAGITHGMDELYKGSHHHHHH 
 
DNA Sequence: GFPuv149AGG 
atgagtaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaattttctgtca
gtggagagggtgaaggtgatgcaacatacggaaaacttacccttaaatttatttgcactactggaaaactacctgttccatggcca
acacttgtcactactttctcttatggtgttcaatgcttttcccgttatccggatcacatgaaacggcatgactttttcaagagtgccatg
cccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaactacaagacgcgtgctgaagtcaagtttgaaggt
gatacccttgttaatcgtatcgagttaaaaggtattgattttaaagaagatggaaacattctcggacacaaactcgagtacaactat
aactcacacagggtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaacattgaagat
ggatccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaaccattacctgtc
gacacaatctgccctttcgaaagatcccaacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggattacac
atggcatggatgaactctacaaagagctccatcaccatcaccatcactaa 
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Protein Sequence: GFPuv149AGG 
MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLP
VPWPTLVTTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGNYK
TRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGI
KANFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKR
DHMVLLEFVTAAGITHGMDELYKELHHHHHH 
 
DNA Sequence: Methanosarcina mazei PylRS 
atggataaaaaaccactaaacactctgatatctgcaaccgggctctggatgtccaggaccggaacaattcataaaataaaacac
cacgaagtctctcgaagcaaaatctatattgaaatggcatgcggagaccaccttgttgtaaacaactccaggagcagcaggact
gcaagagcgctcaggcaccacaaatacaggaagacctgcaaacgctgcagggtttcggatgaggatctcaataagttcctcac
aaaggcaaacgaagaccagacaagcgtaaaagtcaaggtcgtttctgcccctaccagaacgaaaaaggcaatgccaaaatcc
gttgcgagagccccgaaacctcttgagaatacagaagcggcacaggctcaaccttctggatctaaattttcacctgcgataccg
gtttccacccaagagtcagtttctgtcccggcatctgtttcaacatcaatatcaagcatttctacaggagcaactgcatccgcactg
gtaaaagggaatacgaaccccattacatccatgtctgcccctgttcaggcaagtgcccccgcacttacgaagagccagactga
caggcttgaagtcctgttaaacccaaaagatgagatttccctgaattccggcaagcctttcagggagcttgagtccgaattgctct
ctcgcagaaaaaaagacctgcagcagatctacgcggaagaaagggagaattatctggggaaactcgagcgtgaaattaccag
gttctttgtggacaggggttttctggaaataaaatccccgatcctgatccctcttgagtatatcgaaaggatgggcattgataatgat
accgaactttcaaaacagatcttcagggttgacaagaacttctgcctgagacccatgcttgctccaaacctttacaactacctgcg
caagcttgacagggccctgcctgatccaataaaaatttttgaaataggcccatgctacagaaaagagtccgacggcaaagaac
acctcgaagagtttaccatgctgaacttctgccagatgggatcgggatgcacacgggaaaatcttgaaagcataattacggactt
cctgaaccacctgggaattgatttcaagatcgtaggcgattcctgcatggtctatggggatacccttgatgtaatgcacggagac
ctggaactttcctctgcagtagtcggacccataccgcttgaccgggaatggggtattgataaaccctggataggggcaggtttc
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gggctcgaacgccttctaaaggttaaacacgactttaaaaatatcaagagagctgcaaggtccgagtcttactataacgggattt
ctaccaacctgtaa 
 
Protein Sequence: Methanosarcina mazei PylRS 
MDKKPLNTLISATGLWMSRTGTIHKIKHHEVSRSKIYIEMACGDHLVVNNSRSS
RTARALRHHKYRKTCKRCRVSDEDLNKFLTKANEDQTSVKVKVVSAPTRTKK
AMPKSVARAPKPLENTEAAQAQPSGSKFSPAIPVSTQESVSVPASVSTSISSISTG
ATASALVKGNTNPITSMSAPVQASAPALTKSQTDRLEVLLNPKDEISLNSGKPFR
ELESELLSRRKKDLQQIYAEERENYLGKLEREITRFFVDRGFLEIKSPILIPLEYIER
MGIDNDTELSKQIFRVDKNFCLRPMLAPNLYNYLRKLDRALPDPIKIFEIGPCYR
KESDGKEHLEEFTMLNFCQMGSGCTRENLESIITDFLNHLGIDFKIVGDSCMVYG
DTLDVMHGDLELSSAVVGPIPLDREWGIDKPWIGAGFGLERLLKVKHDFKNIKR
AARSESYYNGISTNL 
 
DNA Sequence:  Methanosarcina barkeri PylRS 
atggataagaagccactggatgttctgatttccgctactggtctgtggatgtctcgcactggtactctgcacaagatcaaacacca
cgaagtatctcgctccaagatctacattgaaatggcttgtggtgatcacctggttgttaacaactcccgctcttgtcgcaccgctcg
tgcgtttcgccaccacaaatatcgtaaaacctgcaaacgctgccgcgtgagcgatgaggatattaacaacttcctgactcgctcc
accgagagcaagaactctgtgaaagttcgcgtagtttctgctccgaaagttaagaaagctatgccgaagtctgttagccgtgctc
cgaaaccgctggagaactctgtgtccgcgaaagcgagcaccaacaccagccgttctgttccgtctccagcgaaatctactccg
aactctagcgtgccagcttccgctccagcgccgtctctgacccgctcccagctggaccgtgtagaggctctgctgtctccagaa
gataagatcagcctgaacatggcgaaaccatttcgtgagctggagccggagctggtgacccgccgcaagaacgacttccagc
gtctgtacaccaacgaccgcgaagactacctgggcaaactggaacgcgacatcaccaaattcttcgtagatcgtggtttcctgg
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agatcaaaagcccgatcctgatcccggccgaatatgtggaacgcatgggcatcaacaacgacactgagctgtctaaacaaatc
ttccgcgtagataagaacctgtgtctgcgtccgatgctggcgccgaccctgtataactacctgcgcaaactggaccgcatcctg
ccgggtccaatcaaaatcttcgaagttggtccgtgctatcgtaaagaaagcgatggtaaagagcatctggaagagttcactatgg
taaacttctgccagatgggttctggttgcacccgtgaaaacctggaggcgctgatcaaggaatttctggattatctggaaatcgac
tttgagattgtgggcgactcttgcatggtgtacggtgacactctggacattatgcatggtgatctggagctgtcttctgctgtagtg
ggcccagtttccctggatcgtgagtggggtatcgataaaccgtggattggtgcgggcttcggcctggagcgtctgctgaaagtg
atgcatggctttaagaacatcaaacgtgctagccgtagcgagtcttattacaatggcatctccactaacctgtaa 
 
Protein Sequence: Methanosarcina barkeri PylRS 
MDKKPLDVLISATGLWMSRTGTLHKIKHHEVSRSKIYIEMACGDHLVVNNSRSC
RTARAFRHHKYRKTCKRCRVSDEDINNFLTRSTESKNSVKVRVVSAPKVKKAM
PKSVSRAPKPLENSVSAKASTNTSRSVPSPAKSTPNSSVPASAPAPSLTRSQLDRV
EALLSPEDKISLNMAKPFRELEPELVTRRKNDFQRLYTNDREDYLGKLERDITKF
FVDRGFLEIKSPILIPAEYVERMGINNDTELSKQIFRVDKNLCLRPMLAPTLYNYL
RKLDRILPGPIKIFEVGPCYRKESDGKEHLEEFTMVNFCQMGSGCTRENLEALIK
EFLDYLEIDFEIVGDSCMVYGDTLDIMHGDLELSSAVVGPVSLDREWGIDKPWI
GAGFGLERLLKVMHGFKNIKRASRSESYYNGISTNL 
Construction of Plasmids 
Construction of pETtrio-pylT-sfGFP with amber mutation 
Plasmid pETtrio-pylT(UUA)-PylRS-MCS was derived from pPylRS-pylT-
GFP1TAG149TAA91 and carries a gene (a C34U mutant form of  ) under 
control of the lpp promoter and the rrnC terminator, the wild type Methanosarcina mazei 
tRNA
CUA
Pyl
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PylRS gene under control of the glnS promoter and terminator, and multiple cloning 
sites including NcoI, NotI, SalI and KpnI targeted sites under control of the T7 promoter 
and terminator. To construct pETtrio-pylT(UUA)-PylRS-MCS, two oligonucleotide 
primers forward primer MCS-F 5’-
AGCGCGGCCGCGTCGACGGTACCCTCGAGTCTGGTAAAG-3’ and reverse 
primer MCS-R 5’- ATTGCGGCCGCCCATGGTATATCTCCTTCTTATACTTAAC-3’ 
were used to undergo PCR to amplify pPylRS-pylT-GFP1TAG149TAA. The blunt-end 
PCR product was phosphorylated at its two 5’ ends and directly ligated using T4 DNA 
ligase to form pETtrio-pylT(UUA)-PylRS-MCS 
Plasmid pETtrio-pylT(UUA)-PylRS-sfGFP134TAG that carries an additional 
superfolder green fluorescent protein (sfGFP) gene with an amber mutation at N134 
(sfGFP134TAG) was constructed by cloning the sfGFP134TAG gene to the NcoI and 
KpnI sites of pETtrio-pylT(UUA)-PylRS-MCS. The sfGFP134TAG gene was PCR 
amplified from pBAD-sfGFP134TAG using two oligonucleotide primers 
sfGFP134TAG-F 5’- GATATACCATGGTTAGCAAAGGTGAAGAACTG-3’ and 
sfGFP134TAG-R 5’- CTCGAGGGTACCTCAATGGTGATGATGATGGTG-3’. The 
PCR for the sfGFP134TAG gene amplification was carried out in the following 
conditions: 10 µL of 5X Phusion buffer, 1 µl of 10 mM dNTP mix, 0.5 µL of each 
primer (sfGFP134TAG-F and sfGFP134TAG-R), 0.5 µL of template (pBAD-
sfGFPN134TAG), 0.4 µL Phusion polymerase, and 37 µL of water to get 50 µL total 
volume. The cycling conditions are as follows: (Step 1) 94 ºC – 5 minutes, (Step 2) 95 
ºC – 30 seconds, (Step 3) 50 ºC – 30 seconds, (Step 4) 72 ºC – 60 seconds, (Step 5) 
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Repeat Step 2, 29 times, Step 6) 72 ºC – 5 minutes. 1% agarose gel electrophoresis was 
used to confirm the sfGFP gene. QIAquick gel extraction kit was used to extract and 
clean the PCR product. The amplified gene was digested by NcoI and KpnI restriction 
enzymes and ligated to pETtrio-pylT(UUA)-PylRS-MCS that was predigested by the 
same enzymes. 
 
Construction of pETtrio-pylT-sfGFP with Variant Codon and Anticodon Mutation 
Three plasmids pETtrio-pylT(CUA)-PylRS-sfGFP134TAG, pETtrio-
pylT(UUA)-PylRS-sfGFP134TAA, and pETtrio-pylT(UCA)-PylRS-sfGFP134TGA that 
vary at the anticodon of tRNAPyl and have different nonsense mutations at N134 of the 
sfGFP gene with a C-terminal 6×His tag were derived from pETtrio-pylT(UUA)-PylRS-
sfGFP134TAG. Constructions of these plasmids were carried out using a site-directed 
mutagenesis protocol that was based on Phusion DNA polymerase. In brief, two 
oligonucleotide primers, one of which covers the mutation site were used to amplify the 
whole plasmid of pETtrio-pylT(UUA)-PylRS-sfGFP134TAG to give a blunt-end PCR 
product. This PCR product was phosphorylated by T4 polynucleotide kinase and then 
self-ligated using T4 DNA ligase.  
Plasmid pETtrio-pylT(CUA)-PylRS-sfGFP134TAG carries genes coding 
Pyl
CUAtRNA , PylRS, and sfGFP134TAG; plasmid pETtrio-pylT(UUA)-PylRS-
sfGFP134TAA carries genes coding
Pyl
UUAtRNA , PylRS, and sfGFP with an ochre mutation 
at N134 (sfGFP134TAA); and plasmid pETtrio-pylT(UCA)-PylRS-sfGFP134TGA 
carries genes coding
Pyl
UCAtRNA , PylRS, and sfGFP with an opal mutation at N134 
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(sfGFP134TGA). Plasmid pETtrio-pylT(CUA)-PylRS-sfGFP134TAA that carries genes 
coding
Pyl
CUAtRNA , PylRS, and sfGFP134TAA was derived from plasmid pETtrio-
pylT(UUA)-PylRS-sfGFP134TAA. Primers pylT-F 5’- 
GTCCATTCGATCTACATGATCAGGTT-3’ and pylT-TAG-R 5’- 
TCTAAATCCGTTCAGCCGGGTTAG-3’ were used to construct pETtrio-pylT(CUA)-
PylRS-sfGFP134TAG. Primers sfGFP134-F 5’- GGCAACATTCTGCATAAACTGGA-
3’ and sfGFP134TAA-R 5’- TTATTCTTTAAAATCAATACCTTTCAGTTCAATGC-
3’ were used to construct pETtrio-pylT(UUA)-PylRS-sfGFP134TAA Two set of 
primers: (1) pylT-F 5’- GTCCATTCGATCTACATGATCAGGTT-3’ and pylT-TGA-R 
5’- TTCAAATCCGTTCAGCCGGGTTAG-3’and (2) sfGFP134-F 5’- 
GGCAACATTCTGCATAAACTGGA-3’ and sfGFP134TGA-R 5’-
TCATTCTTTAAAATCAATACCTTTCAGTTCAATGC-3’ were used to run two 
consecutive site-directed mutagenesis reactions to obtain plasmid pETtrio-pylT(UCA)-
PylRS-sfGFP134TGA The pylT(UCA) gene sequence was confirmed using the primer 
PylT-SphI-F 5’-GGAATGGTGCATGCTCGAACTTTT-3’. Plasmid pETtrio-
pylT(CUA)-PylRS-sfGFP134TAA was made from plasmid pETtrio-pylT(UUA)-PylRS-
sfGFP134TAA by the same site-directed mutagenesis using two primers pylT-F 5’- 
GTCCATTCGATCTACATGATCAGGTT-3’  and pylT-TAG-R 5’- 
TCTAAATCCGTTCAGCCGGGTTAG-3.  Duet-F 5’-
TTGTACACGGCCGCATAATC-3’) was used to confirm each mutation at the 134 
position on sfGFP gene. 
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Construction of pETtrio-sfGFP with Opal Codon Mutation 
Plasmid pETtrio-sfGFP134TGA was derived from pETtrio-pylT(UCA)-PylRS-
sfGFP134TGA by digesting it with SphI to remove the 
Pyl
UCAtRNA  gene and parts of the 
PylRS gene and self-ligating the purified digested plasmid backbone. Plasmid pETtrio-
pylT(UCA)-PylRS-sfGFP2TGA carries genes coding
Pyl
UCAtRNA , PylRS, and sfGFP with 
an opal mutation at S2 and a 6×His tag at its C-terminus (sfGFP2TGA). To construct 
this plasmid, the sfGFP2TGA gene was used to replace the sfGFP134TGA gene in 
pETtrio-pylT(UCA)-PylRS-sfGFP134TGA. the sfGFP gene in pBAD-sfGFP was PCR 
amplified using primers sfGFP2TGA-F 5’- AAAGGTGAAGAACTGTTTACCGGCGT-
3’ and sfGFP2TGA-R 5’- TCAAACCATGGTATATCTCCTTCTTAT-3’.  
The PCR product was digested by NcoI and KpnI restriction enzymes and cloned 
into the same two sites of pETtrio-pylT(UCA)-PylRS-sfGFP134TGA which was precut 
by NcoI and KpnI restriction enzymes to remove the sfGFP134TGA insert. The 
sfGFP2TGA gene sequence was confirmed using the sfGFP134TAG-R 5’-
CTCGAGGGTACCTCAATGGTGATGATGATGGTG-3’ 
 
Construction of pETtrio-pylT-sfGFP with Quadruplet Codon and Anticodon Mutation 
Plasmid pETtrio-pylT(UCCU)-PylRS-sfGFP134AGGA was constructed from 
pETtrio-pylT(CUA)-PylRS-sfGFP134TAG.  
 
Construction of pETtrio-pylT-sfGFP with Sense Codon and Anticodon Mutation 
Plasmid pETtrio-pylT(CCU)-PylRS-sfGFP2AGG was constructed from pETtrio-
pylT(CUA)-PylRS-sfGFP2TGA using two consecutive Phusion DNA polymerase-based 
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site directed mutagenesis steps. Primers pylT-F 5’- 
GTCCATTCGATCTACATGATCAGGTT-3’ and pylT-AGG-R 5’- 
TCTTAATCCGTTCAGCCGGGTTAG -3’ were used to construct the CCU anticodon 
on the pylT sfGFP2AGG-F 5’- AAAGGTGAAGAACTGTTTACCGGCGT-3’ and 
sfGFP2AGG-R 5’- 
CCTAACCATGGTATATCTCCTTCTTATACTTAACTAATATACTAAG -3’ were 
used to construct the AGG codon on the sfGFP at the S2 position.  
 
Construction of pETDuet-mbPylRS-pylT(CCU)-GFPuv149AGG 
Further studies were performed by Dr. Yu Zeng from my research group to make 
PylRS-
Pyl
CUAtRNA  competitively recognize AGG during translation to incorporate NCAA 
such as BocK, AllocK and ProK (Figure II-1). pETDuet-mbPylRS-pylTCCU-
GFPuv149AGG was derived from pETDuet–AcKRS–pylTCUA-GFP149TAG which 
contains a pylT(CCU) gene under control of the lpp promoter and the rrnC terminator, 
the codon optimized Methanosarcina barkeri (M.barkeri) PylRS gene and GFPuv gene 
with an AGG mutation at position 149, both are under control of the T7 promoter and 
terminator. The standard QuikChange site-directed mutagenesis was used to generate 
PstI and AgeI restriction sites of pETDuet-AcKRS-pylTCUA-GFP149TAG (pDUET-
pstI-QC-F, 5’-CTGTAACTGCAGGTCGACAAGCTTGCGGCC-3’ and pDUETAgeI-
QC-R, 5’-TGACATACCGGTGGTATATCTCCTTCTTAAAGTTAAAC-3’), then 
ligated with optimized M.barkeri PylRS (mbpylRS-AgeI-F, 5’-
CTGTAAACCGGTATGGATAAGAAGCCACTGGATGTTC-3’ and mbpylRS-PstI-R, 
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5’-GTCGACCTGCAGTTACAGGTTAGTGGAGATGCCATTG-3’ with corresponding 
restrictive sites to generate pETDuet -mbPylRS- pylT(CUA)-GFPUV149TAG first.  
The resulting plasmid then underwent the second QuikChange site-directed 
mutagenesis to mutate the TAG codon at position 149 of GFPuv to the AGG codon 
(GFPuv-AGG-QC-F, 5’-AGGGTATACATCACGGCAGACAAACAA-3’ and GFPuv-
AGG-QC-R, 5’-GTGTGA GTTATAGTTGTACTCGAGTT-3’). And PylT(CUA) was 
replaced by PylT(CCU) from SphI sites of pETtrio-pylT(CCU)-PylRS-sfGFP2AGG.92 
 
Construction of pETtrio-sfGFP with Variant 
Pyl
UCAtRNA Mutation on G73 
Three plasmids pETtrio-pylT(UCA)G73C-PylRS-sfGFP134TGA, pETtrio-
pylT(UCA)G73U-PylRS-sfGFP134TGA, and pETtrio-pylT(UCA)G73A-PylRS-
sfGFP134TGA carry mutations that change G73 of 
Pyl
UCAtRNA to C, U, and A, 
respectively. These plasmids were derived from pETtrio-pylT(UCA)-PylRS-
sfGFP134TGA using Phusion DNA polymerase-based site-directed mutagenesis. To 
make pETtrio-pylT(UCA)G73C-PylRS-sfGFP134TGA, two primers pylT-G73-F 5’- 
GGAAACCCCGGGAATCTAACCCGG-3’ and pylT-G73C-R 5’- 
CCCACTGCCCATCCTTAGCGAAAGC-3’ were employed. Primers pylT-G73-F 5’- 
GGAAACCCCGGGAATCTAACCCGG-3’and pylT-G73U-R 5’- 
TCCACTGCCCATCCTTAGCGAAAGC-3’ were used to construct pETtrio-
pylT(UCA)G73U-PylRS-sfGFP134TGA. Primers pylT-G73-F 5’- 
GGAAACCCCGGGAATCTAACCCGG-3’and pylT-G73A-R 5’- 
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ACCACTGCCCATCCTTAGCGAAAGC -3’ were used to construct pETtrio-
pylT(UCA)G73A-PylRS-sfGFP134TGA.  
sfGFP Protein Expression and Purification 
Amber, Opal, and Ochre Suppression 
Plasmids pETtrio-pylT(CUA)-PylRS-sfGFP134TAG, pETtrio-pylT(UCA)-PylRS-
sfGFP134TGA, and pETtrio-pylT(UUA)-PylRS-sfGFP134TAA were individually used 
to transform E. coli BL21(DE3) cells. For each plasmid, a single colony was selected 
and allowed to grow in 5 mL of LB medium with 100 µg/mL ampicillin at 37 °C 
overnight. The overnight culture was inoculated into 200 mL of 2YT medium with 100 
µg/mL ampicillin and allowed to grow at 37 °C to OD600~1.2. 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and 5 mM BocK were then added to the medium to induce 
expression of sfGFP. Control experiments in which only 1 mM IPTG was added to the 
medium were also carried out. The induced cells were allowed to grow at 37 °C 
overnight and then collected by centrifugation (4,200 rpm for 20 minutes). The collected 
cells were resuspended in 35 mL of lysis buffer (50 mM HEPES, 300 mM NaCl, 10 mM 
imidazole, pH 8.0) and lysed by sonication in an ice water bath. The lysed cells were 
clarified by centrifugation (10,000 rpm for 1 hour). The supernatant was decanted and let 
bind to 5 mL of Ni-NTA superflow resins at 4°C for 1 hour.  
The mixture of the supernatant and resins was then loaded to an empty Qiagen Ni-
NTA superflow cartridge. The resins were washed with 5 volume times of lysis buffer 
and sfGFP was then eluted with buffer (50 mM HEPES, 300 mM NaCl, 250 mM 
imidazole, pH 8.0). To further purify the expressed sfGFP, the protein was equilibrated 
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against buffer A (20 mM Bis-Tris, pH 6.1) and then loaded to a monoS column from GE 
Health Science. The protein was eluted out by running a gradient from buffer A to 100% 
of buffer B (20 mM Bis-Tris, 1 mM NaCl, pH 6.1). The finally purified protein was then 
concentrated to a desired volume and analyzed by SDS-PAGE. To analyze the purified 
protein by electrospray ionization mass spectrometry (ESI-MS) analysis, the buffer of 
the purified protein was changed to the phosphate buffer saline. Without further 
indication, protein purification and characterization in the following experiments were 
the same. 
 
Suppression of an Opal Mutation at S2 Position of sfGFP 
Plasmid pETtrio-pylT(UCA)-PylRS-sfGFP2TGA was used to transform E. coli 
BL21(DE3) cells. A single colony was then used to express sfGFP at two induction 
conditions: (1) 1 mM IPTG and (2) 1 mM IPTG and 5 mM BocK.  
 
Basal Suppression at an Opal UGA Codon 
Plasmid pETtrio-sfGFP134TGA was used to transform E. coli BL21(DE3) cells. 
A single colony was then selected to do protein expression that was induced by the 
addition of 1 mM IPTG. 
  
Mutagenic Analysis of
Pyl
UCAtRNA  
Plasmids pETtrio-pylT(UCA)G73C-PylRS-sfGFP134TGA, pETtrio-
pylT(UCA)G73U-PylRS-sfGFP134TGA, and pETtrio-pylT(UCA)G73A-PylRS-
sfGFP134TGA were used individually to transform E. coli BL21(DE3) cells. A single 
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colony for each plasmid was then selected to do protein expression at two induction 
conditions: (1) 1 mM IPTG and (2) 1 mM IPTG and 5 mM BocK.  
 
Anticodon-Codon Cross Recognition 
Plasmids pETtrio-pylT(CUA)-PylRS-sfGFP134TAG, pETtrio-pylT(CUA)-
PylRS-sfGFP134TAA, pETtrio-pylT(UUA)-PylRS-sfGFP134TAG, and pETtrio-
pylT(UUA)-PylRS-sfGFP134TAA were individually used to transform E. coli 
BL21(DE3) cells. A single colony for each plasmid was then selected and allowed to 
grow in 5 mL of LB medium with 100 µg/mL ampicillin at 37 °C overnight. This 
overnight culture was then inoculated into 500 mL of 2YT medium with 100 µg/mL 
ampicillin and allowed to grow to OD600 ~ 1.2. 1 mM IPTG and 5 mM BocK were then 
provided and cells were allowed to grow at 37 °C overnight. For pETtrio-pylT(UUA)-
PylRS-sfGFP134TAG, expression of sfGFP in the absence of BocK was also tested. 
 
Competitive Recognition of the Third Nucleotide of an Amber Codon 
Plasmid pEVOL-AzFRS was a gift from Dr. Peter Schultz at Scripps Research 
Institute93. It carries one 
Tyr
CUAtRNA  gene under control of a proK promoter and a proK 
terminator, an evolved AzF-specific MjTyrRS (AzFRS) gene under control of a glnS 
promoter and a glnS terminator, and an AzFRS gene under control of a pBAD promoter. 
This plasmid together with pETtrio-pylT(UUA)-PylRS-sfGFP134TAG was used to co-
transform E. coli BL21(DE3) cells. One single colony was selected and allowed to grow 
in 5 mL of LB medium with 100 µg/mL ampicillin and 34 µg/mL chloramphenicol at 37 
°C overnight. This overnight culture was inoculated into 200 mL of 2YT medium with 
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100 µg/mL ampicillin and 34 µg/mL chloramphenicol and allowed to grow to OD600 ~ 
1.2. Expression of sfGFP was then induced. Four induction conditions were tested, 
including (1) 1 mM IPTG only, (2) 1 mM IPTG and 1 mM AzF, (3) 1 mM IPTG and 5 
mM BocK, and (4) 1 mM IPTG, 1 mM AzF, and 5 mM BocK.  
 
AGGA Codon Suppression 
Plasmid pETtrio-pylT(UCCU)-PylRS-sfGFP134AGGA was used to transform E. 
coli BL21(DE3) cells. A single colony was then selected and allowed to grow in 5 mL of 
LB medium with 100 µg/mL ampicillin at 37 °C overnight. This overnight culture was 
then inoculated into 500 mL of 2YT medium with 100 µg/mL ampicillin and allowed to 
grow to OD600 ~ 1.2. Two conditions were used to induce sfGFP expression. One is the 
addition of 1 mM IPTG and the other is the addition of 1 mM IPTG and 5 mM BocK. 
 
AGG Codon Suppression 
Plasmid pETtrio-pylT(CCU)-PylRS-sfGFP2AGG was used to transform E. coli 
BL21(DE3) cells. A single colony was then selected and allowed to grow in 5 mL of LB 
medium with 100 µg/mL ampicillin at 37 °C overnight. This overnight culture was then 
inoculated into 500 mL of 2YT medium with 100 µg/mL ampicillin and allowed to grow 
to OD600 ~ 1.2. Two conditions were used to induce sfGFP expression. One is the 
addition of 1 mM IPTG and the other is the addition of 1 mM IPTG and 5 mM BocK. 
The cells sued for the protein expression of the plasmid pET-pylT(CCU)-PylRS-
GFPUV149AGG were grown in minimal media to limit the amount of Arg present that 
will promote shifting of the AGG codon by endogenous arginyl-tRNAArg. pET-
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pylT(CCU)-PylRS-GFPUV149AGG were grown in GMML to an OD600 ~ 0.5. Addition 
of 0.5 mM IPTG, 0.2 % Arabinose, 10 mM of the respective NCAA (BocK, AllocK and 
ProK)92 
 
Protein Labeling of GFPuv with ProK 
GFPuv containing ProK (1mg/ml in 1×PBS buffer, pH 7.4) was incubated with 
CuSO4 (100 μM), NiCl (1mM), Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (0.5 
mM), and FlAz (2.5 mM) sequentially, followed by Sodium ascorbate (5 mM) at room 
temperature for 3 hours, then TCA (10%) was added to precipitate the proteins on ice for 
30 minutes, followed by 2 volume acetone wash, and SDS-PAGE analysis.92 
 
Mass Spectrometry 
ESI MS experiments were performed using an Applied Biosystems QSTAR Pulsar 
(Concord, ON, Canada) equipped with a nanoelectrospray ion source.  The MS data 
were acquired in positive ion mode (500-2000 Da) using spray voltage of +2000 V and 
flow rate of 700 nL/min. Data analysis and protein signal extraction were performed 
using the BioAnalyst software (Applied Biosystems). A mass range of m/z 500-2000 
was used for spectral deconvolution and the output range was 20000 to 30000 Da using a  
 
 
I performed all experiments except protein labeling of GFPuv with ProK which was 
done by Dr. Zeng. The northern blotting for the aminoacylation assays were carried 
out in Dieter Soll’s research lab during our collaboration. The mass spectra were 
conducted at the Laboratory for Biological Mass spectrometry at Department of 
Chemistry, Texas A&M University. 
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resolution of 0.1 Da and S/N threshold of 20.  
Results and Discussion 
Amber, Opal, and Ochre Suppression Efficiencies of the PylRS-tRNAPyl Pairs 
To demonstrate amber suppression efficiency of the PylRS-
Pyl
CUAtRNA  pair, E. coli 
BL21(DE3) cells transformed with pETtrio-pylT(CUA)-PylRS-sfGFP134TAG were 
used to express sfGFP both in the absence and in the presence of 5 mM BocK, a 
substrate of PylRS. Without BocK in the growth medium, low level of sfGFP expression 
was observed. On the contrary, the addition of BocK promoted sfGFP overexpression 
(Figure II-2A). The ESI-MS analysis of the purified sfGFP displayed two major mass 
peaks at 27,810±1 Da and 27,941±1Da that agree well with the theoretical molecular 
weights of sfGFP with BocK incorporated at N134 (27,940 Da for the full-length 
protein; 27809 Da for the full-length protein without the first methionine (M1)) (Figure 
II-2B1).  
E. coli BL21(DE3) cells transformed with pETtrio-pylT(UUA)-PylRS-
sfGFP134TAA showed an undetectable expression level of sfGFP when BocK was 
absent in the growth medium. The addition of BocK induced sfGFP expression (Figure 
II-2A). The ESI-MS analysis of the purified sfGFP showed two mass peaks (27,940±1 
Da and 27,809±1 Da) that agree well with the theoretical molecular weights of sfGFP 
with BocK incorporated at N134 (Figure II-2B2).  
In comparison to amber suppression, the expression level of sfGFP using ochre 
suppression was lower. E. coli BL21(DE3) cells transformed with pETtrio-pylT(UCA)-
PylRS-sfGFP134TGA exhibited a high expression level of sfGFP both in the absence 
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and in the presence of BocK in the growth medium (Figure II-2A). The ESI-MS analysis 
of purified sfGFP expressed in the absence of BocK showed a mass peak at 27,899±1 Da 
that clearly matched a Trp residue at N134 of sfGFP (calculated mass: 27,898 Da) 
(Figure II-2B3). The ESI-MS analysis of sfGFP expressed in the presence of BocK 
displayed a very interesting spectrum. Mass peaks for both Trp residue at N134 of sfGFP 
(27,900±1 Da) and BocK residue at N134 of sfGFP (27,941±1 Da) were observed. The 
mass peak for the Trp isoform was much more intensive than the BocK isoform (Figure 
II-2B4). 
To test whether the incorporation of Trp at the 134 position is related to the 
nucleotide contents of mRNA around the UGA codon, plasmid pETtrio-pylT(UCA)-
PylRS-sfGFP2TGA was constructed to test the opal suppression. E. coli BL21(DE3) 
cells transformed with pETtrio-pylT(UCA)-PylRS-sfGFP2TGA displayed high sfGFP 
expression levels both in the absence and in the presence of BocK that were much higher 
than in cells transformed with plasmid pETtrio-pylT(UCA)-PylRS-sfGFP134TGA and 
grown in the same conditions (Figure II-3A).  
The ESI-MS analyses of purified sfGFP from cells transformed with pETtrio-
pylT(UCA)-PylRS-sfGFP2TGA displayed similar patterns as sfGFP from cells 
transformed with pETtrio-pylT(UCA)-PylRS-sfGFP134TGA. Two mass peaks for 
sfGFP expressed both in the absence and in the presence of BocK (27,795±1 Da and 
27,927±1 Da in Figure II-3B1 and 27,795±1 Da and 27,926±1 Da in Figure II-3B2) 
match the molecular weights of sfGFP with Trp incorporated at S2 (calculated mass: 
27,926 Da for the full-length protein; 27,794 Da for the full-length protein without M1). 
 43 
 
 
Figure II-2. Suppression of amber, opal, and ochre mutations at N134 of sfGFP by their 
corresponding PylRS-tRNAPyl pairs in the absence and presence of BocK. (A) Proteins 
shown in the gel represent their real relative sfGFP expression levels. Lanes 1 and 2 
were transformed with pETtrio-PylT(CUA)-PylRS-sfGFP134TAG; lanes 3 and 4 were 
transformed with pETtrio-PylT(UUA)-PylRS-sfGFP134TAA; lanes 5 and 6 were 
transformed with pETtrio-PylT(UCA)-PylRS-sfGFP134TGA. ESI-MS spectra of sfGFP 
expressed in cells (B1) transformed with pETtrio-PylT(CUA)-PylRSsfGFP134TAG and 
grown in the presence of 5 mM BocK, (B2) transformed with pETtrio-PylT(UUA)-
PylRS-sfGFP134TAA and grown in the presence of 5 mM BocK, (B3) transformed with 
pETtrio-PylT(UCA)-PylRS-sfGFP134TGA and grown in the absence of BocK, and (B4) 
transformed with pETtrioPylT(UCA)-PylRS-sfGFP134TGA and grown in the presence 
of 5 mM BocK. 
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Figure II-3. Suppression of an opal mutation at S2 of sfGFP by the PylRS-tRNAPyl 
UCA pair. (A) Expression of sfGFP with an opal mutation. Lanes 1 and 2 were 
transformed with pETtrio-pylT(UCA)-sfGFP134TGA and grown in the absence or 
presence of 5 mM BocK; lanes 3 and 4 were transformed with pETtrio-pylT(UCA)-
sfGFP2TGA and grown in the absence or presence of 5 mM BocK. Each protein shown 
in the gel represents their real relative expression levels. ESI-MS of sfGFP expressed in 
cells transformed with pETtrio-pylT(UCA)-sfGFP2TGA and grown in the (B1) absence 
or (B2) presence of 5 mM BocK. 
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For sfGFP expressed in the presence of 5 mM BocK, there were two small peaks at 
27,968±1 Da and 27,835±1 Da that agree well with the molecular weights of sfGFP with 
BocK incorporated at S2 (calculated mass: 27,967 Da for the full-length protein; 27,836 
Da for the full-length protein without M1).  
To further understand opal suppression in the E. coli BL21(DE3) cell strain, plasmid 
pETtrio-sfGFP134TGA that did not carry opal suppressing 
Pyl
UCAtRNA was used to 
transform E. coli BL21(DE3) cells. The transformed cells displayed a relatively high 
detectable level of sfGFP expression with a yield of 4 mg/L (Figure II-4A).The ESI-MS 
analysis of sfGFP resulted from this basal opal suppression showed major mass peaks at 
27,899±1 Da and 27,767±1 Da (Figure II-4B). The molecular weight corresponded to 
sfGFP with Trp incorporated at N134 position.  
The suppression efficiencies of three mutated forms of 
Pyl
UCAtRNA with mutations as 
G73A, G73C, and G73U, respectively were also examined. Cells transformed with either 
pETtrio-pylT(UCA)G73A-PylRS-sfGFP134TGA or pETtrio-pylT(UCA)G73C-PylRS-
sfGFP134TGA displayed similar expression levels of sfGFP both in the presence and in 
the absence of BocK(Figure II-5A). However, cells transformed with pETtrio-
pylT(UCA)G73U-PylRS-sfGFP134TGA showed significantly different expression 
levels of sfGFP when grown in the absence and in the presence of BocK. The ESI-MS  
analysis of sfGFP expressed in the absence of BocK showed a major mass peak at 
27,895±1 Da that matches sfGFP with Trp incorporated at N134 (Figure II-5B1). The 
addition of 5 mM BocK promoted the sfGFP expression level to increase. The ESI-MS  
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Figure II-4. Suppression of an opal mutation at N134 of sfGFP at different conditions. 
(A) Proteins shown in the gel represent their real relative expression levels. Lane 1 was 
transformed with pET-sfGFP134TGA; lanes 2 and 3 were transformed with pET-
pylT(UCA)-sfGFP134TGA and grown in the absence or presence of 5 mM BocK. (B) 
ESI-MS of sfGFP expressed in cells transformed with pETtrio-sfGFP134TGA. 
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Figure II-5. Suppression of an opal mutation at N134 of sfGFP by different tRNAPyl 
UCA variants. (A) Proteins shown in the gel represent their real relative expression 
levels. Lanes 1 and 2 were transformed with pETtrio-pylT(UCA)G73C-sfGFP134TGA 
and grown in the absence or presence of 5 mM BocK; lanes 3 and 4 were transformed 
with pETtrio-pylT(UCA)G73A-sfGFP134TGA and grown in the absence or presence of 
5 mM BocK; lanes 5 and 6 were transformed with pETtrio-pylT(UCA)G73U 
sfGFP134TGA and grown in the absence or presence of 5 mM BocK; lanes 7 and 8 were 
transformed with pETtrio-pylT(UCA)-sfGFP134TGA and grown in the absence or 
presence of 5 mM BocK. The ESI-MS analysis of sfGFP expressed in cells transformed 
with pETtrio-pylT(UCA)G73U-sfGFP134TGA and grown in the (B1) absence or (B2) 
presence of 5 mM BocK. 
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analysis of the purified protein confirmed sfGFP with BocK incorporated at N134 
became dominant (Figure II-5B2). The intensity of the mass peak at 27,940±1 Da that 
matched sfGFP with BocK incorporated at N134 was roughly twice of the mass peak at 
27,898±1 Da which matched sfGFP with Trp incorporated at N134. Since the mass 
spectrometry showed that the sfGFP contained both Trp and BocK incorporated at the 
UGA position further analysis was done in collaboration with Dieter Soll’s research 
group from Yale University. The analysis is to show the source of the Trp read-through 
and show that the Trp is not ligated to
Pyl
UCAtRNA . In vitro aminoacylation studies were 
carried out on PylRS and TrpRS with α–[32P]-labeled tRNA substrates (Figure II-6).63 
Aminoacylation of the 
Pyl
UCAtRNA by the PylRS showed a comparable  amount between 
BocK (52 ± 11%) or Cyc (46 ± 3%) which is similar to the wild type 
Pyl
CUAtRNA  
containing BocK (45 ± 5%) or Cyc (43 ± 9%) (Table II-1)  
The E. coli TrpRS did not ligate the Trp with any of the tRNAPyl variant compared to 
the active tRNATrp (Figure II-7). Based on the data shown, TrpRS had no activity 
towards 
Pyl
UCAtRNA . Incorporation of the Trp could result from the near-cognate (mismatch 
of one codon anticodon) suppresion of UGA by 
Trp
CCAtRNA . Though PylRS-
Pyl
UCAtRNA  
encoded BocK using UCA, the aminoacylated 
Pyl
UCAtRNA  with BocK could not 
outcompete with the suppression by the tRNATrp aminoacylated with Trp completely.  
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Figure II-6. In vitro aminoacylation of tRNAPyl variants by M. mazei PylRS with BocK 
or Nε-cyclopentyloxycarbonyl-L-lysine (Cyc). An additional spot (representing <5% of 
total radiolabel) between the aa-AMP and AMP is an unidentified possibly degraded 
reaction product, often seen in aminoacylation assays. 
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Figure II-7. In vitro aminoacylation of tRNAPyl variants and tRNATrp by E. coli TrpRS 
with Trp. 
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Table II-1. Plateau aminoacylation levels. 
 
Values are in % of total tRNA aminoacylated at plateau level (reached before the 10 
minute time point) of the reaction. n.d. – no aminoacylation detected. 
 
 
 
Figure II-8. Cross recognitions between different anticodons of tRNAPyl and nonsense 
mutations at N134 of sfGFP. Cells were transformed with pETtrio-PylT(NNN)-PylRS-
sfGFP134N’N’N’ and grown in the presence of 5 mM BocK (NNN and N’N’N’ denote 
anticodons and codons specified in the figure). Proteins shown in the gel represent their 
real relative expression levels. 
 52 
 
Anticodon-Codon Cross Recognition 
Transforming E. coli BL21(DE3) cells with pETtrio-pylT(CUA)-PylRS-
sfGFP134TAA followed by growing cells in the presence of 5 mM BocK did not lead to 
detectable expression of sfGFP. E. coli BL21(DE3) cells transformed with pETtrio-
pylT(UUA)-PylRS-sfGFP134TAG showed a detectable but low level of sfGFP 
expression (less than 1 mg/L) (Figure II-8).  
To see whether BocK promoted suppression at the amber mutation site, E. coli 
BL21(DE3) cells transformed with pETtrio-pylT(UUA)-PylRS-sfGFP134TAG was also 
grown in the absence of BocK. As shown in Figure II-9, the sfGFP expression levels 
both in the absence and in the presence of BocK were very similar. Addition of BocK 
did not lead to significant increase of amber suppression. As shown in Figure II-9B1 & 
B2, sfGFP expressed in both conditions displayed mass peaks (27,839±1 Da and 
27,710±1 Da in Figure II-9B1 and 27,840±1 Da and 27,709±1 Da in Figure II-9B2) that 
match sfGFP with glutamic acid (Glu), lysine (Lys), or glutamine (Gln) incorporated at 
N134. Figure II-9B2 did show a mass peak at 27,939±1 Da that matches the molecular 
weight of sfGFP with BocK incorporated at N134. However, its intensity was much 
lower than the mass peak of sfGFP at ~27,840±1 Da.  
Experiments were also carried out to demonstrate that the PylRS-
Pyl
UUAtRNA  pair does 
not interfere with suppression of an amber mutation mediated by an evolved MjTyrRS-
Tyr
CUAtRNA  pair. 
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Figure II-9. Expression of sfGFP in cells transformed with pETtrio-PylT(UUA)-PylRS-
sfGFP134TAG. (A) Cells grown in 2YT medium supplemented without or with BocK. 
ESI-MS of sfGFP expressed in the (B1) absence or (B2) presence of 5 mM BocK. 
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Two plasmids, pETtrio-pylT(UUA)-pylRS-sfGFP134TAG and pEVOL-AzFRS 
were used to transform E. coli BL21(DE3)cells. As shown in Figure II-10A, growing the 
transformed cells in four conditions led to different expression levels of sfGFP. When no 
NCAA or only 5 mM BocK was provided in the medium, only a detectable but very low 
level of sfGFP expression (less than 1 mg/L) was detected. However, addition of 1 mM 
AzF to the medium supplemented with or without BocK promoted sfGFP 
overexpression. The ESI-MS analysis of purified sfGFP in all four conditions displayed 
very interesting spectra (Figure II-10B). Although a mass peak for sfGFP expressed in 
two conditions with the supplement of AzF (27,900±1 Da in Figure II-10B2 and 
27,901±1 Da in Figure II-10B4) matches the calculated molecular weight (27,901 Da) of 
sfGFP with AzF incorporated at N134, a mass peak for sfGFP expressed in two 
conditions without the supplement of AzF (27,859±1 Da in Figure II-10B1 and 
27,860±1 Da in Figure II-10B3) does not match the molecular weight of sfGFP with 
either Lys/Glu/Gln or BocK incorporated at N134. Instead, this mass peak agrees well 
with the molecular weight of sfGFP with Phe incorporated at N134 (calculated mass: 
27,859 Da).  
AGGA Codon Suppression 
E. coli BL21(DE3) cells transformed with pETtrio-pylT(UCCU)-PylRS-
sfGFP2AGGA showed similar sfGFP expression levels both in the absence (138 mg/L) 
and in the presence (122 mg/L) of BocK (Figure II-11) sfGFP proteins expressed in both 
conditions displayed one major mass peak at 27,868 Da  (Figure II-11) that agreed with 
the theoretical molecular weight of sfGFP with arginine (Arg) incorporated at N134 
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Figure II-10. Expression of sfGFP in cells transformed with pETtrio-PylT(UUA)-
PylRS-sfGFP134TAG and pEVOL-AzFRS. (A)Cells were grown in 2YT medium 
supplemented with different combinations of NCAAs. ESI-MS of sfGFP expressed in 
the(B1) absence of both AzF and BocK; (B2) presence of 1 mM AzF; (B3) presence of 5 
mM BocK; and (B4) presence of both 1 mM AzF and 5 mM BocK. 
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(calculated mass: 27,867 Da for the full-length protein). Addition of the BocK to the 
medium did not chase the ESI-MS patterns. Our collaborators from Dieter Soll research 
group conducted in vitro aminoacylation assays to determine if 
Pyl
UCCUtRNA is a competent 
substrate for PylRS (Figure II-12) With BocK, aminoacylation for 
Pyl
UCCUtRNA by the 
PylRS showed a comparable  amount between BocK (40 ± 6%) compared to the wild 
type 
Pyl
CUAtRNA  containing BocK (45 ± 5%) (Table II-1). To determine if the Arg signal 
detected mass from ESI-MS is from the misacylation, tRNAPyl variants were assayed for 
Arg aminoacylation activity. Results showed that although E.coli ArgRS is highly active 
with its native substrate, no tRNAPyl variants could be aminoacylated with Arg (Figure 
II-13). 
AGG Codon Suppression 
E. coli BL21(DE3) cells transformed with pETtrio-pylT(CCU)-PylRS-sfGFP2AGG 
showed similar sfGFP expression levels both in the absence and in the presence of BocK 
(Figure II-14A). sfGFP proteins expressed in both conditions displayed one major mass 
peak at 27,895 Da that agrees well with the theoretical molecular weight of sfGFP with 
arginine (Arg) incorporated at S2 (calculated mass: 27,896 Da for the full-length protein) 
(Figure II-14B). pET-pylT(CCU)-PylRS-GFPUV149AGG showed a higher incorporation 
of the various NCAA (BocK, AllocK, and ProK) dominating the production of GFPUV 
with Arg92 (Figure II-15). The GFPUV was labeled in the absence and presence of ProK 
using a fluorescein azide (FIAz)92 (Figure II-16). 
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Figure II-11. Quadruplet codon AGGA encodes arginine in vivo in E. coli. (A) Protein 
produced by BL21(DE3) cells transformed with pETtrio-pylT(UCCU)-
sfGFP134AGGA, grown with or without BocK. (B) ESI-MS of sfGFP produced by cells 
grown with (B) or without (C) BocK.                                      
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Figure II-12. In vitro aminoacylation of tRNAPyl quadruplet (UCCU) anticodon by M. 
mazei PylRS with BocK or Cyc.  
 
Basal Nonsense Suppression in the E. coli BL21(DE3) Cell Strain 
E. coli BL21(DE3) cells transformed with pETtrio-pylT(CUA)-PylRS-
sfGFP134TAG and grown in the absence of BocK yielded a sfGFP expression level 
close to 1 mg/L. The ESI-MS spectrum of the purified sfGFP clearly indicated a Lys, 
Glu, or Gln residue at  
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Figure II-13. In vitro aminoacylation of tRNAPyl variants and tRNAArg by E. coli 
ArgRS. 
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the amber mutation site. Since PylRS does not recognize Lys, Glu, and Gln and 
Pyl
CUAtRNA  
itself does not mediate detectable amber suppression in the E. coli Top10 cell strain (data 
not shown), this low but detectable sfGFP expression level was due to the basal amber 
suppression in the E. coli BL21(DE3) cell strain67, 88. This basal amber suppression that 
was also demonstrated in one separate study from us88 arises possibly from the 
recognitions of the UAG codon by its near-cognate tRNAs including 
Lys
UUUtRNA /
Glu
UUCtRNA /
lnG
CUGtRNA
94, 95. 
A similar test with E. coli BL21(DE3) cells transformed with pETtrio-pylT(UCA)-
PylRS-sfGFP134TGA and grown in the absence of BocK yielded a sfGFP expression 
level of 8 mg/L. The ESI-MS spectrum of the purified protein showed a Trp residue at 
N134 of sfGFP. To rule out the possibility that 
Pyl
UCAtRNA was charged by E. coli 
tryptophanyl-tRNA synthetase (TrpRS) for the delivery of Trp at the designated opal 
mutation site. Plasmid pETtrio-sfGFP134TGA that did not contain the 
Pyl
UCAtRNA  gene 
was constructed for further tests. E. coli BL21(DE3) cells transformed with this plasmid 
yielded a sfGFP expression level of 4 mg/L. The ESI-MS spectrum of the purified 
protein also showed the incorporation of Trp at N134 of sfGFP. Since our research 
findings recently demonstrated that 
Pyl
UCAtRNA  was not recognized by E. coli TrpRS,
88 we 
concluded that the sfGFP expressed in the above two conditions resulted from the basal 
opal suppression in the E. coli BL21(DE3) cell strain. The observed different sfGFP 
expression levels might be caused by different copy numbers of two plasmids in the 
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transformed cells. This basal opal suppression is the consequence of the recognition of 
the opal codon by tRNATrp. E. coli tRNATrp has a CCA anticodon which is a near-
cognate tRNA of UGA. It forms two Watson-Crick base pairs with the 5’ and middle 
nucleotides of UGA and a wobble base pair with the 3’ nucleotide of UGA, explaining 
its ability to recognize UGA. We have also excluded the possibility that nucleotide 
contents around the opal mutation at N134 of sfGFP facilitated the binding of tRNATrp 
and induced the Trp incorporation at this site. The E. coli BL21(DE3) cells transformed 
with pETtrio-pylT(UCA)-PylRS-sfGFP2TGA also expressed sfGFP in the absence of 
BocK and the expressed protein had Trp at the opal mutation site. The sfGFP expression 
level in E. coli BL21(DE3) cells transformed with pylT(UCA)-PylRS-sfGFP2TGA 
reached to 115 mg/L. This is roughly 20% of the expression level of wild-type sfGFP in 
E. coli BL21(DE3) cells (~500 mg/L, unpublished data). This high efficiency to read 
across an opal codon with the binding of a near-cognate tRNATrp may correlate with the 
short distance from the opal codon to the start codon.  
In contrary to UAG and UGA codons, the UAA codon displays high translation 
termination stringency in the E. coli BL21(DE3) cell strain. Cells transformed with 
pETtrio-pylT(CUA)-PylRS-sfGFP134TAA showed an undetectable basal ochre 
suppression level. This can be explained from several aspects. UAG and UGA are 
recognized by release factor 1 and release factor 2, respectively, whereas UAA is 
recognized by both release factor 1 and release factor 2. Its recognition by both release 
factor proteins, in theory, makes the translation termination at UAA more stringent than 
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the other two stop codons. Another reason lies at the nucleotide contents of UAA. 
Unlike UAG and UGA that could involve a GC base pair interaction, UAA could only 
 
Figure II-14. Suppression of an AGG mutation at S2 of sfGFP by tRNAPyl CCU. (A) 
Expression of sfGFP in cells transformed with pETtrio-pylT(CCU)-sfGFP2AGG and 
grown in the absence or presence of 5 mM BocK. (B) The ESI-MS analysis of sfGFP 
expressed in the presence of 5 mM BocK. 
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Figure II-15. ESI-MS spectra of GFPUV variants expressed in different NCAA 
conditions. (10 mm; (A) BocK (B) AllocK and (C) ProK). 
 
  
 64 
 
form AU pairs or wobble pairs. Its interactions with tRNAs are relatively weak, making 
its misrecognition less possible than UAG and UGA.  
Suppression Efficiencies of the Amber, Opal, and Ochre PylRS-tRNAPyl Pairs 
When co-expressed with PylRS, all three tRNAPyl isoforms 
Pyl
CUAtRNA ,
Pyl
UCAtRNA , 
and 
Pyl
UUAtRNA  are capable of delivering BocK at their corresponding codon sites. 
Pyl
CUAtRNA  was orthogonal in E. coli and displayed the highest efficiency in all three 
isoforms. Given that E. coli BL21(DE3) cells transformed with pETtrio-pylT(UUA)-
PylRS-sfGFP134TAA did not show a detectable expression level of sfGFP in the 
absence of BocK, we could conclude that 
Pyl
UUAtRNA  is fully orthogonal in E. coli. In 
comparison to sfGFP expressed in cells transformed with pETtrio-pylT(CUA)-PylRS-
sfGFP134TAG and grown in the presence of BocK, the sfGFP expression level in cells 
transformed with pETtrio-pylT(UUA)-PylRS-sfGFP134TAA and grown in the presence 
of BocK is five times lower. The low ability of 
Pyl
UUAtRNA  to deliver BocK was possibly 
due to the relative weak base pair interactions between its UUA anticodon, its UAA stop 
codon and the availability of both release factor 1 and release factor 2 to stop the 
translation at a UAA stop codon. In any case, the ochre suppression level achieved by 
the PylRS-
Pyl
UUAtRNA  pair was sufficient to promote overexpression of a protein with an 
ochre mutation. Although a BocK-aminoacylated 
Pyl
UCAtRNA  was able to suppress an opal 
codon for the incorporation of BocK, it did not inhibit the high incorporation of Trp at 
the same site. The ribosome could have permitted the codon anticodon mismatch at the 
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third nucleotide of the codon, so near-cognate suppression of UGA by 
Trp
CCAtRNA
aminoacylated with Trp was not unusual.96, 97  
 
 
 
Figure II-16. Labeling of GFPUV expressed in the absence and in the presence of ProK.  
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As an exogenous tRNA, the sequence and structure of 
Pyl
UCAtRNA  may not be optimal for 
the protein translation process in E. coli. When facing a competition from E. coli 
tRNATrp, the recognition of 
Pyl
UCAtRNA  by the E. coli translation machinery may be 
inhibited. Since the 73rd nucleotide serves as a strong recognition element for most 
tRNAs98, it was mutated in 
Pyl
UCAtRNA  to U, A, and C and searched for a mutant that show 
a higher opal suppression efficiency. When co-expressed with PylRS in the presence of 
BocK, )73( UGtRNA
Pyl
UCA led to higher incorporation level of BocK compared to Trp at the 
same opal mutation site. However, further mutagenesis with )73( UGtRNA
Pyl
UCA is necessary 
to fully inhibit the incorporation of Trp at an opal mutation site. 
Cross Recognition of Anticodon-Codon Pair 
The wobble hypothesis was first introduced by Francis Crick in 1966 to explain the 
observation that a single tRNA is able to efficiently recognize multiple codons89. Based 
on this hypothesis, an ochre suppressor, pylT (UUA) could recognize an amber UAG 
codon. This is a concern when both UAG and UAA codons are used to code two 
different NCAAs. However, cells transformed with pETtrio-pylT(UUA)-PylRS-
sfGFP134TAG and grown in the presence of 5 mM BocK showed a sfGFP expression 
level close to that from the basal amber suppression. This suggests very weak 
recognition of UAG by
Pyl
UUAtRNA .  
Weak base pairing interactions involved with the UUA anticodon may contribute to 
the weak recognition of UAG. However, this was certainly not the determining factor 
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since other tRNAs such as 
Lys
UUUtRNA were also involved in weak base pairing interactions 
to recognize multiple codons. One possible explanation for this weak recognition of 
UAG by 
Pyl
UUAtRNA  is the tRNA modifications.  
All cognate tRNAs are known to exhibit similar affinities for the ribosome A site 
when they bind to corresponding codons99, 100. This uniform binding is unexpected as 
certain codon-anticodon interactions are expected to be more stable than others due to 
factors such as the GC base pair content. It has been proposed that the specific sequence 
and post-transcriptional modification status of the tRNA in the region near the anticodon 
is tuned to ensure nearly indistinguishable binding of tRNAs to the ribosome A site101-
103. This has been the case for tRNAs such as 
Lys
UUUtRNA in which both nucleotides at 34 
and 37 are post-transcriptionally modified to achieve similar recognitions of AAA and 
AAG codons103. Unlike endogenous tRNAs that have corresponding modification 
enzymes, 
Pyl
UUAtRNA  is exogenous and may not be targeted by tRNA modification 
enzymes in E. coli. 
Pyl
UUAtRNA without modifications at its anticodon loop likely has a very 
weak binding affinity to the ribosome A site to associate UAG.  
Results showed that the wobble base pairing at the 3’ nucleotide of a codon was not 
sufficient for recruiting a tRNA to the ribosome A-site. Additional interactions are 
required. This aspect needs to be further investigated. Since 
Pyl
UUAtRNA has a low ability to 
recognize UAG, it is feasible to use an amber suppressor aaRS-tRNA pair and a wild 
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type or evolved PylRS-
Pyl
UUAtRNA  pair to code two different NCAAs at amber and ochre 
mutation sites, respectively, in E. coli.  
During the anticodon-codon cross recognition analysis to examine whether 
Pyl
UUAtRNA  
can compete against 
Tyr
CUAtRNA  to bind UAG in the ribosome A site, we noticed that Phe 
was incorporated at N134 of sfGFP which was expressed in cells transformed with 
pEVOL-AzFRS and pETtrio-pylT(UUA)-PylRS-sfGFP134TAG and grown either in the 
absence or in the presence of BocK. It is possible AzFRS could recognize Phe, leading 
to the misincorporation of Phe. Since AzF is a hydrophobic amino acid and structurally 
very similar to Phe, one would expect that AzFRS that was originally evolved from 
MjTyrRS would probably recognize Phe at a relatively low level and charge 
Tyr
CUAtRNA  
with Phe when AzF is absent in the medium.  
Although not clearly addressed in existing literature, most evolved MjTyrRS-
Tyr
CUAtRNA  pairs did show significant background amber suppression even in minimal 
media54, 104. Since most evolved MjTyrRS variants are for Phe derivatives, it is highly 
possible that background amber suppression caused by these evolved MjTyrRS-
Tyr
CUAtRNA  
pairs was due to their recognition of either Phe or Tyr or both. In this study, the 
background amber suppression induced by the AzFRS-
Tyr
CUAtRNA  pair inhibited both the 
basal amber suppression level and amber suppression induced by the PylRS-
Pyl
UUAtRNA  
pair. This test also provided evidence that amber suppression mediated by the PylRS-
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Pyl
UUAtRNA  pair is too low to be a concern. It also points out that substrate specificities of 
evolved NCAA-specific aaRSs need to be further characterized. 
Codon Suppression for AGGA and AGG 
Our lab and other groups have shown that mutating the anticodon of tRNAPyl does 
not significantly affect its interactions with M. mazei PylRS. Three tRNAPyl isoforms 
that are specific for three stop codons are capable to deliver BocK at their corresponding 
codon sites when co-expressed with PylRS. The ability a tRNAPyl isoform to suppress a 
quadruplet or sensing codon was also determined. Though further work needs to be done 
on the quadruplet codon, the non-standard four base pair allows incorporation of Arg by 
favoring the three-base coding models. Also, the suppression of the AGG codon was 
tested since it is a rarely used codon and 
Arg
CCUtRNA  is limitedly expressed in the E. coli  
BL21(DE3) cell strain105. However, E. coli transformed with pETtrio-pylT(CCU)-
PylRS-sfGFP2AGG only expressed sfGFP with Arg at its S2 position in the presence of 
5 mM BocK. Increasing the BocK concentration to 10 mM did drive the expression of 
sfGFP with BocK incorporated at S2 of sfGFP, which was confirmed by the ESI-MS 
analysis of the purified proteins (data not shown). 
In comparison to the Arg-containing sfGFP isoform that showed a high intensity in 
the ESI-MS spectrum of the purified sfGFP, the intensity for the BocK-containing sfGFP 
isoform was very low. This indicates 
Pyl
CCUtRNA  is charged by M. mazei PylRS with BocK 
in E. coli and is able to deliver BocK at an AGG codon site. However, the M. mazei 
PylRS- 
Pyl
CCUtRNA  pair cannot compete efficiently against the endogenous Arg 
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incorporation system at the AGG codon, same goes for the PylRS- 
Pyl
UCCUtRNA . Similar to
Pyl
UCAtRNA , the sequence and structure of 
Pyl
CCUtRNA  may not be optimized for the protein 
translation machinery in E. coli. An approach reassign the rare AGG codon to code for 
NCAA instead of Arg can be obtained by using a different PylRS- 
Pyl
CCUtRNA from M. 
barkeri and also GFPUV instead of the sequence optimized sfGFP. Results show high 
efficiency incorporation of BocK, AllocK and ProK at the AGG codon in minimal 
medium. To support the genetic incorporation of ProK at the AGG codon site, ProK 
containing a terminal alkyne was labeled with FIAz via a copper catalyzed click 
reaction.  
Conclusion 
In summary, the suppression efficiencies of the original and mutant tRNAPyl , the 
cross recognition between nonsense codons and tRNAPyl anticodons in the E. coli 
BL21(DE3) cell strain have been investigated. Among all tRNAPyl isoforms, 
Pyl
CUAtRNA  
has the highest suppression efficiency for the delivery of BocK at its corresponding 
codon. Besides its orthogonal nature in E. coli, 
Pyl
UUAtRNA  does not induce a significant 
level of suppression at an amber codon. This is contrary to the wobble hypothesis and 
makes it feasible to use amber suppressing aaRS-tRNA pair and the PylRS-
Pyl
UUAtRNA  pair 
to code two different NCAAs at amber and ochre codons respectively in E. coli.  
Data also showed that the PylRS-
Pyl
UCCUtRNA although competent in BocK it 
cannot outcompete AGGA suppression by E. coli’s native tRNAArg aminoacylated by 
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Arg. Our study also demonstrated the PylRS-
Pyl
CCUtRNA  pair cannot efficiently deliver 
BocK at an AGG codon site. Further work to optimize the sequence and structure of 
Pyl
CCUtRNA  for the E. coli translation machinery may be necessary to increase the BocK 
incorporation efficiency and suppress the Arg incorporation at the AGG codon. Further 
studies showed that rare AGG codon can be reassigned to code for NCAA by using a 
different PylRS- 
Pyl
CCUtRNA from M. barkeri and also GFPuv instead of the sequence 
optimized sfGFP. This solves the problem of the low incorporation of NCAA and allows 
different NCAA with unique functionalities to be site-selectively incorporated for 
applications such as therapeutic protein production. 
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CHAPTER III  
RAPID CATALYST-FREE CLICK REACTIONS FOR IN VIVO PROTEIN 
LABELING MEDIATED BY GENETICALLY ENCODED STRAIN-PROMOTED 
ALKENE/ALKYNE FUNCTIONALITIES*  
 
Introduction 
First described by K. Barry Sharpless in 1999, the term “click chemistry” defines 
chemical reactions that are selective, rapid, and highly efficient.106, 107 Early focus of 
click chemistry centered on the Cu+-catalyzed azide-alkyne cycloaddition (CuAAC) 
reaction.108, 109 Due to the biologically inert nature of the azide and alkyne functional 
groups, CuAAC is highly bio-orthogonal. Applications of this reaction in chemical 
biology include activity-based protein profiling and selective biomolecule labeling.110-114  
One potential pitfall of using CuAAC in living systems is the cytotoxic effect of 
Cu+ catalysts, which can be avoided using copper-free azide-cyclooctyne 
cycloaddition.115, 116 Due to strain promotion, the cyclooctyne triple bond has an elevated 
energy state and therefore reacts simultaneously with an organic azide in mild aqueous 
conditions, bypassing the use of a Cu+ catalyst. Although originally described as a 
relative slow reaction, cyclooctyne derivatives that show fast reaction kinetics with 
organic azides have been developed.117-121  
*Reprinted from “Two rapid catalyst-free click reactions for in vivo protein labeling 
of genetically encoded strained alkene/alkyne functionalities”, Kurra, Y.+, Odoi, 
K.A.+, Lee, Y.J., Lu, T., Wheeler, S., Torres-Kolbus, J., Deiters, A., Liu. 
Bioconjugate Chem. 2014. 25 (9), 1730-1738 Copyright 2013, with permission from 
American Chemical Society. + Contributed equally 
 
 73 
 
The pursuit of other fast catalyst-free click reactions that can be applied in living 
systems for labeling biomolecules at bio-relevant concentrations has recently revitalized 
two other reactions, namely inverse electron-demand Diels-Alder cycloaddition 
(EDDAC) and nitrile imine-alkene/alkyne 1,3-dipolar cycloaddition (NIADC) (scheme 
III-1).122-126 Both reactions display rapid kinetic features when a strain-promoted 
alkene/alkyne is involved.  
Applications of these two reactions include labeling biomolecules in cells and 
cancer diagnostics.127-129 In this work, the report shows the kinetic investigations of 
EDDAC and NIADC reactions that involve strain-promoted alkene/alkyne 
functionalities including norbornene, transcyclooctene, and cyclooctyne and their 
applications in labeling proteins that are genetically incorporated with these functional 
groups. 
 
 
Scheme III-1. (A) Tetrazine-alkene/alkyne EDDAC and (B) NIADC reactions. 
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Experimental Section 
Materials 
Reagents were purchased from general chemical manufacturers such as Sigma 
Aldrich, TCI, Alfa Aesar and Chem Impex and used without further purification. 
Anhydrous DMF and Methanol from Sigma-Aldrich and used as is. All reactions 
involving moisture sensitive reagents were carried out in oven-dried glassware under 
argon atmosphere. Thin layer chromatography (TLC) was performed on silica 60F-254 
plates and visualized using UV irradiation at 254 nm. Flash chromatography was 
performed with silica gel (particle size 32-63 µm) from Dynamic adsorbents inc. 
(Atlanta, GA). 
All 1H and 13C spectra were recorded on Varian Mercury-300, INVOA 300 and 
INVOA-500 MHz spectrometers. NMR spectra chemical shifts were reported in parts 
per million (ppm) and referenced to solvent peaks: chloroform (7.27 ppm for 1H and 
77.23 ppm for 13C) or water (4.8 ppm for 1H). A minimal amount of 1,4-dioxane was 
added as the reference standard (67.19 ppm for 13C) for carbon NMR spectra in 
deuterium oxide. 1H NMR spectra are tabulated as follows: chemical shift multiplicity 
(s= singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
number of protons, and coupling constant(s). Mass spectra were conducted at the 
Laboratory for Biological Mass spectrometry at Department of Chemistry, Texas A&M 
University. 
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Chemical Synthesis 
NaH (1.74 g, 72.5 mmol) was washed with dry hexane (15 mL) and then 
decanted. Dry THF (20 mL) was added and the mixture was allowed to stir at room 
temperature. 5-Norbornene-2-ol (NOR, 2.0 g, 18.18 mmol) in THF (15 mL) was also 
added to the flask. Heated to reflux for 1 hour whilst stirring. α-Bromoacetic acid (1.74 
g, 18.18 mmol) in THF (12 mL) was then added to the mixture and refluxing continued 
overnight. The reaction mixture was cooled to room temperature, and concentrated on 
the rotary evaporator. The residue was cooled in an ice bath and water was added 
followed by acidification with 3 M HCl. The aqueous layer was extracted with three 
portions of ether. The extracts were dried with Na2SO4 and concentrated in vacuo to 
form oil. The compound was used directly for the next reaction without further 
purification. 
The above acid compound (1.5 g, 8.92 mmol) was dissolved in DMF (12 mL) 
followed by adding K2CO3 (3.69 g, 26.7 mmol) but methyl iodide (1.14  mL, 17.73 
mmol) was then added dropwise. The mixture was stirred at 60 oC for 1 hour. The 
reaction system was diluted with EtOAc, and then washed sequentially with water and 
HCl (1 M). The organic layer was separated and dried with anhydrous Na2SO4. After 
filtration, the organic layer was concentrated. Column chromatography with 
hexanes/EtOAc as eluent (9:1 v/v) afforded pure methyl ester product 2 (1.10 g, 68%). 
To a stirred solution of LAH (0.230 g, 6.59 mmol) in dry THF (10 mL) at 0 oC 
was added dropwise a solution of 2 (1.0 g, 5.49 mmol) in THF under Argon.  The 
mixture was stirred for 4 hours at room temperature.  It was then cooled to 0 oC, diluted 
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with ether, quenched by dropwise addition of a saturated solution of Na2SO4 (15 mL), 
and extracted with EtOAc. The organic layer was dried with Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by column chromatography 
afforded the product 3 as a liquid (0.610 g, 72%). 
DIAD (1.18 g, 5.84 mmol) was added dropwise slowly to an oven dried flask 
into a solution of compound 3 (0.6 g, 3.89 mmol), compound 4 (1.72 g, 5.84 mmol) and 
TTP (1.42 g, 5.45 mmol) in Dry THF (10 mL) and the mixture was cooled to 0 
oC. The 
reaction mixture was stirred at room temperature overnight. The reaction mixture was 
then concentrated and subjected directly to column chromatography (eluent: 
hexane/EtOAc as 4/1(v/v)). 5 (1.3 g, 78% yield) was afforded as light yellow oil. 
Compound 5 (1.2 g, 2.78 mmol) was dissolved in THF (10 mL) and aqueous NaOH (1.0 
M, 3.61 mL) was added dropwise. The mixture was stirred at room temperature for 2 
hours, diluted with water (10 mL), and then extracted with Et2O (20 mL). The aqueous 
layer was collected and adjusted to pH = 1 with HCl (3.0 M in water).  
The resulting mixture was extracted with EtOAc (10 mL × 2) and the combined 
organic layers were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to get acid compound, which was used directly in the next step without further 
purification.  
The compound (1.0 g, 2.39 mmol) obtained from the above step was dissolved in 
anhydrous dioxane (15 mL) followed by an injection of HCl/dioxane solution (4.0 M, 
1.19 mL). The resulting mixture was stirred at room temperature for 12 hours. The white 
solid was collected by filtration and washed sequentially with EtOAc and 
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dichloromethane (DCM), then dried under vacuum using oil pump to afford the final 
product, NCAA 1 as a white solid (0.609 g, 62% over two steps) (Scheme III-2). 
1H NMR (CD3OD, 300 MHz) δ 7.32 (d, 2H, J = 8.4 Hz), 7.18 (d, 2H, J = 8.4 
Hz), 6.25 (dd, 1H, J = 3.0, 5.7 Hz), 5.93 (dd, 1H,  J = 3.3, 5.7 Hz),  4.29-4.20 (m, 1H), 
4.18-4.16 (m, 1H), 4.11-4.04 (m, 2H),  3.82-3.70 (m, 2H),  3.21 (ABq,  2H, J = 7.8, 14.4 
Hz), 2.76 (m, 1H), 2.03-1.95 (m, 1H), 1.44-1.29 (m, 3H), 0.87 (m, 1H).   
13C NMR (CD3OD, 75 MHz)  δ 169.8, 158.5, 140.3, 137.4, 132.8, 131.0, 130.3, 
130.2, 126.0, 121.6, 114.8, 80.8, 67.5, 67.2, 53.8, 48.5, 45.1, 42.0, 35.0, 33.9, 26.5. 
DIAD (1.30 g, 6.43 mmol) was added dropwise slowly to an oven dried flask 
charged with 1 (0.5 g, 4.54 mmol) and 2 (2.0 g, 6.77 mmol), and TTP (1.60 g, 6.10 
mmol) in Dry THF (15 mL) ) and the mixture was cooled to 0 
oC. The reaction mixture 
was stirred at room temperature overnight, concentrated, and then subjected directly to 
column chromatography (eluent: hexane/EtOAc as 4:1(v/v)) to afford 3 (1.08 g , 62% 
yield) as light yellow oil. 
Compound 3 (1.0g, 2.58 mmol) was dissolved in THF (10 mL) and aqueous 
NaOH (1.0 M, 3.35 mL) was added dropwise. The mixture was stirred at room 
temperature for 2 hours, diluted with water (10 mL), and then extracted with Et2O (20 
mL). The aqueous layer was collected, and adjusted to pH = 1 with HCl (3.0 M in 
water). The resulting mixture was then extracted with EtOAc (10 mL × 2) and the 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure to get acid compound, which was used directly in the next step without 
further purification.  
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The compound (0.7 g, 1.87 mmol) obtained from the above step was dissolved in 
anhydrous dioxane (10 mL) followed by an injection of HCl/dioxane solution (4.0 M, 
1.29 mL). The resulting mixture was stirred at room temperature for 12 hours. The white 
solid was collected by filtration and washed sequentially with EtOAc and DCM, then 
dried under vacuum using oil pump to afford the final product NCAA 2 (Scheme III-3) 
as white solid (0.33 g, 47% over two steps). 
1H NMR (CD3OD, 300 MHz) δ 7.23 (d, 2H, J = 7.2 Hz), 6.93(d, 2H, J = 7.5 Hz), 
6.35 (m, 1H), 6.07 (m, 1H), 4.61(m, 1H), 4.36 (m, 1H), 3.24 (ABq, 2H, J = 6.9, 14.1 
Hz), 3.00 (brs, 1H), 2.91(brs, 1H), 1.94-1.83 (m, 1H), 1.63-1.41 (m, 1H), 1.31-1.15 (m, 
2H).  
 13C NMR (CD3OD, 75 MHz)  δ 170.1, 157.4, 140.9, 132.3, 130.7, 125.8, 115.6, 
115.5, 69.5, 54.0, 45.0, 40.0, 35.0, 33.0, 29.0. 
The synthesis of transcyclooctene derivatives followed the procedures developed 
by Fox et al.130  To a stirred solution of 1,5-cyclooctadiene (10.0 g, 96 mmol, 1.0 equiv) 
in dry DCM (150 mL) at 0 oC was added slowly m-CPBA (18.5 g, 113 mmol, 1.2 
equiv). The mixture was stirred for 1 hour 30 minutes at room temperature. Then a 
saturated solution of Na2S2O3 (15 mL) was added and the mixture was extracted with 
DCM. The organic layer was washed with H2O twice, saturated NaHCO3 twice and then 
saturated Na2S2O3 twice. The organic layer was then dried with Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by column chromatography 
afforded the product 3 as liquid (8.6 g, 72%).  
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To a stirred solution of LAH (2.8 g, 80 mmol) in dry THF (20 mL) at 0 oC was 
added dropwise a solution of 3 (7.8 g, 62.9 mmol) in THF under argon.  The mixture 
was stirred for 4 hours at room temperature It was then cooled to at 0 oC, diluted with 
ether, and quenched by dropwise addition of a saturated solution of Na2SO4 (15 mL). 
The reaction mixture was extracted with EtOAc. The organic layer was then dried with 
Na2SO4, filtered and concentrated in vacuo. Purification of crude product by column 
chromatography afforded the product 4 as liquid (5.78 g, 73%). 
NaH (2.28 g, 52.8 mmol) was washed with dry hexane (15 mL) and then 
decanted. Dry THF (20 mL) was added and the mixture was allowed to stir at room 
temperature cis-Cyclooctene-4-ol 4 (1.668 g, 13.22 mmol) in THF (15 mL) was added to 
the flask. The mixture was stirred and heated to reflux for 1 hour. α-Bromoacetic acid 
(1.838 g, 13.22 mmol) in THF (25 mL) was added and the mixture was allowed to reflux 
overnight. The mixture was cooled to room temperature and then concentrated on the 
rotary evaporator. The residue was cooled in an ice bath and water was added followed 
by acidification with 3 M HCl. The aqueous layer was extracted with three portions of 
Et2O. The extracts were dried with Na2SO4 and concentrated in vacuo to provide an oil 
compound. The title compound was used directly for the next reaction without further 
purification. 
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Scheme III-2. Synthesis of NCAA 1. 
 
 
 
 
 
Scheme III-3. Synthesis of NCAA 2. 
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The above acid compound (1.8 g, 9.89 mmol) was dissolved in DMF (20 mL). 
K2CO3 (2.71 g, 19.63 mmol) was added followed by dropwise addition of methyl iodide 
(1.2 mL, 19.78 mmol). The mixture was stirred at 60 oC for 1 hour. The reaction system 
was diluted with EtOAc, and then washed sequentially with water and HCl (1 M). The 
organic layer was separated and dried with anhydrous Na2SO4. After filtration, the 
organic layer was concentrated. Column chromatography with hexanes/EtOAc as eluent 
(9:1 v/v) afforded pure methylester product 5 in (1.57 g, 60%). 
To a stirred solution of LAH (0.275 g, 7.85 mmol) in dry THF (10 mL) at 0 oC 
was added dropwise a solution of 5 (1.3 g, 6.56 mmol) in THF under argon.  The 
mixture was stirred for 4 hours at room temperature. It was then cooled to 0 oC, diluted 
with ether, and quenched by dropwise addition of a saturated solution of Na2SO4 (15 
mL). The reaction mixture was extracted with EtOAc. The organic layer was then dried 
with Na2SO4, filtered and concentrated in vacuo. Purification of crude product by 
column chromatography afforded the product 6 as liquid (0.66 g, 60%). 
(Z)-2-(cyclooct-4-en-1-yloxy) ethanol 6 (3.8 g, 18.6 mmol) and methyl benzoate 
(4.98 g, 37.2 mmol) were dissolved in 500 mL of 9:1 ether:hexane in a quartz flask. The 
photoisomerization was carried out using the flow apparatus described previously.1,2 The 
column was packed with 8.5 cm of silica gel, and then silver impregnated silica gel (16 
g) on top. The column was flushed with 9:1 ether:hexane (250 mL). The pump was 
turned on at a flow rate of 100 mL/min and irradiation begun. Photoisomerization of the 
mixture was carried out for 6 hours.  
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The column was flushed with 9:1 ether:hexane (250 mL) and then dried with 
compressed air. The silica was placed into an Erlenmeyer flask and stirred with 
ammonium hydroxide (200 mL) and methylene chloride (200 mL) for 5 minutes. The 
silica gel was filtered and the filtrate was placed into a separatory funnel. The organic 
layer was separated, and the ammonium hydroxide layer was extracted three times with 
methylene chloride. The organic layers were combined and washed with water twice. 
The organic layers were then dried with MgSO4, filtered, and purified by column 
chromatography with 5% ether to 30% ether in hexanes. Two diastereomers, 0.989 g 
(32%) of compound 7 (DS2) and 0.366 g (18%) of compound 8 (DS1) (Scheme III-4) as 
colorless oils, were isolated. 
 
Spectroscopic Properties of the Major Diastereomer 7 
1H NMR (CDCl3, 300 MHz) δ 5.66-5.56 (m, 1H), 5.45-5.36 (m, 1H), 3.70-3.35 
(m, 2H), 3.55-3.48 (m, 1H), 3.45-3.40 (m, 1H), 3.08-3.05 (d, 1H, J = 0.9 Hz), 2.41-2.31 
(m, 2H), 2.20-1.89 (m, 6H), 1.64-1.48 (m, 2H). 13C NMR (CDCl3, 75 MHz)  δ 135.3, 
132.3, 86.0, 69.1, 62.0, 40.7, 37.7, 34.5,  32.9, 31.6. 
 
Spectroscopic Properties of the Minor Diastereomer 8  
1H NMR (CDCl3, 300 MHz)  δ 5.46-5.60 (m, 2H), 3.78-3.67 (m, 2H), 3.65-3.62 
(m, 1H), 3.61-3.55(m, 1H), 3.42-3.52 (m, 1H), 2.40-2.02  (m, 4H), 1.88-1.79  (m, 4H), 
1.58-1.50 (m, 1H), 1.28-1.16 (m, 1H). 13C NMR (CDCl3, 75 MHz)  δ 135.8, 131.3, 74.9, 
69.6, 62.1, 40.1, 34.4, 32.9, 29.8, 27.6. 
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Scheme III- 4. Synthesis of transcyclooctene derivatives. 
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DIAD (0.533 g, 2.64  mmol) was added dropwise slowly to an oven dried flask 
charged with compound 8  (0.3 g, 1.76 mmol), compound 9 (0.78 g, 2.64 mmol) and 
TTP (0.646 g, 2.47 mmol) were dissolved in Dry THF¬ (10 mL) ) and the mixture was 
cooled to 0 oC. The reaction mixture was stirred at room temperature overnight. The 
reaction mixture was then concentrated and subjected directly to column 
chromatography with hexane/ EtOAc (4:1) as eluent to afford 10 (0.47 g , 60% yield) as 
light yellow oil. 
Compound 10 (0.4 g, 0.65 mmol) was dissolved in THF (8 mL), and aqueous 
NaOH (1.0 M, 1.06  mL) was added dropwise. The mixture was stirred at room 
temperature for 2 hours, diluted with water (5 mL), and then extracted with Et2O (100 
mL). The aqueous layer was collected, and adjusted to pH = 1 with HCl (3.0 M in 
water). The resulting mixture was extracted with EtOAc (10 mL × 2) and the combined 
organic layers were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to get acid compound, which was used directly in the next step without further 
purification.  
The compound (0.21 g, 0.50 mmol) obtained from the above step was dissolved 
in anhydrous dioxane (8 mL) followed by an injection of HCl/dioxane solution (4.0 M, 
0.5 mL). The resulting mixture was stirred at room temperature for 12 hours. The white 
solid was collected by filtration and washed sequentially with EtOAc and DCM, then 
dried in vacuo using oil pump to afford the final product NCAA 3 as white solid (0.179 
g, 56% over two steps). (Scheme III-5). 
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1H NMR (CD3OD, 300 MHz) δ 7.21 (d, 2H, J = 5.1 Hz), 6.99 (d, 2H, J = 4.8 Hz), 
5.65 (m, 2H), 4.30-4.21 (m, 2H), 4.12-4.09 (m, 1H), 3.87 (t, 1H, J = 5.1 Hz), 3.82-3.62 
(m, 1H), 3.60-3.55 (m, 1H), 3.24 (ABq, 2H, J = 6.9, 14.4 Hz), 2.20-2.14 (m, 2H), 2.09-
1.98 (m, 2H), 1.95-1.60 (m, 6H).  
13C NMR (CD3OD, 75 MHz)  δ 169.8, 158.5, 130.4, 130.3, 114.9, 114.8, 79.2, 
67.6, 66.7, 61.8, 53.8, 36.1, 35.0, 32.1, 19.9. 
DIAD (1.60 g,  7.94  mmol) was added dropwise slowly to an oven dried flask 
charged with compound 7 (0.9 g, 5.29 mmol), compound 9 (2.34 g,7. 94 mmol) and TTP 
(1.94 g, 7.41  mmol) in Dry THF (20 mL) and the mixture was cooled to 0 
oC. The reaction 
mixture was stirred at room temperature overnight, concentrated, and then subjected 
directly to column chromatography with hexane/ EtOAc (4:1) as eluent to afford 11 (1.41 
g , 60% yield) as light yellow oil. 
Compound 11 (1.2g, 1.95 mmol) was dissolved in THF (8 mL) and aqueous 
NaOH (1.0 M, 3.2 mL) was added dropwise. The mixture was stirred at room 
temperature for 2 hours, diluted with water (10 mL), and then extracted with Et2O (20 
mL). The aqueous layer was collected, and adjusted to pH = 1 with HCl (3.0 M in 
water). Then the resulting mixture was extracted with EtOAc (10 mL × 2) and the 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure to get an acid compound, which was used directly in the next step 
without further purification.  
The compound (0.65 g, 1.50mmol) obtained from the above step was all 
dissolved in anhydrous dioxane (8 mL) followed by an injection of HCl/dioxane solution 
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(4.0 M, 1.5 mL). The resulting mixture was stirred at room temperature for 12 hours. 
The white solid was collected by filtration, washed sequentially with EtOAc and DCM, 
and then dried in vacuo using oil pump to afford the final product NCAA 4 (Scheme III-
6) as white solid (0.538g, 56% over two steps). 
1H NMR (CD3OD, 300 MHz) δ 7.30 (d,  2H, J = 9.0 Hz),  6.94 (d,  2H, J = 8.7 
Hz), 5.61 (ddd,  1H, J = 10.8, 15.9 Hz), 5.41 (ddd,  1H, J = 7.5, 16.2 Hz) 4.24-4.20  (m, 
1H), 4.11-4.09 (m, 2H), 3.82-3.68 (m, 1H),  3.66-3.62 (m, 2H), 3.20 (ABq, 2H, J = 6.9, 
14.7 Hz), 2.39-2.23 (m, 2H), 2.19-2.08 (m, 2H), 1.96-1.80 (m, 4H), 1.61-1.47 (m, 2H). 
13C NMR (CD3OD, 75 MHz)  δ 169.8, 158.8, 134.9, 131.9, 130.3, 126.1, 114.8, 
88.0, 67.5, 66.5, 53.8, 40.4, 37.5, 35.0, 34.0, 32.5, 31.3. 
A solution of L-tyrosine (5.45 g, 30 mmol) in methanolic HCl was stirred at 
reflux overnight under argon and then taken to dryness to give pure methyl tyrosinate 
hydrochloride (6.84 g, 98%). To a solution of sodium carbonate (3.87 g, 46.5 mmol) in 
water (70 mL) was added methyl tyrosinate hydrochloride (3.55 g, 15.25 mmol). After 
formation of a clear solution, Fmoc-O-(N-hydroxysuccinimide) (5.2 g, 15.35 mmol) in 
dioxane (70 mL) was added dropwise, giving a white suspension. The mixture was 
stirred under argon overnight, adjusted to pH 2 by addition of 6 N HCl, extracted with 
EtOAc (3 x 100 mL), washed with brine (2 x 20 mL), and dried (NaS04). Removal of  
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Scheme III-5. Synthesis of NCAA 3. 
 
 
 
 
Scheme III-6. Synthesis of NCAA 4. 
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solvent and purification by silica gel chromatography (hexane/EtOAc, 4: 1) afforded 
methyl -Fmoc-L-tyrosinate (3) (6.35 g, 99%). 
The synthesis of cyclooctyne derivatives followed the procedures developed by 
Lemke  et al.131 4.0 g of cycloheptene (41.6 mmol), 9.33 g of Bu tOK (83.3 mmol), and 
9 ml of anhydrous pentane are introduced into a dry round-bottomed flask under argon. 
The solution, placed in an ice/salt bath (<-5 oC), is vigorously stirred and then 5.5 ml of 
bromoform (62.5 mmol) are added dropwise. Once the addition is complete, the mixture 
is allowed to return to room temperature overnight under argon and with vigorous 
stirring. Approximately 50 ml of water are subsequently added and the pH is neutralized 
with 1M HCl. The organic and aqueous phases are separated; the aqueous phase is 
extracted with 3 × 20 ml of pentane and the pentane phase is washed with 3 × 20 ml of 
water. After drying over MgSO4, the solvent is evaporated under vacuum to give orange-
yellow oil. The product 4 is subsequently purified by filtration through silica with 
cyclohexane/AcOEt (19:1) as eluent to afford colorless oil (7.80 g, 70% yield).  
Compound 4 (6.0 g, 22.3 mmol) and anhydrous ethane-1,2-diol (22.2 mL, 447 
mmol, 20 eq) were dissolved in anhydrous acetone (38 mL), Anhydrous AgClO4 (13.9 g, 
67.1 mmol) was added in small portions under exclusion of light and stirred at room 
temperature for 1 hour. After addition of EtOAc (100 mL) and filtration, 1M HCl (100 
mL) was added and the aqueous layer was extracted with EtOAc (3x50 mL). The 
combined organic layer were washed with 1M HCl in saturated NaCl solution (100 mL 
each) and dried over Na2SO4. The solvent was evaporated under reduced pressure and 5 
(2.11 g, 38%) was obtained as yellow oil and used without further purification. 
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Compound 5 (3 g, 12.0 mmol) was dissolved in DMSO (30 mL) and heated to 60 
oC. DBU (3.66 mL, 24.0 mmol, 2.0 eq) was added, the resulting solution was stirred for 
15 minutes and more DBU (14.6 mL, 96.0 mmol, 8.0 eq) was added. The mixture was 
stirred at 60 oC overnight and then cooled to room temperature EtOAc (100ml) and 
water (100 ml) were added. After acidification to pH 1 with concentrated HCl, the 
aqueous phase was extracted with EtOAc (3 x 50ml). The combined organic layer were 
washed with 1M HCl in saturated NaCl solution (100 each) and dried over Na2SO4. The 
solvent was evaporated under reduced pressure. The compound 6 (COY, 1.20 g, 60% 
yield) was afforded after column chromatography as light yellow oil. 
DIAD (1.98 g, 9.82 mmol) was added dropwise slowly to an oven dried flask 
charged with compound 6 (1.10 g, 6.54 mmol), compound 3 (2.89 g, 9.82 mmol) and 
TTP (2.6 g, 9.82 mmol) dissolved in Dry THF (20 mL) and the mixture was cooled to 0 
oC. The reaction mixture was stirred at room temperature overnight. The reaction 
mixture was then concentrated and subjected directly to column chromatography 
(hexane/EtOAc as 4:1) to afford 7 (1.74 g, 60% yield) as light yellow oil. 
Lithium hydroxide monohydrate (44 mg, 1.05 mmol) was added to a stirring 
solution of compound 7 (0.5 g, 0.881 mmol) in THF/H2O (3:1, 8 mL). The solution was 
stirred for 4 hours at room temperature and EtOAc (100 mL) and H2O (100 mL) were 
added. The aqueous phase was carefully acidified to pH 4 by the addition of HCl and 
extracted with EtOAc (4 x 50 mL). The aqueous phase was then evaporated under 
reduced pressure to yield NCAA 5 (Scheme III-7), (0.2 g, 61.9%) as a white solid.  
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1HNMR (300MHz, CD3OD) δ 7.27(d 2H, J = 7.8 Hz), 6.95 (d 2H, J = 7.8 Hz), 
4.32-4.28 (m, 1H), 4.10-4.14 (m, 3H), 3.96-3.80 (m, 1H), 3.62-3.75 (m, 1H), 3.20 (ABq, 
2H, J = 22.0, 6.6 Hz), 2.24-2.04 (m, 2H), 1.98-1.89  (m, 6H), 1.85-1.50 (m, 2H), 
13CNMR (75 MHz, CD3OD):  δ 169.9, 156.8, 130.2, 124.5, 115.4, 99.4, 92.2, 
72.4, 70.1, 60.7, 53.9, 41.9, 35.0, 34.0, 29.5, 26.0, 19.8. 
 
 
 
 
Scheme III-7. Synthesis of NCAA 5. 
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NaH (1.5 g, 62.5 mmol) was washed with dry hexane (15 mL) and then decanted. 
Dry THF (15 mL) was added and the mixture was allowed to stir at room temperature 5-
Norbornene-2-methanol  (2.0 g, 16.12  mmol) in THF (15 mL) was added to the flask. 
The mixture was stirred and heated to reflux for 1 hour. α-Bromoacetic acid (2.23 g, 
16.12 mmol) in THF (10 mL) was added and the mixture was allowed to reflux 
overnight. The mixture was cooled to room temperature and then concentrated on the 
rotary evaporator. The residue was cooled in an ice bath and water was added followed 
by acidification with 3 M HCl. The aqueous layer was extracted with three portions of 
Et2O. The extracts were dried over Na2SO4 and concentrated in vacuo to provide an oil-
type compound. The title compound was used directly for the next reaction without 
further purification. 
The above acid compound (1.5 g, 8.24 mmol) was dissolved in DMF (20 mL) 
followed by the addition of K2CO3 (2.27 g, 16.48 mmol). Methyl iodide (1.05 mL, 16.48 
mmol) was then added dropwise. The mixture was stirred at 60 oC for 1 hour. The 
reaction mixture was diluted with EtOAc, and then washed sequentially with water and 
HCl (1 M). The organic layer was separated and dried over anhydrous Na2SO4. After 
filtration, the organic layer was concentrated. Column chromatography with 
Hexanes/EtOAc as eluent (9:1 v/v) afforded pure methylester product 2 (1.11 g, 72%). 
To a stirred solution of LAH (0.214 g, 6.12 mmol) in dry THF (10 mL) at 0 oC 
was added dropwise a solution of 2 (1.0 g, 5.10 mmol) in THF under argon.  The 
mixture was stirred for 4 hours at room temperature It was then cooled to 0 oC, diluted 
with Et2O and quenched by dropwise addition of a saturated solution of Na2SO4 (10 
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mL). The reaction mixture was then extracted with EtOAc. The organic layer was dried 
with Na2SO4, filtered and concentrated in vacuo. Purification of crude product by 
column chromatography afforded the product 3 (0.59 g, 70%) as liquid. 
DIAD (0.9 g, 4.41 mmol) was added dropwise slowly to an oven dried flask 
charged with compound 3 (0.5 g, 2.97 mmol), compound 4 (1.31 g, 4.46 mmol), and 
TTP (1.09 g, 4.16 mmol) dissolved in Dry THF (10 mL) and the mixture was cooled to 0 
oC. The reaction mixture was stirred at room temperature overnight. The reaction 
mixture was then concentrated and subjected directly to column chromatography with 
Hexane/ EtOAc (4:1) as eluent to afford 5 (0.86 g, 65%) as light yellow oil. 
Compound 5 (0.8 g, 1.79 mmol) was dissolved in THF (10 mL), and aqueous 
NaOH (1.0 M, 2.33 mL) was added dropwise. The mixture was stirred at room 
temperature for 2 hours, diluted with water (10 mL), and then extracted with Et2O (20 
mL). The aqueous layer was collected, and adjusted to pH = 1 with HCl (3.0 M in 
water). The resulting mixture was extracted with EtOAc (2 × 10 mL). The combined 
organic layers were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to get acid compound, which was used directly in the next step without further 
purification.  
The compound (0.6 g, 1.39 mmol) obtained from the above step was dissolved in 
anhydrous dioxane (10 mL) followed by an injection of HCl/dioxane solution (4.0 M, 
0.696 mL). The resulting mixture was stirred at room temperature for 12 hours. The 
white solid was collected by filtration, washed sequentially with EtOAc and DCM, and 
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then dried in vacuo using oil pump to afford the final product NCAA 6 (Scheme III-8) as 
white solid (0.27 g, 53% over two steps). 
1H NMR (CD3OD, 300 MHz) δ 7.20 (d, 2H, J = 8.7 Hz), 6.93 (d, 2H,  J = 7.5 
Hz), 6.13-6.07 (m, 1H), 5.92 (dd, 1H,  J = 3.3, 6.0 Hz),  4.18 (t, 1H, J = 5.2 Hz), 4.13-
4.07 (m, 2H), 3.79-3.69 (m, 2H), 3.23-3.07(m, 4H), 3.04(m, 1H), 2.88(m, 1H), 2.39-
2.34(m, 1H), 1.86-1.76(m, 1H), 1.52-1.24(m, 2H), 0.51(dd, 1H, J = 3.3, 7.5 Hz). 
13C NMR (CD3OD, 75 MHz)  δ 169.8, 158.5, 136.7, 136.3, 136.1, 132.0, 130.3, 
126.1, 114.8, 74.7, 69.1, 67.2, 53.9, 48.9, 44.5, 42.0, 38.4, 35.0, 28.6. 
DIAD (1.22 g, 6.03 mmol) was added dropwise slowly to an oven dried flask 
charged with compound 1 (0.5 g, 4.03 mmol), compound 2 (1.70 g, 5.76 mmol) and TTP 
(1.60 g, 6.03 mmol) dissolved in Dry THF (15 mL) and the mixture was cooled to 0 
oC. 
The reaction mixture was stirred at room temperature overnight. The reaction mixture 
was then concentrated and subjected directly to column chromatography with 
hexane/EtOAc (4:1) to afford 3 (1.04 g, 65%) as light yellow oil. 
Compound 3 (1.0 g, 2.49 mmol) was dissolved in THF (10 mL) and aqueous 
NaOH (1.0 M, 3.2 mL) was added dropwise. The mixture was stirred at room 
temperature for 2 hours, diluted with water (10 mL), and then extracted with Et2O (20 
mL). The aqueous layer was collected and adjusted to pH = 1 with HCl (3.0 M in water). 
The resulting mixture was extracted with EtOAc (2 × 10 mL) and the combined organic 
layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure to 
get acid compound, which was used directly in the next step without further purification.  
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  The compound (0.8 g, 2.58 mmol) obtained from the above step was dissolved in 
anhydrous dioxane (10 mL), and followed by an injection of HCl/dioxane solution (4.0 
M, 1.29 mL). The resulting mixture was stirred at room temperature for 12 hours. The 
white solid was collected by filtration, washed sequentially with EtOAc and DCM, and 
then dried in vacuo using oil pump to afford the final product NCAA 7 (Scheme III-9) as 
white solid (0.4 g, 66% over two steps). 
1H NMR (CD3OD, 300 MHz) δ 7.23 (d, 2H, J = 5.1Hz), 6.91(d, 2H, J = 6.9 Hz), 
6.18 (m, 1H), 5.95 (dd, 1H, J = 3.0, 5.7 Hz), 4.21 (t, 1H, J = 5.7 Hz), 3.73 (t, 1H, J = 6.6 
Hz), 3.57 (t, 1H, J = 9.3 Hz), 3.19 (ABq, 2H, J = 7.8, 14.4 Hz), 3.02 (brs, 1H), 2.85 (brs, 
1H), 2.85-2.58 (m, 1H), 1.99-1.92 (m, 1H), 1.48-1.31 (m, 2H), 0.65 (ddd, 1H,  J = 2.4, 
4.2, 6.9 Hz).  
13C NMR (CD3OD, 75 MHz) δ 169.8, 158.8, 137.1, 131.8, 130.2, 125.0, 114.6, 
71.1, 53.8, 48.9, 43.7, 42.0, 38.2, 28.4. 
Kinetic Characterizations 
All kinetic measurements were carried out using a PTI QMA40 fluorescent 
spectrophotometer. For IEDDAC reactions between strained alkenes/alkynes and FITC-
TZ (Scheme III-10), fluorescent emission was monitored at 515 nm with an excitation 
light at 493 nm. For NADC reactions between strained alkenes/alkynes with a 
hydrazonyl chloride (HZCL) that served as a nitrilimine precursor, fluorescent emission 
was monitored at 480 nm with an excitation light at 318 nm. Data were collected during 
a reaction period of 1 hour. 
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Scheme III-8. Synthesis of NCAA 6. 
 
 
 
 
Scheme III-9. Synthesis of NCAA 7. 
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Scheme III-10. Synthesis of FITC-TZ. 
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DNA and Protein Sequences 
Gene and protein sequences of pylT, Methanosarcina mazei PylRS and sfGFP were 
listed in the DNA sequence of Experimental Section in Chapter II. 
Construction of Plasmid 
Plasmid Construction - pEVOL-pylT-N346A/C348A/Y384F/Y306A  
 The plasmid pEVOL-pylT- Y306A/N346A/C348A/Y384F was derived from 
pEVOL-pylT-N346A/C348A132 that carried a tRNACUA
Pyl
 under the control of the proK 
promoter and terminator and a N346A/C348A form of the Methanosarcina mazei PylRS 
gene under the control of the glnS promoter and terminator. Two primers PylRS-Y384F-
Fwd: 5’-tggggatacccttgatgtaatgcacg-3’ and PylRS-Y384F-Rev: 5’-
aagaccatgcaggaatcgcctacgat-3’ were used to run quick-change mutagenesis to introduce 
the Y384F mutation. The primers PylRS-Y306A-Fwd: 5’-aactacctgcgcaagcttgacagggc-
3’ and PylRS-Y384F-Rev: 5’-cgcaaggtttggagcaagcatgggt-3’ were used to run quick-
change mutagenesis to introduce the Y306A mutation. 
sfGFP Protein Expression and Purification 
sfGFP Protein Expression 
The pET-sfGFPS2TAG plasmid previously reported132 was co-transformed with 
pEVOL-pylT-N346A/C348A/Y384F/Y306A into E. coli BL21 (DE3) cells. From a 
single colony, a 5 mL overnight culture was prepared and inoculated into 300 mL LB 
medium supplemented with 100 µg/mL Ampicillin and 34 µg/mL Chloramphenicol and 
let grow at 37 °C. When OD600 reached 0.6, expression was induced with 1 mM IPTG, 
0.2 % arabinose and 1 mM of a NCAA. After induction for 8 hours, cells were harvested 
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and suspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 
8.0), sonicated in an ice water bath (ice bath temperature was 10 °C before each 3 
minute run of the sonication). The cell lysate was clarified by centrifugation (4 °C for 60 
minutes at 11,000 g).  
The crude supernatant was decanted and allowed to bind to 5 mL of Ni-NTA 
superflow resin at 4 °C for 1 hour. The mixture was loaded into a empty cartridge and 
washed with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0). 
sfGFP was eluted with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, pH 8.0). Eluted fractions were concentrated in 10 k MWCO cut filter unit and 
dialyzed against 10 mM ammonium bicarbonate. The protein purity was analyzed by 
12% SDS-PAGE and characterized using electrospray ionization mass spectrometry 
(ESI-MS). 
Protein Labeling 
FITC-TZ Protein Labeling 
0.1 mM FITC-TZ was added to each of the solutions of sfGFP incorporated with 
a NCAA in PBS (pH 7.4) buffer. The reaction was carried out at room temperature for 1 
hour. The protein was purified with NI-NTA resin and analyzed with 12% SDS-PAGE. 
The fluorescence was detected using a regular UV transilluminator (Figure III-1). 
 
HZCL Protein Labeling 
0.5 mM HZCL was added to a solution of sfGFP incorporated with a NCAA in 
PBS (pH 7.4) buffer. The reaction was also carried out at room temperature for 1 hour. 
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The protein was analyzed with 12% SDS-PAGE. The fluorescence was detected in a 
Biorad ChemiDoc XRS+ system under UV irradiation (Figure III-1). 
 
 
 
Figure III-1. Structure of a (A) Fluorescein Tetrazine Dye (FITC-TZ) (B) Hydrozonoyl 
Chloride, HZCL. 
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Fluorescent Protein Labeling on Living Cell 
BL21(DE3) cell was transformed to carry plasmids pEVOL-PylT-
Y306A/N346A/C348A/Y384F and pETDuet-OmpXTAG. A medium shift protocol was 
used to overexpress the OmpX protein. Bl21(DE3) cell was grown to OD600 of 1 and 
pelleted. After 3 washes of the cell pellet with PBS, the cells were resuspended in 
minimal medium supplied with IPTG (0.5 mM), arabinose (0.2%) and a NCAA 4, 5 and 
6 (5 mM), and was incubated at 25 oC for 20 hours.  The cell was then pelleted and 
washed with isotonic saline 3 times before incubated with FITC-TZ (0.5 mM) or HZCL 
(0.5 mM) at room temperature. The incubation time for cell labeling is typically 3 hours. 
After the reaction, the cell was pelleted by centrifugation, washed with PBS for 4 times 
and subjected to the fluorescence microscopy for cell imaging. The cell culture without a 
NCAA supplement in the medium served as the control and treated following the same 
protocol. 
Microscopy 
Microscopy was performed using an Olympus IX-81 inverted microscope (Olympus 
America, Center Valley PA, USA) equipped with UPLSAPO 100x/1.4 oil immersion 
objective, a Rolera XR CCD camera (Q imaging, Surrey BC, Canada) and a Proscan 
H117 motorized XY stage (Prior Scientific, Rockland, MA, USA) controlled by the 
µManager freeware (http://www.micro-manager.org). A field lens of 1.6x magnification 
was used to achieve Nyquist sampling for imaging.  The following fluorescence filter 
sets (Chroma technology Corp., Bellows Falls, VT, USA) were used, with the central 
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wavelength and bandwidth of the excitation and emission filters as indicated: GFP (Ex. 
470/40; Em. 525/50); DAPI (Ex. 350/50; Em. 460/50). 
Results and Discussion 
Kinetic characterization of EDDAC reactions of norbornene, transcyclooctene, and 
cyclooctyne 
Kinetic investigations of reactions between strain-promoted alkene/alkyne dienophiles 
and tetrazines have been reported.122, 133, 134 However, solvent systems, tetrazines, 
dienophiles, and methods of kinetic determination varied in previous reports, making it 
challenging to compare relative reactivities of dienophiles with tetrazines of interest. We 
chose to characterize EDDAC reactions of strain-promoted alkene/alkyne dienophiles in 
the PBS buffer at pH 7.4 to best represent their kinetics in living systems. 
 
Figure III-2. Structures of four strain-promoted alkene/alkyne molecules. 
 
 
  
 
I performed all experiments except the synthesis of the alkene/alkyne containing 
compounds (NCAA 1-7) and the FITC-TZ dye which were synthesized by Dr. 
Yadagiri Kurra. Characterizations of FITC-TZ and HZCl were also carried out by Dr. 
Yadagiri Kurra. Living cells were fluorescently labeled by Dr. Yan-Juin Lee. 
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Three strain-promoted alkenes, 5-norbornen-2-ol and two diastereomers of (E)-2-
(cyclooct-4-en-1-yloxyl) ethanol, and cyclooct-2-ynol (NOR, DS1, DS2, and COY in 
Figure III-2) as dienophiles and a fluorescein tetrazine (FITC-TZ in Figure III-1) were 
chosen for kinetic studies. DS1 and DS2 are two diasteromeric products (ratio close to 
1:2) of the UV-induced isomerization of (Z)-2-(cyclooct-4-en-1-yloxyl) ethanol. As 
minor products, DS1-like molecules were mostly dismissed in previous reports. Since 
structure differences between DS1 and DS2 may lead to different reactivities with a 
tetrazine, they were both included in our studies.  
FITC-TZ has a tetrazine entity that efficiently quenches the fluorescence 
emission of fluorescein. Its reaction with a dienophile will remove this quenching effect, 
making the reaction to be easily tracked using a fluorometer. Since submicromolar 
concentrations can be applied in this kind of fluorescent studies, superfast reactions can 
be effectively analyzed. The reactions of all four dienophiles with FITC-TZ were carried 
out in pseudo-first-order conditions in which a dienophile was at least 20-fold of FITC-
TZ (Figure III-1).  
For NOR and COY, FITC-TZ was used at 1 µM for optimal signal-to-noise 
ratios of collected data. Concentrations of NOR and COY were chosen to give reliable 
data during a 1 hour reaction for the subsequent analysis. For DS1 and DS2, their 
reactions with FITC-TZ are so fast that the concentration of FITC-TZ had to be 
significantly reduced to 250 pM in order to detect the reaction process, leading to 
relatively low signal-to-noise levels. Data collected at all conditions were fit nicely to a 
single exponential increase equation 𝐹 = 𝐹1 − 𝐹2 × 𝑒
(−𝑘′×𝑡), where F is the detected 
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fluorescent signal at a give time, F1 the final fluorescence, F1-F2 the background 
fluorescent signal, and k’ the apparent pseudo first-order rate constant. The determined 
values of k’ were plotted against dienophile concentrations and fitted to equation 
𝑘′ = 𝑘 × [𝑑𝑖𝑒𝑛𝑜𝑝ℎ𝑖𝑙𝑒] + 𝐶 
where k is a second-order rate constant of a reaction of a dienophile with FITC-TZ. The 
calculated second-order rate constants for all four dienophiles are shown in Table III-1.  
Among all four dienophiles, NOR reacts slowest with FITC-TZ (Figure III-3). 
The determined rate constant is similar to what have been reported of reactions between  
 
 
 
Table III-1. Second-order rate constants of reactions of strain-promoted alkene/alkyne 
dienophiles with FITC-TZ. 
 
 
norbornenes and tetrazines.134-136 The determined rate constant for COY is 20-fold lower 
than what was reported by Lemke and coworkers.137 This discrepancy may be attributed 
to different tetrazine dyes used in the two analyses. Both DS1 and DS2 react exceedingly 
fast with FITC-TZ, several orders of magnitude faster than reactions of NOR and COY. 
For DS2, its reaction with FITC-TZ has a rate constant in the same range of those of 
reported rapid transcyclooctene reactions with tetrazines.133, 134, 138, 139  
The reaction of DS1 with FITC-TZ is almost five-fold of that of DS2. With this 
fast rate constant, a reaction with both reactants at 1 µM will finish to 97% in 100 
 104 
 
seconds. As slightly minor products during synthesis, applications of DS1-like 
molecules have long been ignored. The current study indicates that DS1 is a much better 
choice than DS2 for applications that require labeling molecules at very dilute conditions 
such as in living systems.  
To address this reactivity difference between DS1 and DS2, we carried out a 
detailed computational study at the CPCM-M06-2X/6-311+G(d,p) level of theory140-142 
This level of theory provides accurate reaction barriers for Diels-Alder cycloadditions, 
and has been employed in similar studies of strain-promoted click reactions by Houk and 
co-workers.143  We predict free energy barriers of 14.0 and 15.5 kcal mol–1 for the 
EDDAC of slightly simplified models of DS1 and DS2 with 3-phenyl-1,2,4,5-tetrazine, 
respectively.  This corresponds to a predicted rate for DS2 that is twelve-times that of 
DS1, in reasonable agreement with the experimentally observed five-fold difference. 
The 1.5 kcal mol–1 difference in barrier heights can be explained in part through 
distortion-interaction analyses, in which the energy barrier for bimolecular is 
decomposed into the energy required to distort the reactants into the geometry of the 
transition state (Edist) and the stabilization provided by bringing these two distorted 
reactants together (Eint).  In particular, we found out that both the interaction energies 
and distortion energies slightly favor DS2 over DS1. This net 0.8 kcal mol–1 difference, 
combined with a 0.9 kcal mol–1 contribution from vibrational and entropy effects, leads 
to the final free energy difference of 1.5 kcal mol–1. 
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Kinetic Characterization of NIADC Reactions of Norbornene, Transcyclooctene, and 
Cyclooctyne 
It was demonstrated previously that olefins, serving as dipolarphiles, react with 
diaryl nitrile imines to form fluorescent pyrazoline products with appreciable reaction 
rates in mild aqueous conditions.125 Due to the labile nature of nitrile imines, currently 
two methods are used to generate them transiently in aqueous conditions. One is the 
photolysis of tetrazoles; the other is the simultaneous dissociation of hydrozonoyl 
chlorides in water.144, 145  
The first method has been significantly expanded by Lin and coworkers for 
photo-click labeling of biomolecules.146-149 The second method has been recently applied 
to label biomolecules that contain norbornene and acrylamide functionalities.50, 150 We 
chose the second method due to its relative simplicity during kinetic investigations.  
We recently reported that NOR reacts readily with a hydrozonyl chloride shown 
as HZCL in Figure III-4 with a rate constant as 0.75 M-1s-1.151 Like NOR, both DS1 and 
DS2 also reacted readily with HZCL, which could be detected by following the 
fluorescence emission of the final products. To determine second-order rate constants of 
DS1 and DS2 reactions with HZCL, reactions were set up under pseudo-first-order 
conditions in PBS/acetonitrile (1:1) at pH 7.4.  
Data collected at all conditions were fit nicely to the same single exponential 
increase equation used in the aforementioned EDDAC analyses. The determined k’ 
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Figure III-3. Characterization of FITC reactions with (A) NOR, (B) DS1, (C) DS2, and 
(D) COY. All reactions were carried out in the PBS buffer at pH 7.4. The fluorescence 
emission was detected at 515 nm with the excitation light at 493 nm. For A-D, each 
presents the fluorescence change as a function of time at a given condition shown in the 
top left corner. The insets show the linear dependence of pseudo-first-order rate 
constants of a reaction on dienophile concentrations. 
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Figure III-4. Characterization of HZCL reactions with (A) DS1, (B) DS2, and (C) COY. 
All reactions were carried out in PBS/acetonitrile (1:1) at pH 7.4. HZCL was provided at 
1 μM. The fluorescence emission was detected at 480 nm with excitation at 318 nm. The 
detected at 480 nm with excitation at 318 nm. The insets show the linear dependence of 
the pseudo-first-order rate constants on the dipolarophile concentrations. 
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values were plotted against dipolarphile concentrations and fitted to equation 𝑘′ = 𝑘1 ×
[𝑑𝑖𝑝𝑜𝑙𝑎𝑟𝑝ℎ𝑖𝑙𝑒] + 𝑘2, where k1 is a second-order rate constant of a dipolarphile reaction 
with HZCL and k2 is the rate constant of HZCL hydrolysis. The determined rate 
constants for DS1 and DS2 are shown in Table III-2. Unlike NOR, DS1, and DS2, COY 
does not yield a fluorescent product when it reacts with HZCL.  
To fluorescently sensitize the COY reaction with HZCL, acrylamide, a 
dipolarphile that reacts competitively with HZCL to form a fluorescent product, was 
provided at 50 M. Reactions at all conditions showed single exponential fluorescent 
increase over time. The determined pseudo-first-order rate constants were plotted against  
COY concentrations and fitted to the equation 
𝑘′ = 𝑘1 × [𝐶𝑂𝑌] + 𝑘2′ 
where k1 is a second-order rate constant of the COY reaction with HZCL and k2’ is the 
sum of the rate constant of HZCL hydrolysis and the pseudo-first-order rate constant of 
the HZCL reaction with 50 µM acrylamide. The determined rate constant for COY is 
also presented in Table III-2.  
 As shown in Table III-2, COY has a reactivity toward HZCL similarly as NOR. 
Both DS1 and DS2 react rapidly with HZCL with rate constants more than 20-fold of 
those for NOR and COY. Although elevated energy states of DS1 and DS2 lead to 
higher reactivities toward HZCL than NOR and COY, the rate enhancement is not as 
significant as observed in EDDAC reactions.  
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Genetic Incorporation of Tyrosine Derivatives with Strain-Promoted Alkene/Alkyne 
Functionalities into Proteins in E. coli 
Lysine derivatives that contain strain-promoted alkene/alkyne functionalities 
were previously incorporated into proteins in living cells using different engineered 
PylRS-tRNACUA
Pyl
 pairs.134, 136, 137, 152, 153 A different route was taken to install strain-
promoted alkene/alkyne functionalities into proteins. As previously shown, the 
engineered N346A/C348A mutant of PylRS (PylRS(N346A/C348A)) demonstrated that 
this mutant enzyme in coordination with tRNACUA
Pyl
 was able to incorporate close to 20 
tyrosine and phenylalanine derivatives into proteins at amber mutation sites in E. coli.77, 
81, 154 Since one tyrosine derivative, O-benzyl-tyrosine is spatially close to tyrosine 
derivatives with O-linked norbornene, transcyclooctene, or cyclooctyne, we reasoned  
PylRS (N346A/C348A) might be applied for the genetic incorporation of some of these 
NCAAs. 
Table III-2. Second-order rate constants of reactions between strain-promoted 
alkene/alkyne dipolarphiles and HZCL. 
 
a This rate constant was determined by Jiangyun Wang et al.147 
The high substrate promiscuity of PylRS (N346A/C348A) might also allow using 
just one cellular system for the genetic installation of all strain-promoted alkene/alkyne 
functionalities, providing an advantage over using lysine derivatives. In addition, 
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syntheses of tyrosine derivatives are in general easier than those of lysine derivatives 
with fewer steps involved. Seven O-alkylated tyrosine derivatives with strain-promoted 
alkene/alkyne functionalities, NCAA 1-7 in Figure III-5 were synthesized.  
Their genetic incorporation was tested in an E. coli BL21 system that contained 
two plasmids, pEVOL-pylT-N346A/C348A and pET-pylT-sfGFP2TAG, with genes 
coding PylRS (N346A/C348A), tRNACUA
Pyl
, and superfolder green fluorescent protein 
(sfGFP) with an amber mutation at its S2 position. This E. coli system was not able to 
express sfGFP in GMML (a minimal medium supplemented with 1% glycerol and 0.3 
mM leucine). Providing 2 mM of either of NCAA 1-7 did not yield significant sfGFP 
expression increase. Apparently, the active site pocket of PylRS (N346A/C348A) is not 
big enough to accommodate the stretched and bulky side chains of NCAA 1-7.  
To expand the active site pocket, we introduced two more mutations Y306A and 
Y384F to PylRS (N346A/C348A) to afford PylRS (Y306A/N346A/C348A/Y384F) and 
used this gene to replace the PylRS (N346A/C348A) gene in pEVOL-pylT-
N346A/C348A to obtain plasmid pEVOL-pylT-Y306A/N346A/C348A/Y384F. E. coli 
BL21 cells transformed with pEVOL-pylT-Y306A/N346A/C348A/Y384F and pET-
pylT-sfGFP2TAG were not able to express sfGFP in lysogeny broth (LB) medium.  
The Y306A mutation to PylRS (N346A/C348A) apparently decreases the activity 
of the original mutant enzyme on phenylalanine and reduces the misincorporation of 
phenylalanine in a rich medium. However, supplementing LB with 1 mM of one of five  
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Figure III-5. Structures of O-alkylated tyrosine derivatives that contain strain-promoted 
alkene/alkyne functionalities. 
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NCAAs (1, 2, 4, 5, and 6) induced sfGFP overexpression (Figure III-6). The addition of 
2 mM NCAA 3 or 7 into LB medium only led to minimal sfGFP expression increase. 
All five purified sfGFP variants had molecular weights determined by electrospray 
ionization mass spectrometry analysis that agreed well with their theoretical molecular 
weights (Table III-3).  
 
Labeling Proteins Incorporated with Strain-Promoted Alkene/Alkyne Functionalities 
using EDDAC and NIADC Reactions In vitro 
With sfGFP proteins incorporated with different NCAAs in hand, we proceeded 
to test the labeling of the proteins with FITC-TZ and HZCL. To label sfGFP proteins 
with FITC-TZ, reactions were set up in the PBS buffer with the addition of 100 µM 
FITC-TZ for 1 hour. As expected, sfGFP proteins incorporated with NCAAs 1, 2, 4, 5, 
and 6 were efficiently labeled with FITC-TZ and showed intense fluorescence in a 
denaturing SDS-PAGE gel under UV irradiation Figure III-7A.  
As a control, sfGFP with N-Boc-lysine incorporated at its S2 position (sfGFP-
BocK) could not be labeled with FITC-TZ under the same conditions. All protein 
samples were treated with SDS and heated at 100 °C for 20 minutes to totally quench the 
intrinsic GFP fluorescence before they were analysed by SDS-PAGE. The same 
treatment was also done with proteins labeled with HZCL. For labeling with HZCL, 
each protein was incubated with 0.5 mM HZCL in the PBS buffer for 1 hour before they 
were analyzed on a denaturing SDS-PAGE gel under UV irradiation, Figure III-7B.  
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Figure III-6. Site-specific incorporation of five NCAAs that contain strain-promoted 
alkene/alkyne functionalities into sfGFP at its S2 position. Proteins were expressed in E. 
coil BL21 cells transformed with pEVOL-pylT-Y306A/N346A/C348A and pET-pylT-
sfGFP2TAG. Cells were grown in LB medium supplemented with 2 mM of a NCAA for 
8 hours. Supplementing LB with 2 mM of 3 or 7 did not yield sfGFP expression 
increase. Therefore, data for these two NCAAs are not presented. 
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Table III-3. Detected and theoretical molecular weights (MWs) of sfGFP proteins with 
different NCAAs incorporated at the S2 position. 
 
 
.  
 
 
 
 
 
 
 
 
a
With an error of ±1 Da. 
b
sfGFP with 1, 2, 4, 5, or 6 incorporated at the S2 position. 
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Figure III-7. Selective labeling of sfGFP proteins incorporated with strain-promoted 
alkene/alkyne functionalities with (A) FITC-TZ and (B) HZCL. In A and B, top panels 
show denaturing SDS-PAGE analysis of proteins stained with Coomassie blue and the 
bottom panels are from fluorescent imaging of the same gels before Coomassie blue 
staining. In A, the fluorescent image was captured by a digital camera and displayed was 
real color of the emitting light. In B, the fluorescent image was captured by a Bio-Rad 
ChemiDoc XRS system 
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sfGFP proteins incorporated with 1, 2, 4, and 6 were fluorescently labeled after 
their reactions with HZCL. As expected, the labeling product of sfGFP-5 could not be 
fluorescently visualized due to the non-fluorescent reaction product of cyclooctyne with 
HZCL. As a control, wild-type sfGFP could not be labeled with HZCL under the same 
conditions 
Labeling Proteins Incorporated with Strain-Promoted Alkene/Alkyne Functionalities 
using EDDAC and NIADC Reactions in Living Cells 
Additionally, the IEDDAC and NADC reactions were also used to label proteins 
that bear site-specifically incorporated NCAAs with strained alkene/alkyne 
functionalities in living cells. pEVOL-pylT-Y306A/N346A/C348A/Y384F and a 
previously constructed plasmid pETDuet-OmpXTAG that contained an E. coli outer 
membrane protein OmpX gene with an AAAAXAA (A denotes alanine and X denotes 
the NCAA) insertion between two extracellular residues, 53 and 54, were used to 
transform E. coli BL21 cells. The transformed cells were grown in LB supplemented 
with 2 mM of 4, 5, or 6 to produce OmpX with these NCAAs site-specifically 
incorporated.  
The subsequent reactions with FITC-TZ fluorescently labeled the expressed 
proteins at the bacterial cell surface. Similar reactions with HZCL also fluorescently 
labeled the expressed proteins except for OmpX incorporated with 5, whose labeling 
with HZCL led to a non-fluorescent product (Figure III-8). Collectively, our assembled 
in vitro and cell labeling data demonstrate the high efficiency and selectivity of 
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IEDDAC and NADC reactions in the labeling of newly developed and genetically 
encoded strained alkene/alkyne NCAAs. 
 
 
 
Figure III-8. Selective labeling of sfGFPs that contained site-specifically incorporated 
NCAAs with strained alkene/alkyne functionalities with (A) FITC-TZ and (B) HZCL in 
E. coli cells. Cells were labeled with FITC-TZ and HZCL for 3 hours and then washed 
with PBS buffer 3 times before undertaking epifluorescent and differential interface 
contrast (DIC) imaging. 
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Conclusion 
In summary, we have kinetically characterized IEDDAC and NADC reactions 
that involve strained alkene/alkyne functionalities including norbornene, trans-
cyclooctene, and cyclooctyne, and applied the two reactions to selectively label proteins 
bearing these functionalities. Being a rapid catalyst-free click reaction with a high bio-
orthogonality, IEDDAC has received substantial attention recently.128, 130, 138, 155 Our 
study showed that all three strained alkene/alkyne functionalities undergo rapid 
IEDDAC reactions with tetrazines and rate constants close to 300 000 M−1 s −1 could be 
reached.  
Our study also revealed that all three functionalities undergo fast reactions with 
diaryl nitrilimines at rate constants close to 20 M−1 s −1. To the best of our knowledge, 
the current study is the first report of fast reaction kinetics between trans-cylooctenes 
and diaryl nitrilimines.  
To synthesize proteins with site-specifically encoded strained alkene/alkyne 
functionalities, a mutant PylRS-tRNACUA
Pyl
 pair was developed, which has been 
successfully applied to incorporate five tyrosine derivatives containing norbornene, 
trans-cyclooctene, and cyclooctyne functionalities into proteins at amber mutation sites 
in E. coli. Proteins bearing these tyrosine derivatives were fluorescently labeled using 
IEDDAC and NADC reactions both in vitro and in living cells. Our current study has 
significantly expanded the tool kits for protein labeling. Potential applications of the 
developed methods include studies such as protein folding/dynamics, protein trafficking, 
and protein−protein/DNA interactions. 
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CHAPTER IV  
DEMETHYLASE: SUBSTRATE SPECIFICITY ANALYSIS ON HISTONE 
PROTEINS 
 
Introduction 
Nucleosomes, the primary building block of chromatin plays a very important 
role in epigenetics by regulating cellular processes such as replication, repair, and 
transcription to maintain the proper function of the cell. In the nucleosome, the histone 
octamer comprises globular core proteins and a flexible, unstructured N-terminal tail. 
The globular protein consists of two sets of four histone core proteins which entails a 
tetramer of H3 and H4 together with dimer of H2A and H2B wrapped around twice with 
a 147 base pairs of DNA.156 Numerous PTM such as acetylation, methylation, 
phosphorylation, ubiquitylation occur on the flexible, unstructured N-terminal tails of 
the histone core proteins in response to extracellular or intracellular stimuli. This affects 
the state of the chromatin assembly by either loosening (euchromatin) or tightening 
(heterochromatin)157 (Figure IV-1). 
Alteration of the chromatin assembly affects the histone-histone interactions or 
histone-DNA interactions which regulates the gene expression in vivo.158 The acetylation 
functional group for instance neutralizes the positive charge on the histone and 
eventually loosens the binding between histone and DNA. This can initiate gene 
transcription as well as replicate or repair the DNA.159, 160 In the case of histone 
H3K56Ac, it blocks formation of higher-order chromatin arrays, but does not destabilize 
 120 
 
the nucleosome. Since the addition and removal of the PTM is dynamic, the acetylation 
is simultaneously removed to regulate the cell cycle progression and avoid DNA 
damage.161 Another modification such as methylation can either transcriptionally 
activate genes at H3K4, H3K36 and H3K79 or silence genes at H3K9, H3K27, and 
H4K20.162, 163  Ubiquitination, a larger modification, is known to play a vital role in gene 
activation or repression.  
These modifications on the histone N-terminal tail can also lead to a process 
called histone crosstalk due to its dynamic process. In the dynamic process, a particular 
site can either add or remove the modification of another site making the state of the 
chromatin dependent on the type of PTM or set of PTMs to yield different cellular 
responses. For example, phosphorylation at H3S10 is known to promote acetylation at 
the H4K16 site to control the transcription elongation.164  Lysine Nε-amine is highly 
diversified with modifications such as acetylation (Ac) and mono-, di-, tri-methylation 
(M1, M2, M3) present on different sites in the nucleosome. These different 
modifications not only regulate cellular processes but can cause mis-regulations in gene 
expression which can lead to several diseases such as cancer, diabetes etc.158, 165, 166  
Due to histone’s high complexity, it is challenging to study the function of a 
particular modification or its effects on the same core protein or different histone core 
proteins. Several methods such as native chemical ligation, expressed peptide ligation, 
and solid state synthesis have been used to obtain the histone PTM mimics but these 
techniques have drawbacks such as their inability to obtain a homogenous modified 
histone, low yields and tedious synthetic work.167, 168  
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Figure IV-1. Several Nε-amine lysine modification on H2A and H2B histone proteins. 
 
 
  
 122 
 
Here we show a simple method by which modifications such as mono- or, 
dimethyl lysine can be recombinantly synthesized on the histone proteins to study the 
epigenetic erasers such as histone lysine demethylases (HKDMs) on the M1 and M2 
modification at different lysine sites. These PTM variants are very necessary to study the 
crosstalk pathways present on the same histone (cis-tail) or different histones (trans-tail) 
of the four histone proteins for the regulation of gene expression. 
Lysine methylation is one of the most studied modifications in histones with 
several histone methyltransferases (HMTs) and HKDMs enzymes discovered. The level 
of methylation added (M1, M2, M3) on the lysine residue by HMTs play different roles. 
For example monomethylation at H3K9, H3K27, and H4K20 are related to transcription 
activation but trimethylation is related to transcription repression.169, 170 These 
methylations on lysine residues (Figure IV-2) are controlled by HKDMs through a 
reversible process.  
 
 
 
Figure IV-2. Structures of mono-, di-, tri-methyl-L-lysines and compound 1 for M1K 
synthesis. 
 
  
 123 
 
Altering these modifications can cause various diseases, therefore investigating 
how these HKDMs catalyze the removal of methylation can give more insight into 
discovering several HDAC inhibitors as potential drug targets. Currently, there are two 
classes of HKDMs regulated by flavin adenine dinucleotide (FAD) -dependent Lysine 
Specific Demethylase 1 and 2 (LSD1 and LSD2) and α-ketoglutarate (α-KG), Fe (II) and 
molecular oxygen-dependent Jumonji C (JmjC) family for demethylation. LSD1 and 
LSD2 can effectively demethylase mono- and di-methylation, while the JmjC family can 
demethylate all 3 methylation types.169, 171, 172 Several methods have been used to 
determine specific sites for methylation, but our approach will yield a full length 
recombinant protein with desired methylation to study the specificity of the both 
HKDMs families on different lysine sites. In this study, we will focus on 
monomethylation on different lysine sites on histone H2A, H2B and H3. 
To carry out this modified synthesis on the histones H3, H2A and H2B, the 
lysine derivatives will be genetically incorporated into protein directly during translation 
using the Pyl incorporation machinery which is found in M. mazei to co-translate Pyl, 
into protein.57 33 This naturally occurring system paves a way to incorporate other 
diverse NCAAs into protein to study and manipulate biological process in histones. This 
same Pyl incorporation machinery will be used to effectively synthesize histones with 
defined modifications.  
Firstly, one main issue to address is the difficulty to select monomethyl-lysine or 
M1K from free lysine because they differ by only a methyl group which cannot be 
selectively taken up by PylRS wild type (Figure IV-2). Several research groups 
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including our lab have used either wild-type or evolved PylRS-
Pyl
CUAtRNA  pair to produce 
protein with monomethylation. Nε-Boc-Nε-methyllysine has been successfully 
incorporated into histone H3 at the K9 position using the wild-type PylRS- pair. 2% 
TFA was used to deprotect the boc protecting group to obtain the Histone with Nε-
methyllysine.173 Another route to recover Nε-methyllysine is via UV photolysis using a 
photocaged Nε-methyllysine.76, 174 Nε-(o-nitrobenzyloxycarbonyl)-Nε-methyllysine was 
successfully incorporated into protein using he evolved PylRS- pair. The 
nitrobenzyloxycarbonyl group was deprotected using UV light.  
Though these two methods produced the desired monomethylated product, an 
alternative route is discussed. The monomethyl-lysine precursor, compound 1 (MNCK) 
containing nitrobenzyl group was used for selection. According to Chin et al. the 
nitrobenzyl group can be easily removed by using E. coli’s nitroreductase which was 
shown to convert the majority of the nitrobenzylcarbamoyl lysine to lysine when 
incorporated into proteins.175, 176 With that idea, we suggest that Compound 1 can also be 
subjected to enzymatic reduction using E. coli nitroreductase and further reduced with 
Na2S2O4 to recover M1K in E. coli for further studies (Figure IV-3). In this study, we 
report the incorporation of M1K at various Lys sites on histones and the display of LSD1 
enzymatic activity via peroxidase coupled assay. 
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Figure IV-3. Reduction of compound 1 with E. coli nitroreductase to recover M1K. 
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Experimental Section 
Materials 
Reagents were purchased from general chemical manufacturers such as Sigma 
Aldrich, TCI, Alfa Aesar and Chem Impex and used without further purification. 
Methanol from Sigma-Aldrich and used as is. All reactions involving moisture sensitive 
reagents were carried out in oven-dried glassware under argon atmosphere. Thin layer 
chromatography (TLC) was performed on silica 60F-254 plates and visualized using UV 
irradiation at 254 nm. Flash chromatography was performed with silica gel (particle size 
32-63 µm) from Dynamic adsorbents inc. (Atlanta, GA). 
All 1H and 13C spectra were recorded on Varian Mercury-300, INVOA 300 and 
INVOA-500 MHz spectrometers. NMR spectra chemical shifts were reported in parts 
per million (ppm) and referenced to solvent peaks: chloroform (7.27 ppm for 1H and 
77.23 ppm for 13C) or water (4.8 ppm for 1H). A minimal amount of 1,4-dioxane was 
added as the reference standard (67.19 ppm for 13C) for carbon NMR spectra in 
deuterium oxide. 1H NMR spectra are tabulated as follows: chemical shift multiplicity 
(s= singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
number of protons, and coupling constant(s). Mass spectra were conducted at the 
Laboratory for Biological Mass spectrometry at Department of Chemistry, Texas A&M 
University. 
The N-terminal His-tagged human histones (H2A, H2B, H3) plasmids were 
purchased from Epoch Life Science Inc. The plasmid pGEX-6P-1 vector encoding the 
LSD1 which was used for the demethylase assay was obtained from Dr. Philip A. Cole at 
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John Hopkins University School of Medicine. The pan anti mono- or dimethyllysine 
antibody was purchased from PTM biolabs.  
Chemical Synthesis 
Copper (II) sulfate pentahydrate (2.5 g, 10 mmol) in water was added into a 
aqueous solution of lysine hydrochloride (3.7 g, 20 mmol) and sodium bicarbonate (4.7 
g, 56 mmol) in small portions to prevent excessive bubble formation. 4- Nitrobenzyl 
chloroformate (2.53 g, 13.36 mmol) in dioxane (5 mL) was then added dropwise in 5 
min, followed by sodium hydroxide (0.49 g, 12.25 mmol) in one portion. The reaction 
mixture was stirred at room temperature for 16 hours, filtered, washed with water (100 
mL), ethanol (50 mL) and diethyl ether (50 mL), and dried in the open air for 1 hour to 
give the crude copper complex (2.40 g, 97%) as a blue solid. All the above copper 
complex (2.40 g, ~7.40 mmol) was suspended in sodium hydroxide solution (0.2 N, 100 
mL, 20 mmol), and a solution of 8-hydroxylquinoline (1.40 g, 9.64 mmol) in 1,4-
dioxane (10 mL). The resulting green suspension was stirred at room temperature 
overnight and filtered. The filtrate was adjusted to pH 3 with hydrochloric acid (3 N) and 
extracted with ethyl acetate (40 mL x 2). The organic extracts were discarded, and the 
aqueous phase was concentrated to about 20 mL and loaded onto an ion-exchange 
column made from Dowex 50WX4-400 cation-exchange resin (~14 mL bed volume). 
The column was washed with excessive water (300 mL) and then eluted with pyridine (1 
M, 450 mL) to give a yellow solid upon evaporation, which was suspended in ethanol, 
filtered, washed ethyl acetate dried to give 6 (1.46 g, 65% for two steps) as a white solid. 
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c 1.02, 3 N HCl). All other characterization data were identical to that of 
6 from the longer route (Scheme IV-1).  
1HNMR (CD3OD, 300MHz) ;  δ 8.23 (d, 2H, J = 8.1 Hz), 7.62 (d, 2H, J = 8.4 
Hz), 5.22 (s, 2H), 3.85-3.78 (m, 1H), 3.19-3.18 (m, 2H), 2.15-1.82(m, 2H), 1.73-1.42 
(m, 4H). 
13CNMR (CD3OD, 75 MHz);  δ 169.4, 156.8, 147.0, 144.6, 127.8, 123.3, 65.0, 
53.4, 40.1, 29.8, 29.0, 22.1. 
To a 250 mL of round-bottom-flask was added acid compound (3 g, 7.89 mmol), 
4-(dimethyl- amino)pyridine (DMAP, 0.482 g,  3.94  mmol), p-toluenesulfonic acid 
monohydrate (p-TSA, 0.757 g, 3.94 mmol) and MeOH (100 mL). N,N′-
dicyclohexylcarbodiimide (DCC, 2.14 g, 9.46 mmol) was dissolved in CH2Cl2 (15 mL) 
and added dropwise to the above solution over 1 hour. Then the resulting mixture was 
stirred at room temperature for 20 hours. The solvents were removed under reduced 
pressure and the residue was diluted with EtOAc (50 mL). Then the reaction mixture 
was filtered through Celite and washed with EtOAc (30 mL × 3). The filtrate was dried 
over anhydrous Na2SO4 and then concentrated under reduced pressure and purified by 
column chromatography to afford product 2 (2.18 g, 70% yield).  
 
Nα-Boc-Nε-Benzyl-Nε-Methyl-L-Lysine Methyl Ester (4) 
To a solution of crude 3 (~10.6 mmol) in methanol (100 mL) was added 
formaldehyde (37% aqueous solution, 3.00 mL, 40.3 mmol), and the reaction mixture 
was stirred at room temperature for 30 min. The mixture was then cooled in an  
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Scheme IV-1. Synthesis of intermediate for Compound 1. 
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ice bath, and sodium borohydride (0.77 g, 20.4 mmol) was added portionwise. The 
mixture was then stirred further at room temperature for 4 hours, and water (30 mL) was 
added dropwise to quench the reaction. Most of the methanol was evaporated under a 
reduced pressure, and the residue was dissolved in ethyl acetate (100 mL), washed with 
water (30 mL), hydrochloric acid (1 N, 30 mL), sodium hydroxide (1 N, 30 mL) and 
brine (30 mL), dried (Na2SO4), evaporated, and flash chromatographed 
(EtOAc/hexanes, 1:1 then 5% to 10% methanol in dichloromethane) to give 4 (3.32 g, 
86% yield for three steps) as a yellow oil.  
 
 Nα-Boc-Nε-4-Nitrobenzyloxycarbonyl -Nε-methyl-L-lysine methyl ester (5)  
A solution of 4 (2.58 g, 7.07 mmol) in methanol (50 mL) was hydrogenated 
under a H2 balloon in the presence of palladium on alumina (10 wt.% Pd, 0.50 g, 0.47 
mmol) at room temperature for 5 hours. The mixture was then filtered over a pad of 
Celite and evaporated to give the crude amine (Boc-Lys(Me)-OMe) as a grey oil.  
To a solution of the above amine (~7.07 mmol) and diisopropylethylamine (2.00 
mL, 11.5 mmol) in anhydrous dichloromethane (40 mL) cooled in an ice bath was added 
4-Nitro-benzyl chloroformate (95%, 1.50 mL, 10.5 mmol) dropwise over 10 minutes, 
and the mixture was stirred at room temperature for 12 hours. The mixture was then 
diluted in ethyl acetate (100 mL), washed with sodium hydroxide (0.5 N, 40 mL) and 
brine (40 mL), dried (Na2SO4), evaporated, and flash chromatographed 
(EtOAc/hexanes, 1:3) to give 5 (2.59 g, 90% for two steps) as a colorless oil. 
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Nε-(2-Nitrobenzyl) Oxycarbonyl-Nε-Methyl-L-lysine (1)  
To a solution of 6 (2.59 g, 6.34 mmol) in THF (20 mL) was added lithium 
hydroxide solution (0.5 M, 25.0 mL, 12.5 mmol), and the mixture was stirred at room 
temperature for 3 hours. The mixture was diluted in water (20 mL) and extracted with 
ether (30 mL x 2). The ether extracts were discarded, and the remaining aqueous 
solution was adjusted to pH 3 with hydrochloric acid (3 N), with the concomitant 
formation of white precipitate. The suspension was extracted with ethyl acetate (50 mL x 
2), and the combined organic phases were washed once with brine (30 mL), dried 
(Na2SO4), and evaporated to give the crude carboxylic acid as a colorless oil, which was 
directly used without further purification. The above crude acid (~6.34 mmol) was 
dissolved in 1,4-dioxane (15 mL), and hydrogen chloride in 1,4-dioxane (4.0 M, 5.0 mL, 
20.0 mmol) was added. The resulting white suspension was stirred at room temperature 
for 12 h, evaporated, redissolved in a minimal amount of water, and loaded onto an ion-
exchange column made from Dowex 50WX4-400 cation-exchange resin (~14 mL bed 
volume). The column was washed with excessive water (300 mL) and then eluted with 
pyridine (1 M, 450 mL) to give 1 (1.51 g, 81% for two steps) as a white powder.  
1H NMR analysis showed a 1:1 mixture of rotamers at room temperature. Major 
rotamer: 1HNMR (CD3OD, 300MHz) ; δ 8.26 (dd, 2H, J = 1.8, 8.7 Hz), 7.44 (d, 2H, J = 
8.4 Hz), 5.11 (s, 2H), 3.97 (t, 1H, J = 3.6 Hz ), 3.15-3.36 (m, 2H), 3.02 (s, 3H), 1.99-
1.92 (m, 2H), 1.65 (t, 2H, J = 3.6 Hz) 1.51-1.44 (m, 2H).  
13CNMR (CD3OD, 75 MHz); δ 169.4, 156.8, 147.0, 144.6, 127.8, 123.3, 65.0, 
53.4, 40.1, 29.8, 29.0, 22.1. Characteristic peaks of the minor rotamer: 1H NMR 
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(CD3OD, 300MHz) δ 2.95 (s, 3 H); 13C NMR (CD3OD, 75 MHz δ) 128.2, 67.2, 49.2, 
34.2. 
 
 
Scheme IV-2. Synthesis of Compound 1also known as MNCK. 
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DNA and Protein Sequences 
Gene and protein sequences of pylT, Methanosarcina mazei PylRS and sfGFP were 
listed in the DNA sequence of Experimental Section in Chapter II. 
 
DNA Sequence of Optimized Histag-TEV-H3  
Atgggcagcagccatcaccatcatcaccacagccaggatccggaaaatctgtacttccaggctcgcaccaaacagactgctc
gtaagtccactggcggtaaagcgccgcgtaaacagctggcaaccaaggcagcgcgtaaaagcgctccagctactggcggc
gtgaagaagccgcaccgttatcgcccgggtactgtggctctgcgtgaaatccgccgctaccagaaaagcaccgaactgctgat
tcgcaaactgccatttcaacgtctggttcgcgaaattgctcaggatttcaaaaccgacctgcgcttccagtctagcgctgtgatgg
cactgcaagaggcgtctgaggcatatctggttggcctgttcgaagataccaacctggcagcaatccatgcaaagcgtgtaacca
ttatgccgaaagacatccaactggctcgtcgtatccgtggtgagcgtgcg 
 
Protein Sequence of Optimized Histag-TEV-H3 
MGSSHHHHHHSQDPENLYFQARTKQTARKSTGGKAPRKQLATKAARKSAPAT 
GGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSS 
AVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
 
DNA Sequence of Optimized Histag-TEV-H2A 
Atgggcagcagccatcaccatcatcaccacagccaggatccggaaaatctgtacttccagtctggtcgtggtaaacaaggtgg
taaagcacgtgcaaaggctaagactcgtagcagccgtgccggtctgcagtttccagtgggtcgcgttcaccgtctgctgcgtaa
aggcaactatgctgaacgtgtgggtgctggtgcaccggtttacctggcagctgtactggaatatctgaccgcagagattctgga
gctggcaggtaacgcagctcgtgataataagaagacccgcatcatcccacgtcacctgcagctggccatccgcaacgatgag
gaactgaacaaactgctgggcaaagttactatcgctcaaggtggcgttctgccgaacatccaggcagttctgctgccgaagaa
gaccgaatcccaccacaaagcgaaaggtaagtga 
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Protein Sequence of Optimized Histag-TEV-H2A 
MGSSHHHHHHSQDPENLYFQSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHR
LLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLA
IRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTESHHKAKGK* 
 
DNA Sequence of Optimized Histag-TEV-H2B 
Atgggcagcagccatcaccatcatcaccacagccaggatccggaaaatctgtacttccagtcagaaccagctaaatctgcacc
ggctccgaagaaaggctctaagaaggctgttaccaaggctcagaagaaagatggtaagaaacgcaaacgttctcgtaaagaa
agctattctgtgtacgtgtataaagttctgaaacaagtacatccagacactggcatttccagcaaagcgatgggcattatgaacag
cttcgttaacgatatcttcgaacgtatcgcaggcgaagcgagccgtctggctcactataacaaacgttctaccatcacctctcgtg
aaattcaaactgcagttcgtctgctgctgccaggtgaactggctaaacacgcggttagcgaaggcactaaagcagttaccaaat
acacttcttccaaatga 
 
Protein Sequence of Optimized Histag-TEV-H2B  
MGSSHHHHHHSQDPENLYFQSEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRS
RKESYSVYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKR
STITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
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Table IV-1 Primer sequences of Lys site mutations on H2A. 
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Table IV-2. Primer sequences of Lys site mutations on H2B. 
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Construction of Plasmids 
Each of the human histone wild-type gene, H3, H2A and H2B were cloned into 
petDuet-1 using BamH I and Hind III as the restriction sites. Specific lysine sites were 
mutated to amber mutation to obtain the desired mutants. His-tag was present on the N-
terminal of each wild-type histones followed by a TEV protease digestion sequence. Ten 
Histag-TEV-H3 mutants were constructed as previously reported (K4, K9, K14, K18, 
K23, K27, K36, K56, K79, K115).177 Different lysine positions on the Histag-TEV H2A 
(K5, K9, K13, K36) and H2B (K5, K12, K17, K20, K23, K34) were mutated to amber 
mutations using PFU or Phusion Quikchange mutagenesis. (Table IV-1 and Table IV-2). 
Optimized M. Mazei PylRS mutant (NCKRS) possessing the following mutant: L309G, 
C348V, Y384F was selected to take Compound 1, MNCK  
sfGFP Protein Expression and Purification 
Before expressing MNCK in histones, the uptake of this NCAA was first tested 
in sfGFP. Plasmid pET-sfGFPN13TAG was co-transformed with pEVOL-pylT-NCKRS 
into E. coli BL21(DE3) cells. A single colony was selected and allowed to grow in 5 mL 
of LB medium with 100 µg/mL ampicillin at 37 °C overnight. The overnight culture was 
inoculated into 200 mL of Lysogeny broth (LB) medium with 100 µg/mL ampicillin and 
allowed to grow at 37 °C to OD600~0.8. 1 mM IPTG and 1 mM MNCK were then added 
to the medium to induce expression of sfGFP. Control experiments in which only 1 mM 
IPTG was added to the medium were also carried out. The induced cells were allowed to 
grow at 37 °C for 8 hours and then collected by centrifugation (4,200 rpm for 20 
minutes). The collected cells were resuspended in 35 mL of lysis buffer (50 mM 
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HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by sonication in an ice 
water bath. The lysed cells were clarified by centrifugation (10,000 rpm for 1 hour).  
The supernatant was decanted and let bind to 5 mL of Ni-NTA superflow resins 
at 4°C for 1 hour. The mixture of the supernatant and resins was then loaded to an empty 
Qiagen Ni-NTA superflow cartridge. The resins were washed with 5 volume times of 
lysis buffer and sfGFP was then eluted with buffer (50 mM HEPES, 300 mM NaCl, 250 
mM imidazole, pH 8.0). The purified protein was concentrated to a desired volume and 
analyzed by SDS-PAGE. For further analysis, western blot was carried out to detect the 
incorporation of MNCK. The sample was ran on an SDS-PAGE gel and transferred to 
the nitrocellulose membrane following the western blot protocol. After the transfer, the 
membrane was coated with 5% fat-free milk for 2 hours at room temperature. The 
membrane was then washed with PBST buffer (PBS with 0.1% tween-20, 10 mL) on the 
shaker three times before adding the first antibody, pan antimono-, dimethyl lysine 
(1:1000) overnight at 4 °C. After first antibody, the membrane was washed again with 
PBST buffer six times at about 5 minute intervals. The membrane was treated with 
second antibody (1: 10000) from Jackson ImmunoResearch (West Grove, PA) at room 
temperature for 1 hour. The membrane then was washed by PBST buffer, three times. 
Results was visualized with Pierce ECL Western Blotting Substrate. Images were taken 
by ChemiDoc XRS+ system from Bio-Rad. 
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Histone Protein Expression and Purification 
The above plasmids with histone mutants encoded were individually co-
transformed with pEVOL-pylT-NCKRS and transform into E. coli BL21(DE3) cells. 
Same procedure for the protein expression and mutant as compared to the sfGFP protein 
expression and purification. After expression, the collected cells were resuspended in 35 
mL of lysis buffer containing 20 mM Tris (pH 7.5), 500 Mm NaCl, 0.1% NaN3, 0.1% 
Triton X-100, then lysed. The cell lysate was centrifuged (6000 rpm for 30 minutes) and 
pellet was collected and washed with 20 mM Tris (pH 7.5), 500 mM NaCl, 0.1% NaN3. 
Next, the pellet was dissolved in urea buffer containing 20 mM Tris (pH 7.5), 500 NaCl, 
and 6 M Urea. Cells were clarified by centrifugation (10,000 rpm for 1 hour). The 
supernatant was decanted and purification process was carried out using the Qiagen Ni-
NTA superflow cartridge. The protein was eluted with urea buffer containing 300 
imidazole. 
LSD1 Protein Expression and Purification 
pGEX-6P-1-LSD1 plasmid178 which is GST-tagged human LSD1Δ1 = LSD1 
(171-852) was transformed into E. coli BL21(DE3) cells. Cells were grown in 1 L 2YT 
medium to an OD600 of 1.0 at 37 °C, induced with 1 mM IPTG and expressed at 16 °C 
for 20 hours. Cells were harvested by centrifugation (4,200 rpm for 20 minutes). The 
collected cells were resuspended in 80 mL of ice cold lysis buffer (280 mM NaCl, 5.4 
mM KCl, 20 mM Na2HPO4, 3.6 mM KH2PO4, 1 mM EDTA, 10 mM DTT, and 10% 
glycerol pH 7.4) and lysed by sonication in an ice water bath. The lysed cells were 
clarified by centrifugation (10,000 rpm for 1 hour). The supernatant was decanted and let 
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bind to 5 mL of glutathione-Sepharose 4 fast flow column (GE Healthcare). The column 
was pre-equilibrated with the lysis buffer and the clarified lysate loaded on to column 
and allowed to bind with resin for 5 hours. Column was then washed with 75 mL lysis 
buffer and eluted with elution buffer containing 50 mM reduced glutathione added to the 
lysis buffer (280 mM NaCl, 5.4 mM KCl, 20 mM Na2HPO4, 3.6 mM KH2PO4, 1 mM 
EDTA, 10 mM DTT, 50 mM GSH and 10% glycerol pH 7.4). The purified LSD1 was 
dialyzed using buffer containing 20 mM HEPES-NaOH (pH 7.5), 50 mM NaCl in 
preparation for the demethylase assay. 
LSD1 Histone Demethylase Assay 
A peroxidase-coupled assay which detects the amount of hydrogen peroxide 
released was used to determine the amount of H2O2 production during LSD1 
demethylation process (Figure IV-4). Ampliflu™ Red (Sigma), a colorless non 
fluorescent produces a fluorescent resorufin upon oxidation.179 Reaction was carried out 
in a 96-well plate reader with a total volume of 100 µL. The reaction sample contains 10 
µM Ampliflu™ Red, 0.76 µM horseradish peroxidase, 10 µM mono-or dimethylated 
histone H3 at the Lys4 position (Sigma) in 20 mM HEPES-NaOH (pH 7.5), 50 mM 
NaCl buffer. Samples were prepared with or without 50 nM LSD1. The changes in 
fluorescence was monitored with excitation at 530 nm and emission at 590 nm using a 
Synergy H4 Hybrid Multi-Mode Microplate Reader (BioTek). 
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Figure IV-4. Ampliflu Red fluorescence mediated LSD1 demethylase assay used to 
detect generation of hydrogen peroxide to test the activity of LSD1 on different Lys sites 
on each histone protein. 
 
 
  
 
I performed all experiments except the synthesis of alkene/alkyne containing 
compounds (NCAA 1-7), the FITC-TZ dye which was synthesized by Dr. Yadagiri 
Kurra. 
 
λ
Ex    
=  530 nm 
λ
Em
  =  590 nm 
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Results and Discussion 
Synthesis of Histones with Post-Translational Lysine Methylation (M1K) for Probing 
Substrate Specificities of Histone Demethylases 
In order to profile lysine recognition sites of LSD1 on H2A, H2B and H3 
proteins, the selected PylRS variant, NCKRS, was first used to incorporate 1 mM 
MNCK into sfGFP at the amber mutation site on N134 position. Without MNCK in the 
growth medium, no level of sfGFP expression was observed. On the contrary, the 
addition of MNCK promoted sfGFP overexpression. Western blot further confirmed that 
expressed protein has incorporated MNCK (Figure IV-5A) because there was no 
detection on sfGFP wild-type. This means MNCK has been successfully incorporated 
into sfGFP without background.  
Based on our previous success in incorporating MNCK in sfGFP, we expect to 
see similar results in histone H2A, H2B, H3 protein irrespective of the lysine sites in the 
absence and presence of 1 mM MNCK. So far certain lysine sites on H3 have been 
successfully incorporated with 1 mM MNCK (Figure IV-6), MNCK have also been 
incorporated into specific Lys sites on H2A and H2B (Figure IV-7). 
To obtain M1K, the p-nitrobenzyl carbamate on the MNCK could be 
successfully cleaved off enzymatically using E. coli’s nitroreductase (Figure IV-3). 
Steady-state kinetics have shown that the E. coli’s nitroreductase enzyme follows the 
Ping Pong Bi mechanism. This occurs when either NADH or NADPH donates two 
electrons to the flavin mononucleotide (FMN) cofactor during its binding to the enzyme 
and releases NAD+ or NADP+.180, 181 Nitro-aromatic group containing substrates such as  
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Figure IV-5. Incorporation of MNCK into sfGFP. (A) SDS-PAGE and western blot 
analysis shows the incorporation of MNCK by NCKRS-tRNACUA. Lane 1 contains no 
added NCAA, lane 2 is expressed wild-type of sfGFP, and lane 3 has MNCK 
incorporated. (B) ESI-MS of sfGFP incorporated with MNCK but has been converted to 
M1K. 
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Figure IV-6. Incorporation of MNCK into Histone H3 at various Lys sites. (A) SDS-
PAGE analysis shows the incorporation of MNCK by the mutant NCKRS-tRNACUA. 
Each lane represents the Lys sites which MNCK incorporated. (B) SDS-PAGE ad 
western blot analysis of MNCK incorporation at H3K4. 
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Figure IV-7. Incorporation of MNCK into Histone H2A and H2B Lys sites respectively. 
SDS-PAGE analysis shows the incorporation of MNCK by the mutant NCKRS-
tRNACUA.  
 
 
MNCK activates the enzyme reduction process to produce M1K, the desired unprotected 
lysine derivative. Recent studies in our lab showed that E. coli’s nitroreductase can 
undergo deprotection of the nitrobenzyl group in sfGFP (Figure IV-5B). 
Detailed mechanism of the removal of the nitro-substituted Cbz is currently 
unknown but it is the likely the reduction of the aromatic nitro moiety before or after cell 
lysis.176 Also the nitrobenzyl group can be further reduced using sodium hyposulfite.182  
ESI-MS showed that MNCK converted to M1K based on a clear mass shift. The purified 
sfGFP displayed two major mass peaks at 27728±1 Da and 27728±1Da that agree well 
with the theoretical molecular weights of sfGFP with MNCK incorporated at N134 
(27858Da for the deprotected full-length protein; 27723 Da for the deprotected full-
length protein without the first methionine (M1)) (Figure IV-5B).  
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HKDMs Activity on each H2A or H2B or H3 Protein Containing M1K 
As mentioned previously, it is challenging to incorporate methyl-L- lysine directly onto 
histone because M1K only differs from lysine by the insertion of methyl group, therefore 
using M1K derivative is necessary since it undergoes simple methods to recover M1K. 
All expressed histone H2A, H2B and H3 lysine sites containing M1K can be used to test 
the activity LSD1 which is one of the HKDMs. LSD1 is known to generate hydrogen 
peroxide during the demethylation reaction. Using the peroxidase-coupled assay, the 
LSD1 activity and reaction kinetics can be determined based on the amount of H2O2 
produced. Ampliflu™ Red is converted to resorufin in the presence of H2O2, thus the 
production of H2O2 during a demethylation reaction was detected using this method. 
Though there was background, there was a clear difference between the reaction with or 
without LSD1 (Figure IV-8). 
Conclusion 
In summary, we showed that a methyl-lysine precursor can be genetically 
incorporated into proteins in E. coli. This precursor molecule undergoes a presumptive 
enzymatic process to covert to methyl-lysine after its incorporation. This is confirmed 
with the incorporation of this precursor into sfGFP and its mass spectrometry and 
Western blot analysis. We have further used this developed approach to synthesize a 
number of methyl-histone proteins and activities of a histone demethylase, LSD1 on 
these methyl-histones are under characterization. 
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Figure IV-8. Ampliflu Red based fluorescence studies on LSD1 demethylase assay on 
(A) mono-methyl-H3K4 peptide (B) di-methyl-H3K4 peptide. 
 
 
  
D: Ampliflu Red                     H: Horseradish Peroxidase 
P: Peptide                               E: LSD1 
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CHAPTER V  
CONCLUDING REMARKS AND FUTURE OUTLOOK 
 
Based on the unique Pyl incorporation machinery, extensive research on the 
PylRS-tRNAPyl pair has yielded over 100 NCAAs incorporated into proteins. The lack of 
an editing domain in PylRS makes it promiscuous and allows misacylated tRNAPyl 
possible to incorporate NCAA such as BocK. Also, studies showed that the anticodon of 
the native tRNAPyl ( Pyl
CUAtRNA ) does not significantly affect its interaction with the 
catalytic domain of PylRS, hence in this study, the abilities of the codon recognition of 
both the original or evolved M. mazei pyrrolysyl (Pyl)-tRNA synthetase (PylRS)-
tRNAPyl pair to encode other BocK was further explored. In addition, the sense or 
quadruplet codons was also explored to expand the current NCAA-coding codons. This 
systematic studies elucidated on the suppression efficiencies of the PylRS-tRNAPyl pair 
containing either amber, ochre, opal, sense or quadruplet codon-anticodon.  
The ochre suppression level achieved by PylRS- Pyl
UUAtRNA  pair was low compared 
to the PylRS- Pyl
CUAtRNA  but it was sufficient to promote overexpression of a protein with 
an ochre mutation. In the case of the opal suppression with PylRS- Pyl
UCAtRNA  pair, there 
was high level of sfGFP expression in the absence of BocK. ESI-MS on this purified 
protein showed that Trp has been incorporated into the protein. Further analysis 
confirmed the orthogonality of PylRS-tRNAPyl pair because the Pyl
UCAtRNA  was not 
recognized by E. coli’s TrpRS. This concluded that there was no mis-acylation of the 
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Pyl
UCAtRNA with Trp but rather a competition between the two pairs. E. coli’s TrpRS-
tRNATrp pair with CCA anticodon is near cognate to the PylRS- Pyl
UCAtRNA  pair bearing 
UCA anticodon. Since the discriminator base G73 on the acceptor stem is a major 
identity element for tRNAPyl, G73 was mutated to either U, A or C to determine its 
effects on the opal suppression efficiency. Pyl
UCAtRNA G73U was found to compete with the 
tRNATrp. In pursuit of fully inhibiting the incorporation of Trp at the opal mutation site, 
further mutagenesis on the Pyl
UCAtRNA with the G73U mutant is necessary. For reassigned 
rare sense codon (AGG) to encode NCAA, there was a mixture of BocK and Arg 
incorporated. In the case of quadruplet (AGGA) codons, there was a misreading of the 
first three nucleotide of AGGA by the endogenous arginyl—tRNAArg hence Arg was 
incorporated along with the NCAA. Further studies will be to replace all of the AGG 
codons with other Arg codons as well as remove the Arg
CCUtRNA to enable the specific 
incorporation of NCAA at the AGG codon site. 
Based on the assessment of the codons previously, PylRS- Pyl
CUAtRNA  pair 
displayed the highest efficiency. For the next studies, an evolved pair of PylRS- Pyl
CUAtRNA  
was used to incorporate into proteins unique chemical functionalities such as strained 
alkene/alkyne entities such as norbornene, trans-cyclooctene, and cyclooctyne. These 
proteins bearing these unique functionalities were successively labeled with a 
fluorescein tetrazine dye and a diaryl nitrilimine both in vitro and in living cells via rapid 
catalyst-free click reaction under biologically relevant conditions. This study has 
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expanded the tool kits of protein labeling for potential applications in protein folding, 
protein trafficking etc. 
Lastly, with the PylRS-tRNAPyl pair, the histone PTMs which is known to play a 
very important in chromatin states and epigenetic regulations of gene expressions can be 
mimicked to help gain understanding on the complex networks of the PTMs. PTMs such 
as mono-methylation is a challenge to install into proteins because it differs from Lys by 
just one methyl group making it difficult to directly select or incorporate it. In this 
particular study, using the PylRS- Pyl
CUAtRNA  pair, the M1K was successfully incorporated 
at several Lys sites in histone H2A, H2B, H3 without the concern of Lys 
misincorporation. This work has allowed the intensive profiling of enzymatic substrate 
specificity across various mono-methyllysine sites on the histone substrates. This 
profiling will map out the effects of epigenetic erasers such as HKDMs. 
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